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An Investigation into Parental Well-Being and Child Behaviour in 
Phenylketonuria (PKU) 
Olivia Ambler 
 
Thesis abstract 
The current thesis was submitted on the 26
th
 May 2017 in partial fulfillment of the 
award of Doctor in Clinical Psychology (DClinPsy) at Cardiff University. The thesis 
is comprised of an abstract and three papers; paper one is a systematic review and 
paper two is an empirical study, both of which have been written in preparation for 
submission to the Journal of Inherited Metabolic Disease. Paper three is a critical 
review of the process of carrying out this work, with reflections on the challenges that 
arose and how these were resolved.  
 
The systematic review aimed to identify the factors that are associated with well-
being in parents who care for a child with PKU. Six electronic databases were 
searched (Scopus, PsycINFO, Medline, Embase, EBSCO Cinahl and Web of Science) 
of papers published between 1965 and November 2016. The search yielded 189 
articles; 15 were included in the final review. Quality ratings revealed six studies 
scored within the ‘moderate’ range and nine within the ‘high’ range.  Demographic 
variables were the most widely reported factor associated with parental well-being, as 
identified by seven studies. Social support was the next most reproducible factor 
associated with well-being, as identified by six studies. The clinical implications of 
these findings are discussed and recommendations are made for future research. 
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The aims of the empirical study were to identify what factors predict distress for 
parents who care for a child with PKU and to examine the incidence of behaviour 
problems in children with the condition. Thirty-eight parents of children and 
adolescents (up to and including 18 years old) with PKU and 32 parents in the general 
population participated in the study. Parents in both groups completed self-report 
measures of psychological resilience, child behaviour, perceived social support and 
psychological distress. Parents of children with PKU also completed measures of their 
child’s care dependency and behaviour related to developmental or intellectual 
disabilities. Findings from a multiple regression analysis showed that child behaviour 
related to anxiety and psychological resilience predicted 35% of the variance in 
distress scores for parents of children with PKU, whereas child behaviour and 
resilience predicted 19% of the variance in distress for parents in the general 
population. The implications of these findings are discussed with reference to further 
research and clinical practice.  
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Paper one 
 
A Systematic Review of the Factors Associated with Well-Being in Parents of 
Children with Phenylketonuria (PKU) 
 
Olivia Ambler and Dougal J Hare
*
 
Cardiff University, School of Psychology 
 
 
 
This systematic review has been written in preparation for submission to the Journal 
of Inherited Metabolic Disease. Please see Appendix 7 for a copy of the author 
guidelines. The word count in this version has been extended to provide additional 
context. 
  
 
Word count abstract: 250 
Word count excluding abstract, tables and references: 4,573 
Number of tables and figures: 4 
 
 
*Correspondence should be directed to: Dr Dougal Julian Hare, Research Director, 
South Wales DClinPsy Programme, 11
th
 Floor Tower Building, School of 
Psychology, Park Place, Cardiff University, Cardiff, CF10 3AT, 
HareD@cardiff.ac.uk. 
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Abstract  
Phenylketonuria (PKU) is an inherited metabolic condition that is diagnosed in 
infancy and requires life-long management. Parents of children with PKU are 
required to implement a strict diet and treatment regime during their offspring’s 
childhood and adolescence. If this is not adhered to, children with PKU can develop 
intellectual disabilities and other serious medical problems.  
 
This systematic review is the first to explore parents’ experiences of caring for a child 
with PKU, with the aim of identifying what factors are associated with psychological 
well-being. Six electronic databases were searched, yielding 189 articles. Inclusion 
criteria were studies that used a formal measure of psychological functioning with 
parents of children and adolescents with PKU. Fifteen articles were selected for 
inclusion in the review. Quality ratings were generally good; six studies scored in the 
‘moderate’ range and nine scored in the ‘high’ range. The findings revealed 
demographic variables were collectively the most widely reported factor associated 
with parental well-being, as identified by seven studies. Social support was the next 
most reproducible predictor of well-being, as identified by six studies. This has 
implications for the role of social networks in supporting families affected by PKU, 
particularly mothers and parents of young children. Future research should focus on 
building on this evidence base using longitudinal study designs and larger, more 
diverse samples. This may help gain a better understanding of the challenges parents 
face at different stages of their child’s development and how to tailor support 
appropriately. 
 
Keywords: Phenylketonuria, parents, well-being, social, support, demographic. 
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Synopsis: This systematic review identified that demographic information and social 
support were the two most widely reported factors associated with the well-being of 
parents who care for a child with PKU. 
 
Introduction  
Phenylketonuria (PKU) is a rare inherited genetic disorder that affects approximately 
1 in every 10,000 people in the UK (Cleary, 2015). The condition is caused by a 
deficiency of enzyme phenylalanine hydroxylase, which is needed to metabolise 
amino acid phenylalanine (Phe) into tyrosine (Blau et al 2010). In the absence of this 
enzyme, toxic levels of Phe can accumulate in the body causing neurological damage 
and the development of intellectual disabilities (Blau et al 2010). As Phe is found in 
many protein-rich foods, children with PKU are immediately started on a low-protein 
diet with amino acid supplements following diagnosis (Fidika et al 2013). Parents are 
responsible for closely supervising their child’s daily nutritional intake, attending 
regular clinic appointments and submitting the child’s blood samples to measure Phe 
levels against a target range (Medford et al under review). Providing this is managed 
well, children with PKU can develop intellectual abilities that are within the normal 
range for their age (MacLeod and Ney 2010).  
 
In light of the high responsibility placed on parents to manage the treatment regime, it 
is likely that caring for a child with PKU impacts on psychological well-being. 
Studies suggest that parents of children with PKU are more vulnerable to mental 
health difficulties and have poorer quality of life compared to those in the general 
population (Gunduz et al 2015; Mahmoudi-Gharaei et al 2011). Possible reasons for 
this include a sense of loss from not having given birth to a healthy child and varying 
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expectations around treatment, which are some of the major challenges highlighted 
for new parents of children with PKU (Awiszus and Unger 1990). In line with this, a 
significant proportion of parents report experiencing a trauma reaction upon learning 
their child had PKU, which can persist for years following the diagnosis (Lord et al 
2005). Given the chronic nature of the condition, parents are also likely to experience 
recurrent concerns about their child’s health and well-being (Streisand and Tercyak 
2004).    
 
To date, few studies have examined the predictors of parental well-being in PKU. 
Extant findings highlight that parental well-being is closely related to child age 
(Fidika et al 2013), with children’s older age significantly predicting parents’ quality 
of life (Ten Hoedt et al 2011). Other predictors of well-being include the parents’ 
higher educational attainment level (Gunduz et al 2015), larger social network size 
(Lord et al 2005) and less difficulty meeting the child’s health care needs (Waisbren 
et al 2004). In addition to this, some studies suggest psychological resilience, as 
measured by levels of personal hopefulness and resolution, predicts psychological 
distress in mothers of children with PKU (Lord et al 2008).  
 
Despite the range of factors found to impact on parents’ well-being, to date, the 
majority of meta-analyses and systematic reviews have focused on individuals with 
the PKU, as opposed to the wider family (Moyle et al 2007; Smith and Knowles 
2000). Moreover, there is a lack of consensus regarding what helps support parents 
with the emotional impact of caring for a child with PKU due to the diverse findings 
in the current literature. Therefore, in order to best support families affected by PKU, 
an understanding of the factors associated with parental well-being is warranted. The 
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aim of this paper is to provide the first systematic review of the available evidence to 
identify the factors associated with well-being in parents of children and adolescents 
with PKU. 
 
Method 
Literature search strategy 
A search was run on the 3
rd
 November 2016 of databases Scopus, PsycINFO, 
Medline, Embase, EBSCO Cinahl and Web of Science. The following search terms 
were used (with MeSH terms included): Phenylketonuria* or PKU or Phenylalanine* 
or hyperphenylalaninaemia and parent* or mother* or father* or matern* or patern* 
or guardian* or caretaker* or caregiver* and stress* or anxi* or depress* or 
well*being or distress*.  The initial search yielded 353 articles, which was reduced to 
164 after duplicates were removed. Inclusion criteria were studies with parents or 
carers of children and adolescents (up to and including 18 years old) with PKU, the 
use of a formal psychological functioning measure and publication in a peer-
reviewed, English language journal between 1965 and 3
rd
 November 2016. Exclusion 
criteria were: meta-analyses; reviews; conference or dissertation abstracts; editorials; 
case reports and periodicals. 
 
An overview of the search strategy is presented within the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) framework (Moher et al 2009) 
in Figure 1.  
 
-------------------------------------- Insert Figure 1 here --------------------------------------- 
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The first author (OA) screened titles and abstracts and selected relevant articles (N= 
32) for full text eligibility review. An independent researcher replicated this process 
and any discrepancies around eligibility were discussed and resolved. Inclusion and 
exclusion criteria were applied, resulting in the exclusion of 19 studies: eight 
conference and dissertation abstracts; two reviews; one article published in German 
language; one case study; one periodical; five studies that did not use a formal 
measure of psychological functioning and one study that did not include parents.  
 
The reference lists of relevant studies were searched, resulting in two additional 
articles. A final 15 studies were included in the review. Due to the heterogeneity in 
outcome measures and the lack of randomised controlled trials represented, it was not 
deemed appropriate to conduct a meta-analysis (Centre for Reviews and 
Dissemination 2009). Therefore, a systematic review of the studies was carried out.  
 
Quality assessment tool 
Study quality was assessed using the Quality Assessment Tool for Studies with 
Diverse Designs (QATSDD; Sirriyeh et al 2012). The QATSDD was chosen due to 
its applicability to a range of research designs and methodologies and good reliability 
and validity (Sirriyeh et al 2012). The first author assessed the studies against a 4-
point scale ranging from 0 (‘not at all’) to 3 (‘complete’) using the 14 QATSDD 
criteria for quantitative designs (Appendix 8). Studies were interpreted according to 
their quality ratings. For ease of reference, studies scoring between 0 and 14 were 
referred to as falling within a ‘low’ range, 15 and 28 within a ‘moderate’ range and 29 
and 42 within a ‘high’ range.  
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An independent researcher replicated the scoring process, rating five randomly 
selected studies. This demonstrated moderate inter-rater reliability (k= .55), with all 
scores within the same rating categories. 
 
Results 
Characteristics of studies 
Fifteen studies were identified through the search process, all of which utilised cross-
sectional designs (see Table 1). Five studies compared a sample of parents of children 
with PKU to a control group only (Bosch et al 2015; Gunduz et al 2015; Jusiene and 
Kučinskas 2004; Kazak et al 1988a; Kazak et al 1988b), six used no control or 
comparison group (Fidika et al 2013; Lord et al 2005; Lord et al 2008; Mahmoudi-
Gharaei et al 2011; Read 2004; Reber et al 1987), two compared the experimental 
group to parents of children with other genetic biochemical disorders (Read 2003; 
Waisbren et al 2004) and two compared the experimental group to parents of children 
with other neurodevelopmental and genetic biochemical disorders, in addition to 
controls (Kazak 1987; Ten Hoedt et al 2011). Three studies shared the same dataset 
(Kazak, Reber & Carter, 1988; Kazak, Reber & Snitzer, 1987; Reber, Kazak & 
Himmelberg, 1987). Studies were conducted in several countries including: Australia; 
Iran; France; Germany; Lithuania; Italy; Spain; the Netherlands; Turkey; the United 
Kingdom and the majority in the United States of America. Sample sizes ranged from 
29 to 253, representing a total of 1,125 parents of children and adolescents with PKU. 
The measure of psychological functioning varied across the studies; the majority 
examined psychological distress, some assessed parenting stress and others examined 
quality of life.  
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--------------------------------------- Insert Table 1 here --------------------------------------- 
 
Quality ratings 
Quality ratings ranged from 20 to 34, representing 48% to 81% of the maximum 
possible score of 42. The mean score was 28.6, which represented 68% of the 
maximum possible score. None of the studies scored within the ‘low’ range, six 
scored within the ‘moderate’ range (Gunduz et al 2015; Jusiene and Kučinskas 2004; 
Kazak 1987; Kazak et al 1988a; Mahmoudi-Gharaei et al 2011; Read 2003) and nine 
within the ‘high’ range (Bosch et al 2015; Fidika et al 2013; Kazak et al 1988b; Lord 
et al 2005; Lord et al 2008; Read 2004; Ten Hoedt et al 2011; Waisbren et al 2004; 
Reber et al 1987). No observable relationship emerged between the year of 
publication and the quality of studies reviewed.  
 
Reasons for lower ratings included limited or no justification for the choice of 
analytic method selected, incomplete recruitment data and little or no assessment of 
the quality of the measurement tools used (see Table 2). A few studies recruited large 
participant samples of >100 parents from a range of settings and several recruited 
small sample sizes of <50 parents, often from a single. Finally, only one study (Bosch 
et al 2015) provided evidence of user involvement in the study design and evidence 
that the sample size had been considered in terms of the analysis. As all the studies 
scored within the ‘moderate’ and ‘high’ categories, none were excluded on the basis 
of the quality ratings. Rather, the quality ratings were used to give due consideration 
to the robustness of the findings. 
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Research findings 
Study findings were organised according to the measure of psychological well-being 
employed, which included quality of life, parenting stress and psychological distress 
(see Table 3).  
  
--------------------------------- Insert Tables 2 and 3 here ------------------------------------ 
 
Quality of life 
Quality of life was measured in four studies. Quality of life in parents of children with 
PKU was comparable to the general population (Bosch et al 2015) and, in some cases, 
superior to control groups and parents of children with other biochemical genetic 
disorders (Ten Hoedt et al 2011). Both of these studies used large, representative 
samples and scored within the ‘high’ quality range of the QATSDD. One study 
reported worse quality of life in parents of children with PKU compared to the 
general population (Mahmoudi-Gharaei et al 2011). However, this study used a 
smaller, less representative sample than the other studies, and scored within the 
‘moderate’ quality range of the QATSDD.   
 
Three studies examined the predictors of quality of life using regression and linear 
mixed model analysis. A number of psychological variables were reported in the 
findings. Family stress was found to significantly predict parents’ quality of life in 
one study, which scored within the ‘high’ quality range of the QATSDD (Fidika et al 
2013) and depression was shown to significantly predict this is in another scoring 
within the ‘moderate’ quality range (Mahmoudi-Gharaei et al 2011). However, as 
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neither study used a control or comparison group, it is not possible to discern whether 
these trends are unique to caring for a child with PKU. 
 
Significant negative correlations were found between the psychological subscale of 
quality of life and stress, anxiety and depression and family history of substance 
misuse was significantly negatively related to total quality of life scores in one study 
(Mahmoudi-Gharaei et al 2011). However, 16.3% and 6.1% of the participants 
reported other chronic illnesses and psychological disorders within the family that 
were not controlled for by the researchers (Mahmoudi-Gharaei et al 2011). Therefore, 
these factors could have impacted on the findings reported. 
 
Children’s older age was significantly correlated with quality of life (Fidika et al 
2013; Mahmoudi-Gharaei et al 2011) and this was a significant predictor of mental 
health-related quality of life (Ten Hoedt et al 2011). Moreover, anxiety about blood 
Phe levels and guilt around poor adherence to the diet regime were identified as 
contributing to worse quality of life for parents (Bosch et al 2015). However, this was 
based on mean questionnaire scores as opposed to more formal methods of statistical 
analysis, which limits the conclusions that can be drawn from these findings (Bosch et 
al 2015).  
 
Social support predicted quality of life in two studies. Emotional support and loss of 
friendship were found to significantly predict mental health-related quality of life 
(Ten Hoedt et al 2011). Perceived social support was also shown to significantly 
predict parental quality of life and mediated the impact of family stress on this (Fidika 
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et al 2013). This trend was more pronounced for parents of younger children with 
PKU (Fidika et al 2013).  
 
Parenting stress  
Parenting stress was measured by four studies in total, all of which used the Parenting 
Stress Index. In general, parenting stress was low for parents of children with PKU, 
being reported as non-significantly different to a control group (Kazak et al 1988b) 
low in comparison to parents of children with clinically identified genetic disorders 
(Waisbren et al 2004) and low in comparison to mothers of children with 
mitochondrial diseases (Read 2003). Parents of children with PKU reported fewer 
worries about their child’s health and future, less difficulty meeting their child’s extra 
health care needs and a lower impact of the condition on all aspects of their personal 
lives compared to parents of children with mitochondrial diseases (Read 2003). 
However, the study participants were recruited through an online listserv (Read 
2003). This could have yielded a less representative sample by recruiting parents who 
have previous experience of participating in studies and are therefore likely to be 
highly motivated. 
 
The total number of child behaviour problems was significantly correlated with 
parenting stress (Reber et al 1987). However, Phe control, cognitive development and 
child IQ showed no significant association with parenting stress (Reber et al 1987). 
These findings contrast to those reported in another study, which used multiple 
regression analysis to identify the potential predictors of parenting stress in families 
affected by PKU compared to a range of other genetic biochemical disorders 
(Waisbren et al 2004). Child developmental level (as measured by adaptive 
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behaviour), satisfaction with social support and difficulty meeting the child’s health 
care needs significantly predicted parenting stress, together explaining 51% of the 
variance in scores (Waisbren et al 2004). Although these studies both scored within 
the ‘high’ quality range of QATSDD, they yielded different findings regarding the 
demands of managing treatment for PKU and parenting stress (Reber et al 1987; 
Waisbren et al 2004). This discrepancy could reflect the different times that two 
studies were carried out, as a number of refinements have made to the low-Phe diet 
over the past 60 years (Singh et al 2014). Therefore, it is possible that findings from 
earlier studies are less sensitive to the emotional impact of the treatment for PKU, as 
this was less restrictive at that time (Singh et al 2014). 
 
Psychological distress 
Ten studies measuring parents’ psychological distress were identified, with six 
measuring anxiety and depression, one assessing adjustment to the diagnosis of PKU 
and emotional stress, two examining trauma reactions and one assessing coping. 
Levels of anxiety and depression were elevated for parents of children with PKU 
compared to a control group (Gunduz et al 2015). However, distress levels for parents 
of children with PKU did not significantly differ to controls in two studies (Kazak 
1987; Kazak et al 1988b). In fact, fathers of children with PKU were reported to have 
the lowest levels of distress across all groups (Kazak 1987; Kazak et al 1988b). It 
bears consideration that these two studies emanated from the same research group, 
which used the same research methods and outcome measures. This could account for 
the similar findings reported (Kazak 1987; Kazak et al 1988b).  
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Trauma scores were generally low across the research findings, with only 12% of 
mothers and 5% of fathers scoring above the clinical cut-off for trauma (Lord et al 
2005). Fathers also reported better adjustment to their child’s diagnosis of PKU and 
lower distress levels compared to mothers (Lord et al 2008). The findings highlighted 
numerous demographic factors associated with distress. For example, family language 
background, specifically when the family’s first language was not English, 
significantly predicted trauma for fathers and distress for mothers (Lord et al 2005; 
Lord et al 2008).  
 
Mothers of children with PKU had significantly higher depression and anxiety scores 
compared to fathers and parents in control groups (Gunduz et al 2015) and fathers’ 
younger age significantly predicted their trauma scores (Lord et al 2005). Children’s 
younger age was significantly correlated with distress for both parents (Kazak 1987) 
and approached significance as a predictor of mothers’ trauma reactions (Lord et al 
2005). In line with this, one study reported trauma in response to being a PKU gene 
carrier significantly decreased over time, which may also reflect the impact of 
increasing child age (Read 2004). However, by contrast one study found no 
significant correlations between child age and parents’ anxiety and depression scores 
(Gunduz et al 2015). In addition to this, an ANCOVA for mothers’ stress and marital 
satisfaction, controlling for child age, found stress levels were still significantly 
higher than those reported for the control group (Kazak 1987). However, both of these 
studies scored within the ‘moderate’ quality range of the QATSDD and yielded low 
scores for the representativeness of the participant samples (Gunduz et al 2015; Kazak 
1987). By contrast, the former study scored within the ‘high’ quality range and used a 
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larger, more representative sample, which could account for the different trends 
reported (Read 2004).  
 
Families who experienced financial difficulties providing low-protein products for 
their child had significantly higher depression and anxiety scores compared to 
families who experienced little or no difficulties (Gunduz et al 2015). Belonging to a 
less skilled occupation group was a non-significant predictor of fathers’ distress, 
accounting for 10% of the variance in scores (Lord et al 2008). Similarly, lower 
academic attainment level significantly predicted anxiety and depression in parents of 
children with PKU (Gunduz et al 2015). In contrast to these findings, non-significant 
correlations were reported between parents’ distress levels and a range of 
demographic variables, including children’s age and gender, mothers’ age and 
education and fathers’ occupation (Gunduz et al 2015; Lord et al 2005; Lord et al 
2008).  
 
Aspects of parents’ social support networks were associated with psychological 
distress. Perception of their partner being less caring, smaller social networks and less 
satisfaction with social support were each significantly correlated with mothers’ 
trauma scores (Lord et al 2005). Smaller support networks and perception of their 
partner being less caring also significantly predicted trauma, accounting for 19% of 
the variance in mothers’ scores (Lord et al 2005). However, as these findings emanate 
from the same research group, it is possible that they represent the specific 
expectations of the authors or funding body, leading to circular lines of investigation. 
Additionally, the low prevalence of PKU in the general population could give rise to 
the same participants being recruited for studies in this field as a result of convenience 
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sampling as opposed to purposeful sampling. This too, could lead to repetitive 
findings being reported in the research literature. 
 
Personal stress and marital satisfaction were highly significantly negatively correlated 
for both mothers and fathers (Kazak 1987). One study found main effects for distress 
with smaller social networks and greater network density (Kazak et al 1988a). This 
trend was more pronounced for mothers of children with PKU than fathers, for whom 
there were main effects of network size but not density (Kazak et al 1988a). A 
possible reason for this trend is due to differences in the way mothers and fathers 
perceive and utilise social support (Kazak et al 1988a). 
 
Managing the treatment demands of PKU was associated with parents’ distress levels. 
For example, concerns about PKU, specifically around treatment adherence and the 
impact of PKU on the child’s health and well-being, were significantly correlated 
with trauma scores in parents (Lord et al 2005). However, one study found no 
significant correlation between psychological distress and markers of treatment 
adherence, including child IQ, Phe control and cognitive development (Reber et al 
1987). As previously stated, it is possible that these findings are influenced by 
changes to the low-Phe dietary guidelines over the past 60 years (Singh et al 2014).  
 
Psychological variables included low levels of personal hopefulness and lack of 
resolution to the diagnosis of PKU, which significantly predicted parents’ distress 
(Lord et al 2008). In addition, escape-avoidance coping was significantly correlated 
with reported distress (Lord et al 2008). Other findings show anxiety and depression 
were highly significantly correlated with each other (Gunduz et al 2015). Finally, 
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parents’ emotional coping was significantly correlated with children’s anxiety, 
depression, somatic complaints and internalising behaviours (Jusiene and Kučinskas 
2004). However, this study yielded a low quality score on the QATSDD and used a 
stress coping strategies questionnaire as opposed to a standardised measure of 
distress. Therefore, the findings are not directly comparable with those reported in the 
other studies. 
 
Discussion 
The aim of this systematic review was to identify the factors associated with 
psychological well-being in parents of children with PKU. Fifteen studies measuring 
quality of life, parenting stress and psychological distress were examined. The 
findings highlighted a range of factors associated with parents’ well-being, including: 
demographic variables; social support networks; psychological variables; child 
behaviour and the demands of managing treatment. Overall, the distribution of quality 
ratings was good. All studies were above the ‘low’ score category, six scored within 
the ‘moderate’ category and nine studies scored within the ‘high’ category.   
  
Demographic variables were the most widely reported factor associated with parents’ 
well-being, identified by seven of the reviewed studies. Four studies revealed 
demographic variables significantly predicted parental well-being and three reported 
statistically significant correlations. Demographic variables spanned a range of 
factors, including the family’s language background, socioeconomic status, 
occupation level, gender and age. A trend emerged whereby mothers were found to be 
more vulnerable to distress than fathers, which may reflect their greater involvement 
in caring for the child with PKU (Gunduz et al 2015). There was also a trend for 
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increasing child age to be associated with improved parental well-being. A potential 
explanation for this is that parents of younger children are still adapting to the protein-
restricted diet and may feel more uncertain about their child’s health and development 
(Ten Hoedt et al 2011). These findings are supported by studies with parents of 
children with developmental delay and type 1 diabetes, which highlight the role of the 
demographic variables in parenting stress and coping (Barak-Levy and Atzaba-Poria 
2013; Streisand et al 2005). However, it should be noted that three of the reviewed 
studies reported non-significant correlations between demographic factors and 
parental well-being. These inconsistent findings suggest that collectively, 
demographic variables may not be a robust determinant of parents’ well-being, but 
further research is needed to clarify this.   
 
Social support was the next most reproducible factor related to parental well-being, 
identified in six of the reviewed studies. Four studies used regression analysis and 
mixed model analysis, one used correlation analysis and one used an ANOVA. 
Larger, more dispersed social networks were associated with reduced psychological 
distress in parents, particularly mothers, and perceived social support mediated the 
impact of family stress on quality of life. This indicates that social support systems 
are protective for parents’ well-being and may enhance psychological resilience. 
Similar findings are reported in the literature on children with long-term conditions 
(Horton and Wallander 2001), including cancer and congenital heart disease 
(Speechley and Noh 1992; Tak and McCubbin 2002). A recent study by Thomas et al 
(2017) also found fewer people in the social network and poor satisfaction with social 
support were related to worse health related quality of life in parents of children with 
a range of inherited metabolic conditions.  
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The third most reproducible factor associated with parental well-being was 
psychological variables. Three studies found psychological variables significantly 
predicted well-being and one study reported a significant correlation. Following this, 
child behaviour and the demands of managing the diet and treatment regime for PKU 
were identified by three studies in relation to parental well-being. Two studies found a 
significant correlation between child behaviour and parental well-being and one study 
reported child developmental level (as measured by adaptive behaviour) was a 
significant predictor of well-being. In addition to this, one study found the demands of 
managing treatment for PKU significantly predicted well-being, another reported a 
significant correlation with well-being and one study reported guilt regarding poor 
treatment adherence and anxiety about blood Phe levels had the greatest impact on 
parents’ quality of life. Due to the low numbers of studies represented here, further 
research is needed to clarify the implications of these findings in relation to parental 
well-being.  
 
Limitations 
Firm conclusions cannot be drawn from the research findings due to heterogeneity in 
the study methodologies, outcome measures and statistical analyses used. For 
example, some studies examined data from parents of children with PKU only, whilst 
other studies pooled data from parents of children with a range of health conditions, 
including PKU, and compared this to controls. Overall, sample sizes were small and 
few studies provided detailed information on the sample characteristics. Moreover, 
many studies recruited families from a single clinic. This meant it was difficult to 
discern the representativeness of the samples included. However, it should be 
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acknowledged that the low prevalence of PKU limits the potential recruitment of 
large sample sizes with parents of children and young people. Finally, as was 
identified in the QATSDD ratings, very few studies considered the sample size in 
terms of the analysis, which may have limited the power of some statistical analyses.  
 
Recommendations for clinical practice 
There are a number of recommendations for professionals working in clinical settings 
based on the findings reviewed. For example, it may be beneficial for professionals to 
routinely assess parental well-being to identify individuals who require additional 
support. Health care staff should also be aware of the higher vulnerability of mothers 
and parents of younger children when supporting families affected by PKU. Families 
may benefit from support programmes that focus on empowering parents to actively 
seek out a range of social relationships and broaden their social networks (Fidika et al 
2013). It may also be beneficial to develop interventions that are tailored to managing 
the specific challenges parents face at different stages of their child’s development, 
however further research is warranted to clarify this.  
 
Recommendations for further research 
Further research in this area is needed to develop a better understanding of the 
different factors associated with well-being in parents of children with PKU. Studies 
with large, diverse sample sizes would help clarify the relationship between 
demographic variables and parental well-being in PKU. Longitudinal study designs 
would also be valuable for measuring changes to parental well-being over the course 
of the child’s condition, in order to identify the stages where additional support is 
needed (Fidika et al 2013). A small number of studies identified a link between 
29 
psychological variables, child behaviour, the demands of managing treatment and 
parental well-being. Further research into these factors is warranted to gain a more 
holistic understanding of how to support families affected by PKU.  
 
Conclusion 
This systematic review was the first to examine the factors associated with well-being 
in parents who care for a child with PKU. In summary, demographic variables and 
social support were the two most widely reported factors associated with parental 
well-being. There was a trend for parents’ well-being to improve with increasing child 
age and mothers were highlighted as more vulnerable to distress than fathers. This has 
implications for developing interventions in clinical practice that are tailored to the 
child’s developmental level and promote social support for parents. However, further 
studies are needed to build on this evidence base, to overcome the methodological 
variability and generate further recommendations around how best to support families 
affected by PKU.  
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Figure 1. PRISMA diagram demonstrating the search strategy (Moher et al 2009) 
Records identified through 
database searching (N= 353) 
S
cr
ee
n
in
g
 
In
cl
u
d
ed
 
E
li
g
ib
il
it
y
 
Id
en
ti
fi
ca
ti
o
n
 
Number of duplicates 
removed (N= 189) 
Records excluded (N= 132) 
 
 
 
Total number of full-text articles 
excluded (N= 19) 
 -8 conference/dissertation abstracts 
 -1 unavailable in English 
 -2 reviews 
 -1 periodical 
 -1 case report 
 -5 with no formal measure of 
psychological functioning  
 -1 without parents or carers 
 
Studies included (N= 13) 
Additional studies identified 
through reference checking 
(N= 2) 
Studies included in review 
(N= 15) 
Records screened using titles 
and abstracts (N= 164) 
Full-text articles assessed 
for eligibility (N= 32) 
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Table 1. Methodological characteristics of the reviewed studies 
 
No. Study Design Comparison group Country Primary aim Cohort characteristics 
 
 
Total 
score/ 
quality 
range 
1 Bosch AM, 
Burlina A, 
Cunningham 
A et al 
(2015) 
Cross-
section
al 
Un-matched control 
group 
7 
European 
countries 
control 
group 
recruited 
in USA 
To describe the health-
related quality of 
individuals with PKU 
and their families. 
N= 253 children with PKU 
N= 253 parents 
 
71% of children had mild-moderate PKU, 75% had 
classic PKU. 
 
27.3% of parents were male 
72.3% of parents were female 
32 
High 
2 Fidika A, 
Salewski C, 
Goldbeck L 
(2013) 
Cross-
section
al 
None Germany To describe predictors 
of quality of life in 
parents of children with 
PKU.  
N= 89 children with PKU 
N=89 parents 
 
51% of children female, 49% male. Age range of 
children was 0.8-19.2 years.  
 
Parent sample was 85.6% female, 14.6% male, 84.3% 
of parents had one child with PKU, 14.6% had more 
than one child with PKU, 98.9% of parents were 
Caucasian, 87.6% were married, 74.2% were 
employed, 64.1% had 8-10 years education, 35.9% had 
>10 years. 
31 
High 
3 Gunduz M, 
Arslan NM, 
Unal O, 
Cakar S, 
Kuyum P, 
Bulbul SF 
(2015) 
Cross-
section
al 
Un-matched control 
group 
Turkey To investigate the 
incidence of and risk 
factors for depression 
and anxiety in parents 
of children with PKU. 
N= 61 children with PKU 
N= 61 parents 
N= 36 control group parents 
 
Children were 1-11 years old, 32 male and 29 female.  
36 healthy children in control group. 
Parents were 28-40 years old, 18 were male, 43 female. 
7 families had more than one child with PKU. 
28 
Moderate 
36 
No. Study Design Comparison group Country Primary aim Cohort characteristics Total 
score/ 
quality 
range 
4 Jusiene R, 
Kučinskas V 
(2004) 
Cross-
section
al  
Matched control 
group 
 
Lithuania To investigate 
emotional and 
behavioural problems 
in children with PKU 
and parents’ 
adjustment to the 
child’s illness. 
N= 37 parents of children with PKU 
N= 37 control group parents 
 
Children were 4-14 years old. 20 female, 17 male. 
Treatment for PKU was started early and continued 
without interruption. 
 
Limited demographic information provided for parents. 
 
 
20 
Moderate 
5 Kazak AE 
(1987) 
Cross-
section
al  
Matched control 
group, parents of 
institutionalised 
individuals with 
‘mental retardation’ 
and spina bifida  
USA To explore personal 
stress, marital 
satisfaction and social 
networks in children 
with disabilities. 
N=43 PKU families maintained on a low Phe diet.  
N= 43 matched control group 
N= 36 ‘mentally retarded’ group 
N= 46 parents of children with spina bifida 
 
Age range of PKU children= 1-8 years, mean= 3 years.  
 
22 
Moderate 
6 Kazak AE, 
Reber M, 
Snitzer L 
(1988b) 
Cross-
section
al  
Matched control 
group  
USA To explore the 
relationships between 
psychological distress, 
parenting stress, 
marital satisfaction, 
child behaviour and 
family cohesion in 
parents of children with 
PKU and controls. 
N=45 children with PKU 
N= 45 parents (both parents completed the scales) 
N= 49 control parents and children 
 
Children were ages 6 and younger, mean age= 3.  
 
Average length of marriage= 7.5 years, number of 
children= 2.1, mother’s age= 28.8 years, father’s age= 
32.7 years, mother’s education= 12.9 years, father’s 
education= 13.1 years. Average family income= 
$25,575 USD 
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High 
37 
No. Study Design Comparison group Country Primary aim Cohort characteristics Total 
score/ 
quality 
range 
7 Kazak AE, 
Reber M, 
Carter A 
(1988a) 
Cross-
section
al  
Matched control 
group 
 
 
 
 
 
 
 
 
 
USA To explore 
characteristics of social 
networks in parents of 
children with PKU 
against a control group 
and to explore the 
relationships between 
distress and social 
networks. 
N=45 children, N= 45 parents, N= 49 controls  
 
Child ages= up to 6 years old, mean age= 3.  
Average age of mothers= 28.8 years, fathers= 32.7 
years. Average length of marriage= 7.5 years, number 
of children= 2.1 
 
Mother’s education= 12.9 years, father’s education= 
13.1 years. Average family income= $25,575 USD 
28 
Moderate 
8 Lord B, 
Wastell C, 
Ungerer J 
(2005) 
Cross-
section
al  
None Australia To investigate parent 
trauma reactions to 
PKU and the nature of 
their concerns about 
PKU. 
N= 67 parents (65 mothers, 61 fathers) 
Age range of mothers = 19-51 years old, fathers= 25-
51 years old. Child ages= 3 months-12 years old.  
 
All children were on a treatment plan for PKU. 
25% of mothers and 33% of fathers had migrated to 
Australia from overseas. 95% of fathers and 49% of 
mothers were in the paid workforce.   
 
 
34 
High 
9 Lord B, 
Ungerer J, 
Wastell C 
(2008) 
Cross-
section
al  
None Australia To examine parents’ 
resolution of the 
diagnosis of PKU, 
personal hopefulness, 
stress coping strategies 
and child and parent 
outcomes. 
N= 55 children, N= 55 parents (52 mothers, 47 
fathers). Child ages= 2-12 years old, parent ages= 24-
51 years old. 
 
93% of children had classic PKU. 
31% mothers and 26% fathers had migrated from 
overseas, 94% of fathers and 56% of mothers were in 
the paid workforce, 60% of fathers and 50% of mothers 
had completed tertiary education. 
 
33 
High 
38 
No. Study Design Comparison group Country Primary aim Cohort characteristics 
 
 
Total 
score/ 
quality 
range 
10 Mahmoudi-
Gharaei J, 
Mostafavi S, 
Alirezaei N 
(2011)  
  
Cross-
section
al 
None Iran 
 
To investigate quality 
of life, anxiety and 
depression in parents of 
children with PKU. 
N=49 parents, mean age 35.63 years old (59.2% were 
mothers, 40.8% were fathers). 
 
Mean age of children = 9.84 years old. 
51% were female, 49% male (number of children not 
stated). 
 
16.3% and 6.1% of participants reported another 
chronic illness and severe psychiatric disorder in their 
first-degree family members. 22.4% of participant 
family members had a history of substance misuse.  
23 
Moderate 
11 Read CY 
(2003) 
Cross 
section
al  
Mothers of children 
with mitochondrial 
disease 
USA To compare the impact 
of disease and 
dependence on health 
services in mothers of 
children with 
mitochondrial disease 
and PKU. 
N= 29 mothers of children with PKU, age range 20-58 
years old, 76% were married. 
 
N= 29 mothers of children with mitochondrial disease. 
 
Children age range= 0-18 years old (55% girls, 45% 
boys), 90% Caucasian. 57% of mothers Catholic, 29% 
Protestant, 14% other.  
 
25 
Moderate 
12 Read CY 
(2004) 
Cross-
section
al  
None USA To investigate the 
psychological impact 
of being a PKU gene 
carrier 
N= 83 parents, mean age was 38 years old, mean time 
since diagnosis was 9 years (range= 1-42 years). 
 
 
 
 
34 
High 
39 
No. Study Design Comparison group Country Primary aim Cohort characteristics 
 
 
Total 
score/ 
quality 
range 
13 Ten Hoedt 
AE, 
Maurice-
Stam H, 
Boelen CCA 
et al (2011) 
Cross-
section
al  
Parents of children 
with galactosemia, 
un-matched control 
group, parents of 
children with 
lysosomal storage 
diseases, 
organic acidurias or 
mitochondrial 
respiratory chain 
defects. 
The 
Netherla
n-ds 
To investigate health-
related quality of life in 
parents of children with 
PKU and galactosemia 
compared to parents of 
healthy children and 
children with other 
metabolic diseases. 
N= 116 parents of children with PKU 
N= 69 parents of children with galactosemia 
N= 434 control parents 
N= 108 parents of children with other metabolic 
diseases 
 
PKU parent sample: 43.1% male, 56.9% female, 35.3% 
high education level, 39.7% middle, 25% low. 94% of 
parents were born in the Netherlands. 7.8% of parents 
had another chronic disease. 
 
Child ages= 1-19 years old. 
30 
High 
14 Waisbren 
SE, Noel K, 
Fahrbach K 
et al (2004) 
Cross-
section
al  
Parents of children 
with 38 biochemical 
genetic disorders, 
including: 
galactosemia; 
arginosuccinic 
academia; glutaric 
acidemia types I and 
II; chain 
acyl-CoA 
dehydrogenase 
deficiency and maple 
syrup urine disease. 
USA To examine the 
predictors of parenting 
stress in parents of 
children with 
biochemical genetic 
disorders. 
N= 112 parents (89% mothers, 10% fathers, 1% 
grandparents). 
 
Median family size= 2 children, 54% of children boys, 
46% girls, age range= 6 months-18 years old.  
 
91% of sample families were white, 6% Hispanic, and 
2% African American and middle class. 75% were 
married, with a median family size of 2 children. 
30 
High 
15 Reber M, 
Kazak AE, 
Himmelberg 
P (1987) 
Cross-
section
al 
None USA To investigate the 
impact of caring for a 
chronically ill child on 
family functioning. 
N= 41 children, < 8 years old, classic or atypical PKU, 
N= 41 parents 
Mean family income = $25,000, maternal/ paternal 
education = 12.9/ 13.1 years. 
30 
High 
40 
 
Table 2. QATSDD item scores  
 
 
 
 
 Study number 
QATSDD criteria item 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1. Explicit theoretical framework 2 3 1 3 3 3 3 3 3 2 1 3 2 3 3 
2. Statement of aims/objectives in main body of the 
report 
3 3 3 2 3 3 3 3 3 2 3 3 2 3 3 
3. Clear description of research setting 2 3 3 2 1 3 3 3 3 3 2 3 3 3 3 
4. Evidence of sample size considered in terms of 
analysis 
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
5. Representative sample of target group of a 
reasonable size  
3 2 2 1 1 1 1 2 2 1 1 2 3 3 1 
6. Description of procedure for data collection 1 3 2 1 2 2 2 3 2 2 2 3 3 2 3 
7. Rationale for choice of data collection tool(s) 3 2 3 2 3 3 3 3 3 2 2 3 3 3 3 
8. Detailed recruitment data 2 3 2 1 1 2 2 2 2 1 1 3 2 2 2 
9. Statistical assessment of reliability and validity of 
measurement tools  
1 0 1 0 1 3 2 3 3 1 3 3 1 2 3 
10. Fit between stated research question and method 
of data collection  
3 3 3 2 3 3 3 3 3 3 3 2 3 2 3 
11. Fit between research question and method of 
analysis 
3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 
12. Good justification for analytical method selected 3 3 2 1 0 1 1 3 3 1 2 3 3 1 0 
13. Evidence of user involvement in design 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
14. Strengths and limitations critically discussed 3 3 3 2 1 2 2 3 3 2 2 3 2 3 3 
Total score 32 31 28 20 22 29 28 34 33 23 25 34 30 30 30 
41 
 
Table 3. Overview of the study findings 
 
No. Cohort 
size of 
parents 
Age 
range of 
children 
Measure of 
psychological 
functioning 
Measurement tool Analysis 
 
 
Overview of the factors associated with psychological 
functioning 
1 253 9-17+ 
years old 
Quality of life  
 
PKU-Quality of 
Life (PKU-QOL) 
Descriptive statistics were used to document 
mean quality of life scores across samples.  
 
Mean domain scores were interpreted 
according to reference values from general 
population samples for PedsQL, the SF-36 and 
CHQ-PF28. 
 
The highest impact scores on PKU-QOL for parents 
were on for the following domains:  
 
-Guilt if low-protein diet is not followed 
-Guilt if poor adherence to supplements  
-Anxiety about blood Phe levels 
 
 
2 89 0.8-19.2 
years old 
 
Quality of life  
  
 
 
Ulm Quality of Life 
Inventory for 
Parents of 
Chronically Ill 
Children  
ANOVAs and Pearson’s correlations were 
used to assess impact of socio-demographic 
variables on quality of life.  
 
Multiple regression analysis measured the 
predictors of quality of life. Simple mediation 
analysis to examine the relationship between 
social support, perceived stress and quality of 
life. Significance was set at p< .05 level. 
Factors linked to quality of life: 
 
-Parent age and child age  
-Perceived social support 
-Family stress  
 
Perceived social support mediated the impact of family 
stress on quality of life. 
3 61 1-11 
years old 
Anxiety and 
depression 
Beck Depression 
Inventory and the 
State Trait Anxiety 
Inventory 
Pearson’s correlation, Student t-test and 
Mann-Whitney U-test were used to compare 
mean depression and anxiety scores. Multiple 
regression analysis was used to examine the 
predictors of anxiety and depression. Scores 
were interpreted at the p< .05 level. 
Factors linked to anxiety and depression:  
 
-Parents with a lower academic attainment level  
-Difficulty providing low protein products  
-Parenting a child with ‘mental retardation’  
-Depression and anxiety  
42 
No. Cohort 
size of 
parents 
Age 
range of 
children 
Measure of 
psychological 
functioning 
Measurement tool Analysis 
 
Overview of the factors associated with psychological 
functioning 
 
4 37 4-14 
years old 
Coping Coping Strategies 
Questionnaire 
The Student t-test and Mann-Whitney U-test 
were used to compare mean scores on the 
questionnaire domains between the samples. 
Pearson’s correlation was used to examine the 
relationships between scores on the coping 
strategies questionnaire and child behaviour 
checklist. Chi square analysis was used to 
explore the association between variables; 
multiple regression analysis was used to 
examine the predictors of psychological 
adjustment in children with PKU. Scores were 
interpreted at the p< .05 level. 
Parents who reported feeling anger and guilt also 
reported significantly more child behavior problems on 
the following domains:  
 
-Withdrawn behaviour 
-Anxious or depressed behaviour 
-Social problems 
-Attention problems 
-Internalising behaviours  
-Total number of behavior problems 
 
Child anxiety, depression, somatic complaints and 
internalising behaviour were significantly correlated with 
emotional coping in parents. 
5 43 1-8 years 
old  
Anxiety and 
depression  
 
The Langner 
Symptom Checklist 
Pearson correlations and Hotelling’s T were 
used to examine the relationships between 
child age, personal stress, marital satisfaction 
and social network variables.  
 
An ANCOVA was used to explore the 
relationship between mothers’ stress and 
marital satisfaction, controlling for child age. 
Scores were interpreted at the p< .05 level. 
Factors linked to anxiety, depression and personal stress:  
 
-Mothers  
-Marital satisfaction  
-Child age  
 
No significant differences between the groups were 
found for marital satisfaction, social network size or 
density or fathers’ personal stress. 
6 45 0-6 years 
old  
Anxiety, 
depression and 
parenting 
stress. 
The Langner 
Symptom Checklist 
and the Parenting 
Stress Index 
Pearson correlations and Hotelling’s T were 
used to compare distress, marital satisfaction, 
parenting stress and family cohesion. Student 
t-test was used to compare mean scores. 
Statistical significance was set at the p< .05 
level.  
No significant differences were found between groups in 
terms of distress, marital satisfaction, parenting stress 
and family cohesion.  
 
Mothers were more distress than fathers in PKU sample. 
PKU fathers had lowest distress levels across all groups. 
Parenting stress was within normal limits for all groups. 
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No. Cohort 
size of 
parents 
Age 
range of 
children 
Measure of 
psychological 
functioning 
Measurement tool Analysis 
 
Overview of the factors associated with psychological 
functioning 
 
7 45 0-6 years 
old  
Anxiety and 
depression  
The Langner 
Symptom Checklist 
Hotelling’s T was used to compare social 
network size and density between the groups.  
 
ANOVAs compared the relationships between 
distress and social network characteristics. 
Student t-tests were used to compare group 
differences in social network characteristics, 
p< .05. 
 
No differences between social network structure 
characteristics between PKU families and controls.  
 
Main effects found for total network size and density for 
mothers’ distress. For fathers’ distress, main effects were 
found for total network size but not density. 
 
 
8 67 3 months 
-12 years 
old  
Trauma Impact of Events 
Scale 
Pearson correlations were used to look at the 
relationships between trauma, demographic 
variables and concerns about PKU.  
 
Multiple regression analysis was used to 
examine the predictors of trauma reactions. 
Scores were interpreted at the p< .05 level for 
statistical significance. 
Factors linked to trauma: 
 
-Concerns about PKU 
-Less satisfaction with social support 
-Perceptions of partner as less caring  
-Smaller social networks  
-Children’s younger age  
-Severity of PKU  
-Fathers’ younger age  
-Fathers’ family language background  
9 55 2-12 
years old 
Resolution/ 
adjustment to 
diagnosis of 
PKU & 
emotional 
stress  
Interviews and the 
Malaise Inventory 
Hierarchical regression was used to examine 
the predictors of distress.  Student t-tests, 
ANOVAs, Chi square and Spearman’s 
correlation analyses were used to compare 
relationships between variables.   
 
Scores were interpreted at the p< .05 level for 
statistical significance. 
Factors linked to distress: 
 
-Mothers 
-Family language background  
-Low personal hopefulness  
-Low resolution to diagnosis  
-Occupation level  
-Escape-avoidance coping  
 
Personal hopefulness was significantly related to total 
child behaviour problems.  
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No. Cohort 
size of 
parents 
Age 
range of 
children 
Measure of 
psychological 
functioning 
Measurement tool Analysis 
 
 
Overview of the factors associated with psychological 
functioning 
 
10 49 
 
Not 
stated 
Quality of life, 
anxiety and 
depression 
   
WHOQOL-BREF 
and the  
Depression and 
Anxiety Stress 
Scale 
Pearson and Spearman correlation analysis 
was used to compare findings between 
different groups. Stepwise linear regression 
analysis was used to examine the predictors of 
quality of life.  Scores were interpreted at the 
p< .05 level for statistical significance. 
Factors linked to lower quality of life levels: 
 
-PKU families 
-History of substance misuse  
-Child age  
-Depression and anxiety 
 
 
11 29 0-18 
years old 
Parenting 
stress 
 
Parenting Stress 
Index Short-Form 
Pearson correlation analysis and two sample t-
tests were used to compare scores on 
parenting stress, child adjustment and the 
demands of caring for the child between 
parents of children with PKU and parents of 
children with mitochondrial disease. Statistical 
significance was interpreted at the p< .00001 
level. 
 
 
 
 
Factors linked to reduced parenting stress: 
 
-Use of fewer health care services  
-Less worry about the child 
-Little difficulty meeting their child’s extra care needs  
-Lower impact of the disease on aspects of personal life  
-Fewer psychoaffective and socioeconomic strains 
 
 
 
12 83 Not 
stated 
Trauma Impact of Events 
Scale 
Student’s t-test was used to compare trauma 
scores between two time points.  
 
Paired samples t-tests were also used to 
compare subscale scores with the change in 
trauma levels over time. Statistical 
significance was interpreted at the p< .01 
level. 
 
Trauma scores around the impact of being a PKU gene 
carrier significantly decreased over time, particularly 
scores on the intrusion and avoidance subscales.  
 
This relationship was not significantly correlated with 
age of the parent, number of years since the diagnosis or 
the health or development of the child.  
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No. Cohort 
size of 
parents 
Age 
range of 
children 
Measure of 
psychological 
functioning 
Measurement tool Analysis 
 
 
Overview of the factors associated with psychological 
functioning 
 
13 116 1-19 
years old 
Quality of life TNO-AZL 
Questionnaire for 
Adult’s Health 
related Quality of 
Life 
Chi square and ANOVAs were used to test 
group differences on socio-demographic 
characteristics, with significance at p< .01 
level. ANOVAs by group and gender were 
conducted to test group differences on health-
related quality of life scores, with significance 
set at p< .001. Linear mixed model analysis 
was used to examine the predictors of mental 
health-related quality of life for parents of 
children with PKU and galactosemia. 
Statistical significance was set at the p< .05 
level. 
Parents of children with PKU reported higher quality of 
life scores than controls in 8 out of 12 of the 
questionnaire domains (p<0.001).  
 
Mental health-related quality of life was predicted by:  
 
-Children’s older age 
-Emotional support  
-Loss of friendship   
-Perception of the disease development as stable over the 
past year  
14 112 6 months 
-18 years 
old 
Parenting 
stress  
Parenting Stress 
Index-Short Form 
Student t-tests were used to compare child 
developmental level, parenting stress, timing 
of diagnosis and treatment for PKU.  Pearson 
correlations were used to measure associations 
between difficulties meeting the child’s health 
care needs, social support and parenting stress. 
Multiple regression analysis was used to 
determine the predictors of parenting stress, 
with p< .001 set for statistical significance. 
Parenting stress predicted by: 
 
-Child developmental level (as measured by adaptive 
behaviour)  
-Satisfaction with social support  
-Difficulty meeting the child’s health care needs  
 
Parents of children with PKU had significantly lower 
levels of parenting stress, fewer difficulties meeting their 
child’s health care needs and higher levels of social 
support compared to parents of clinically identified 
children. 
15 41 <8 years 
old 
Anxiety and 
depression and 
parenting 
stress. 
The Langner 
Symptom Checklist 
and the Parenting 
Stress Index 
Pearson’s correlation was used to examine 
mothers’ and fathers’ scores for: distress; 
parenting stress; family cohesion and 
adaptability; marital satisfaction; child 
behaviour; demographic variables and child 
cognitive development scales. Significance 
was set at the p< .05 level. 
Significant positive correlation between total child 
behaviour problems and parenting stress. 
 
No significant correlations between Phe control and 
distress, parenting stress, marital adjustment, family 
cohesion and adaptability. Psychological distress and 
parenting stress was not correlated with children’s IQ, 
cognitive development or disease management. 
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Abstract  
Phenylketonuria (PKU) is an inherited metabolic condition that can lead to the onset 
of intellectual disabilities if not strictly managed through a low-protein diet. Parents 
are responsible for supervising their child’s treatment for PKU, which may impact on 
their experience of distress (Gunduz et al 2015). This cross sectional study aimed to 
identify the factors that contribute to distress in parents who care for a child with 
PKU, distinct from parents in the general population. Thirty-eight parents of children 
and adolescents with PKU and 32 parents in the general population completed 
questionnaires measuring psychological resilience, child behaviour problems, 
perceived social support and distress. Parents of children with PKU also completed 
measures of their child’s care dependency and behaviour related to developmental and 
intellectual disabilities. The findings revealed no statistically significant differences in 
distress between the groups, but parents of children with PKU reported more child 
behaviour problems. Multiple regression analysis identified that psychological 
resilience and child anxious behaviour explained 35% of the variance in distress for 
parents of children with PKU. By comparison, psychological resilience and generic 
child behaviour only accounted for 19% of the variance in distress for parents in the 
general population. This has implications for developing interventions in clinical 
settings that aim to reduce parents’ distress by enhancing their psychological 
resilience and supporting them to manage child behaviour difficulties, particularly 
anxious behaviour. Future research should include larger, more diverse samples and 
use longitudinal study designs.  
 
Keywords: Phenylketonuria, parents, child, distress, behaviour, resilience. 
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Synopsis: This research study identified that psychological resilience and child 
anxious behaviour predict 35% of the variance in distress experienced by parents of 
children with PKU, whereas generic child behaviour problems and resilience account 
for 19% of the variance in distress for parents in the general population. 
 
Introduction 
Phenylketonuria (PKU) is a rare metabolic condition that is diagnosed in infancy and 
requires life-long management (Cleary 2015). The condition is caused by a deficiency 
or absence of phenylalanine hydroxylase, an enzyme needed to convert amino acid 
phenylalanine (Phe) into tyrosine (Moyle et al 2007). In the absence of this enzyme, 
toxic levels of Phe accumulate in the central nervous system, leading to irreversible 
damage to brain structures and cognitive function (Blau et al 2010). As Phe is found 
in protein-rich foods, the main form of treatment for PKU is a protein-restricted diet 
with amino acid supplements (Campbell and Ross 2003). Parents are responsible for 
managing their child’s treatment for PKU, which involves supervising their diet, 
regularly meeting with health professionals and submitting blood samples to measure 
Phe concentrations (Campbell and Ross 2003). Due to this high level of responsibility 
and the adverse consequences of poor compliance, caring for a child with PKU is 
likely to impact on levels of psychological distress experienced by parents. 
 
‘Psychological distress’ is defined as ‘a state of emotional suffering characterised by 
symptoms of depression (lost interest; sadness; hopelessness) and anxiety 
(restlessness; feeling tense)’ (Drapeau et al 2012; Mirowsky and Ross 2002). This 
concept is widely used as an indicator of mental health status in clinical, population 
and intervention studies (Drapeau et al 2012). Research into psychological distress 
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has encompassed a range of outcome measures, such as measures of stress, quality of 
life, well-being and depression (Massé et al 1998; Ridner 2004).  
 
To date, few studies have examined distress in parents of children and young people 
with PKU. Moreover, the extant research has yielded inconsistent findings. Parents of 
children with PKU report higher levels of depression and anxiety compared to the 
general population (Mahmoudi-Gharaei et al 2011), but other studies suggest parents’ 
well-being is comparable to control groups (Kazak et al 1987), and in some cases, 
superior to parents of children with other biochemical disorders (Ten Hoedt et al 
2011). These inconsistent findings could reflect methodological issues such as the 
diverse range of outcome measures used across studies, some of which may not be 
sensitive to the specific impact of PKU on psychological functioning (Bosch et al 
2015). To overcome this limitation, a recent large-scale international study developed 
a PKU-specific questionnaire measuring quality of life in patients and their parents 
(Bosch et al 2015). The findings revealed that mean scores on generic quality of life 
domains were comparable to the general population. However, parents of children 
with PKU reported a high emotional impact of the condition, anxiety around blood 
Phe concentrations and guilt if the diet was not adhered to (Bosch et al 2015). 
 
In order to support parents with the specific challenges of caring for a child with 
PKU, first it is necessary to understand the different factors that contribute to distress. 
Findings from research into long-term conditions, such as asthma, indicate that a 
sense of coherence and family hardiness predicts parental well-being (Svavarsdottir et 
al 2000). High levels of parenting stress have also been reported in parents of young 
children with type 1 diabetes (Streisand et al 2005). Satisfaction with social support 
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was associated with parental quality of life in research on a range of inherited 
metabolic conditions (Thomas et al 2017). Similar findings are reported in the 
research literature on PKU, with younger child age (Ten Hoedt et al 2011) and levels 
of personal hopefulness predicting parents’ distress (Lord et al 2008). Moreover, child 
adaptive functioning, satisfaction with social support and difficulty meeting the 
child’s health care needs were found to account for 50% of the variance in parenting 
stress (Waisbren et al 2004). However, these findings are not consistent across 
studies, as some report non-significant relationships between demographic variables, 
the demands of managing treatment and parental distress (Gunduz et al 2015; Reber et 
al 1987). Other findings suggest that although psychological resilience is a significant 
predictor of parents’ distress, social support and child dependency are not (Medford et 
al under review). A recent systematic review also identified a number of limitations in 
the current literature, including heterogeneity in study methodologies, small sample 
sizes and an overall lack of studies (Ambler and Hare in press). This highlights a need 
for more rigorous research to identify the factors that contribute to distress in parents 
of children and young people with PKU.  
 
Another factor that could affect distress in parents of children who have long-term 
conditions is the presence of child emotional and behavioural problems (Craig et al 
2016). Children with PKU are reported to present 1.5-1.9 times the rate of behaviour 
problems observed in the general population (Smith and Knowles 2000). Findings 
across studies indicate high rates of internalising problems, such as depression and 
anxiety (Jahja et al 2013), reduced social competence and lack of autonomy in this 
clinical population (Brumm et al 2010). Moreover, individuals with PKU were found 
to be twice as likely to exhibit repetitive movements (Klaverboer et al 1994) and 
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impulsive behaviour compared to control groups (Christ et al 2006; Smith et al 1988). 
This could be due to a number of reasons. Elevated Phe levels have been linked to a 
reduction in the concentration of neurotransmitters dopamine and serotonin, which are 
involved in mood regulation and executive functioning (Kolb and Whishaw 2003). 
High blood Phe has also been associated with increased rates of anxiety and 
depression in children with PKU (Ten Hoedt et al 2011) and executive functioning 
deficits, such as reduced inhibitory control (Albrecht et al 2009). Alternatively, other 
studies report more internalising problems for adolescents with good dietary 
adherence, suggesting that the restrictive nature of the diet itself could impact on 
behaviour (Cappelletti et al 2013).  
 
However, the implications of these findings are limited due to poor experimental 
control in many of the studies (Christ et al 2006) and an overall lack of research in 
this area (Smith and Knowles 2000). Moreover, few studies have examined the 
impact of child behaviour on parents’ distress and many of the extant findings are 
correlational, making it difficult to infer a causational relationship (Reber et al 1987). 
Therefore, in order to identify how best to support families affected by PKU, further 
research into child behaviour and the impact of this on parents’ distress is warranted. 
 
The aims of the current study were to: (i) determine whether parents of children with 
PKU are more vulnerable to distress compared to those in the general population (ii) 
to examine behaviour problems experienced by children with PKU in comparison to 
their control peers and (iii) to identify what factors predict distress in parents of 
children with PKU, distinct from parents in the general population. It was 
hypothesised that parents of children with PKU would report higher levels of distress 
 52 
compared to parents in the general population and a higher incidence of child 
behaviour problems. It was also hypothesised that child behaviour problems and 
psychological resilience would predict distress in parents of children with PKU.  
 
The current study was carried out in conjunction with two other research studies at the 
University of Manchester investigating treatment adherence, psychological well-being 
and parents’ experiences of caring for a child with in PKU (Medford et al under 
review; Carpenter et al in press).  
 
Method 
Participants  
Experimental group 
Parents of children and adolescents were invited to participate in the study if their 
child was between 0 and 18 years old and had a formal diagnosis of PKU. Exclusion 
criteria were the presence of any other physical or mental health difficulties or 
significant caring responsibilities that could impact on parents’ distress levels.  
 
Control group 
Parents of children and adolescents were invited to participate if their child was 
between 0 and 18 years old and did not have a diagnosis of PKU, or any other 
physical health condition. Parents were also invited to participate if they were not 
affected by any other significant caring responsibilities, or any physical or mental 
health problems that could impact on distress levels. 
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Measures 
Demographic information 
A demographic questionnaire (Medford et al under review) was used to obtain 
information such as parent age, child age, average family income and highest 
qualification (see Appendix 1 for questionnaires).   
 
Psychological distress 
The General Health Questionnaire (GHQ-12) was used to measure psychological 
distress (Goldberg and Williams 1998). Higher scores on this self-report measure 
indicate a greater severity of distress (anxiety and depression), with scores above 12 
indicating distress within the clinical range (Goldberg et al 1997). The GHQ-12 has 
shown good reliability and validity (Missen et al 2012), with an internal consistency 
of α= 0.70 (Kim et al 2013).  
 
Psychological resilience 
The Resilience Scale for Adults (RSA) is a self-report measure of psychological 
resilience. It has six subscales: perception of self; social competence; structured style; 
planned future; social resources and family cohesion (Friborg et al 2005). Higher 
scores indicate higher levels of resilience. Scores were summed across the subscales 
to provide a total score for resilience in this study. Studies show good internal 
consistency for total scores on the RSA (α= 0.93; Friborg et al 2003).  
 
Perceived social support 
The Multidimensional Scale of Perceived Social Support (MSPSS) was used to 
measure levels of perceived social support (Zimet et al 1988). The MSPSS has three 
 54 
subscales: significant other, friends and family. It is scored using a 1-7 point likert 
scale; the sum of subscale scores provides a total score for perceived social support. 
The MSPSS has demonstrated good psychometric properties and internal consistency 
(α= 0.88; Zimet et al 1988).  
 
Child behaviour 
The Eyberg Child Behavior Inventory (ECBI) is a parent-report questionnaire 
measuring disruptive behaviours in children ages 2-16 (Eyberg and Ross 1978). The 
ECBI has two subscales: an intensity scale to measure the frequency of behaviour 
problems and a problem scale to assess whether parents perceive their child’s 
behaviour as a problem. Higher scores on the questionnaire indicate higher levels of 
behaviour problems, with a cut-off score of 131 for disruptive behaviour on the 
intensity scale and 15 on the problem scale. High internal consistency scores are 
reported for the intensity subscale (α= 0.94) and the problem subscale (α= 0.92; 
Axberg et al 2008).  
 
The Developmental Behaviour Checklist Parent/Carer Version (DBC) was used to 
assess behaviour related to developmental disorders in families affected by PKU. This 
questionnaire measures the incidence of child behaviour and emotional problems over 
a six-month period, for children ages 4-18 (Einfeld and Tonge 1995). There are five 
subscales: disruptive/ antisocial; self-absorbed; communication disturbance; anxiety 
and social relating. A total score can also be calculated, with a clinical cut-off of 46 
for behaviour relating to intellectual or developmental disabilities. The questionnaire 
has demonstrated good psychometric properties, with internal consistencies ranging 
between α= 0.66 and α= 0.91 for individual subscales (Einfeld and Tonge 2002).  
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Child dependency 
A child dependency questionnaire was developed by Medford et al (under review) to 
measure how much a child depends on their caregiver to adhere to a low protein diet. 
Scores on this questionnaire range from 1-7, with higher scores indicating higher 
levels of the child’s care dependency. 
 
Procedure 
Recruitment 
To recruit parents of children with PKU, an advert for the study was posted on the 
National Society for Phenylketonuria (NSPKU) website, newsletter and online social 
media sites (Twitter and Facebook; see Appendix 2). The NSPKU is a UK-based third 
sector organisation that provides support to parents, professionals and adults affected 
by PKU. The researcher (OA) also attended three events organised by the NSPKU, 
including two conferences and a community event, to raise awareness of the study. 
Study adverts were displayed on the Cardiff University premises to recruit parents in 
the general population (Appendix 3). Any parents seeking further information were 
encouraged to contact the researcher using the email address displayed on study 
adverts. 
 
All eligible parents were posted a questionnaire pack containing the research 
questionnaires, participant information sheets and a consent form (see Appendix 4 
and 5). For parents in the general population, questionnaires included the GHQ-12, 
RSA, MSPSS and the ECBI. Parents of children with PKU were asked to complete 
the same questionnaires as those in the general population, with the addition of the 
DBC and the child dependency questionnaire. All parents were provided with a pre-
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stamped envelope to return the completed questionnaires and consent forms to the 
researcher. An opt-out form was also provided for parents to fill in and return if they 
no longer wished to participate in the study. An additional questionnaire pack was 
sent with a reminder letter (Appendix 5.8) if the initial questionnaire pack was not 
responded to. 
 
Once data collection was complete, all parents were entered into a prize draw to win a 
£100 shopping voucher.  
 
Approval for the study was gained from Cardiff University School of Psychology 
Ethics Committee (EC.16.07.12.4554A2; see Appendix 3). 
 
Statistical Analysis 
Scores were non-normally distributed for all parent-report measures in the 
experimental group except for ECBI intensity subscale and RSA total score, which 
were normally distributed (see Appendix 6 for all SPSS output). Subscale scores for 
the MSPSS and the child dependency scale were positively skewed. Scores on all 
subscales of the DBC were negatively skewed, as were scores for the GHQ-12 and the 
ECBI problem subscale. 
 
In the control group, all scores were non-normally distributed except for the ECBI 
intensity subscale, the RSA and the GHQ-12, which were normally distributed. 
Subscales of the MSPSS were all positively skewed and scores on the ECBI problem 
subscale were negatively skewed. 
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Due to the high number of non-normally distributed variables and the small sample 
sizes, bootstrapping approaches were used to provide a non-parametric alternative for 
t-tests, Pearson’s correlations and multiple regressions based on 1,000 samples. This 
process was selected due to its higher statistical power than other approaches, 
particularly for studies with small sample sizes (Williams and MacKinnon 2008).  
 
An independent samples t-test was used to compare levels of distress and child 
behaviour problems reported by parents of children with PKU to the general 
population. Pearson’s correlations were used to measure the association between 
variables. Bonferroni corrections were not used in the analysis based on studies 
suggesting these are inappropriately conservative and can increase Type 2 error to 
unacceptable levels in studies with small samples (Bland, 1996; Nakagawa 2004). 
 
A multiple regression analysis was selected to examine the predictors of 
psychological distress, as measured by scores on the GHQ-12. Predictor variables 
were selected based on the correlations between variables and GHQ-12 scores.  
 
All data analysis was carried out using IBM SPSS Statistics 20 software package, 
with the p value set at 0.05.  
 
Results 
Participants 
Experimental group  
Forty-nine parents contacted the researcher regarding taking part in the study. Four 
parents responded to the NSPKU website advert, 18 responded to adverts posted on 
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social media sites and 27 following the NSPKU conferences and community event. 
Forty parents returned completed forms and questionnaires, with two parents opting 
out. Therefore, 38 eligible parents were included, representing a 78% participation 
rate. Thirty-four children met the age criteria for the ECBI and 28 for the DBC.   
 
Six fathers and 32 mothers were represented. Four parents did not state their 
household income; the mean value for the remaining 34 parents was £56,029.41 
(range= £10,000-150,000, SD= 32,976.33) and parents’ mean age was 40 years and 6 
months (range= 25-59, SD= 8.12). Parents reported a range of qualifications; five 
(14%) had a Master’s degree; 17 (46%) had Undergraduate degrees; two (5%) had 
Doctorates; four (11%) had Diplomas; eight (22%) had GCSE’s; one had A-levels 
(3%) and one parent did not state their highest qualification. Child mean age was 8 
years and 1 month (range 1-17 years, SD= 5.36). Twenty-one (55%) of the children 
were female and 17 (45%) were male. The majority of families lived in the UK, with 
30 (76%) from England and Wales (79%), three (8%) from Northern Ireland, one 
(3%) from the Republic of Ireland, three (8%) from Scotland and one family from 
New Zealand (3%).  
 
Control group 
Fifty-six parents contacted the researcher about taking part in the research in response 
to the study adverts. Thirty-two parents returned completed questionnaires, 
representing a 57% participation rate. All children met the age criteria for the ECBI. 
Thirty families met the age criteria for the ECBI. 
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The sample represented eight (25%) fathers and 24 (75%) mothers. The mean parent 
age was 38 years (range= 27-54, SD= 7.12) and the mean child age was 5 years and 6 
months (range= 3 months-14 years, SD= 3.85). Eighteen (56%) of the children were 
male and 14 (44%) were female. Two parents did not state their average income but 
the mean household income for the remaining 29 parents was £73,333.33 (range= 
£18,000-150,000, SD= 33,777.50). A range of qualifications were represented: 
Twenty-two (69%) parents reported Undergraduate degrees; six (19%) had Master’s 
degrees; two (6%) reported Diplomas; one (3%) had A-levels and one (3%) had 
GCSE’s. Nineteen of the parents lived in Wales (59%) and 13 lived in England 
(41%). English was the first language for all parents in both groups.  
 
Descriptive statistics for scores on parent-report measures 
Mean scores for distress were comparable across the two groups (see Table 1), with 
nine parents scoring above the cut-off for distress in the experimental group and six in 
the control group. Scores on measures of resilience and social support were lower for 
parents of children with PKU compared to those in the general population. Parents of 
children with PKU also reported more child behaviour problems, with six parents 
scoring above the threshold on the ECBI intensity subscale and five on the problem 
subscale. By comparison, three parents from the general population scored above the 
threshold on the problems subscale of the ECBI. The incidence of behaviour related 
to developmental disorders was reported as low, with three parents scoring above the 
clinical cut-off for behaviour related to developmental and intellectual disabilities.  
 
---------------------------------- Insert Table 1 here ------------------------------------------- 
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Independent samples tests for distress and child behaviour problems 
An independent samples t-test with bootstrapping was carried out to compare distress 
and child behaviour problems between the two samples (see Appendix 6.3). Reported 
levels of distress, as measured by the GHQ-12, did not significantly differ across the 
two groups t(68)= -.84, pb= .40. The extent to which behaviour was considered a 
problem also did not significantly differ between the samples, t(64)= -1.732, pb= .08. 
However, the intensity of child behaviour problems approached statistical 
significance t(64)= -1.911, pb= .05. 
 
Correlations between parent-report measures and distress 
Experimental group 
Scores on the GHQ-12 were positively correlated with all measures of child 
behaviour, with a significant relationship emerging between anxious subscale of the 
DBC and the GHQ-12, p< .05 (see Table 2). A highly significant negatively 
correlation was found between scores on the GHQ-12 and the RSA, p< .01. Negative 
correlations emerged between the GHQ-12 and subscales of the MSPSS, except for 
the friend subscale, which was positively correlated with the GHQ-12. The child 
dependency scale scores were positively correlated with the GHQ-12, and 
significantly positively correlated with subscales of the DBC p< .05; p< .01.  
 
--------------------------------------- Insert Table 2 here --------------------------------------- 
 
Additional correlation analyses were run to examine the associations between child 
age and measures of behaviour problems (see Appendix 6.4). The findings revealed 
significant negative associations between child age and the self-absorbed subscale of 
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the DBC (Pearson’s r= -.45, p< .05) and the intensity subscale of the ECBI (Pearson’s 
r= -.49, p< .05). All other non-significant relationships were negative, except for the 
social-relating subscale of the DBC, which was positive (Pearson’s r= .12, p= .55). 
 
Control group 
The GHQ-12 was negatively correlated with all subscales of the MSPSS, although 
these were non-significant, p> .05 (see Table 3). A small positive correlation emerged 
between the intensity subscale of the ECBI and scores on the GHQ-12, p> .05. By 
contrast, a negative correlation was found for scores on the GHQ-12 and the problem 
subscale of the ECBI, p> .05. Subscales of the MSPSS were highly significantly 
positively correlated with each other, indicating a degree of overlap between these 
constructs, p< .01. Scores on the RSA were positively correlated with subscales of the 
MSPSS, with a significant correlation found for the friend subscale. RSA scores were 
positively correlated with the problem subscale of the ECBI and negatively correlated 
with the intensity subscale, although these were non-significant, p> .05.  
 
Further correlation analysis revealed a positive correlation between child age and the 
problem subscale of the ECBI (Pearson’s r= .09, p= .66), indicating that behaviour 
difficulties in older children were considered to be more problematic for parents in 
this group. By contrast, a negative relationship emerged between child age and the 
intensity subscale of the ECBI, suggesting that younger children experience a higher 
incidence of behaviour problems (Pearson’s r= - .24, p= .21).  
 
--------------------------------------- Insert Table 3 here --------------------------------------- 
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Predictors of psychological distress 
A multiple regression analysis was carried out to identify the predictors of distress in 
parents (Table 4). The anxiety subscale of the DBC and RSA total scores were 
entered into the regression model based on their significant correlations with the 
GHQ-12 (p< .01 and p< .05 respectively) and similar findings reported in the 
literature (Medford et al under review). Together, these variables explained 35% of 
the variance in GHQ-12 scores. RSA total scores was a significant predictor variable 
(Finalβ= -.45, p< .05), but the anxiety subscale of the DBC was not (Finalβ= .36, p= 
18).  
 
----------------------------------- Insert Table 4 here ------------------------------------------- 
 
No significant correlations were found between GHQ-12 scores and scores on 
measures of resilience, social support and child behaviour for parents of children 
without PKU. Therefore, the intensity and problem subscales of the ECBI and RSA 
total scores were entered into the regression model to provide a control comparison 
model of distress to parents of children with PKU. These variables explained 19% of 
the variance in parents’ GHQ-12 scores. However, whilst RSA total scores was a 
significant predictor variable (Finalβ= -.50, p< .01), the intensity and problem 
subscales of the ECBI were not (Finalβs= -.13 and -.25;  p= .55 and .15 respectively). 
 
Discussion 
This study had three aims; to examine levels of parental distress, child behaviour 
problems and determine what factors contribute to parents’ distress in families 
affected by PKU. Contrary to the first research hypothesis, levels of distress were 
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generally low for parents of children with PKU and were non-significantly different 
to parents in the general population. This indicates good parental well-being in this 
clinical population, which is consistent with studies demonstrating comparable levels 
of distress to control groups and parents of children with other biochemical conditions 
(Kazak et al 1987; Ten Hoedt et al 2011). However, contrasting findings are also 
reported (Gunduz et al 2015) and research suggests that many outcome measures are 
not sensitive to the unique stressors associated with caring for a child with PKU 
(Bosch et al 2015). In light of this, parental distress could have been masked by the 
low specificity of the GHQ-12 in the current study. 
 
In accordance with the second hypothesis, parents of children with PKU reported a 
higher intensity of child behaviour problems compared to those in the general 
population, which approached statistical significance. Parents of children with PKU 
also reported more problematic behaviours than those in the general population, 
although this difference was non-significant. These findings are consistent with the 
relevant research (Smith and Knowles 2000). Interestingly, for parents of children 
with PKU, psychological distress was positively correlated with greater satisfaction 
with social support from friends. One possible explanation for this is that parents of 
children with PKU who seek support from other parents may draw negative 
comparisons between their children and feel more distressed as a result. 
 
For parents in the general population, a trend emerged whereby parents who 
considered their child’s behaviour to be more problematic reported lower levels of 
psychological distress. This could reflect high rates of support-seeking behaviour in 
this group or the protective value of resilience on parents’ distress levels.   
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Although scores on measures of child behaviour were generally low, mean scores on 
the DBC were highest for antisocial/disruptive behaviour, indicating a relatively 
higher prevalence of this form of behaviour. Problems with social relating were 
positively correlated with child age, which is in line with research indicating lower 
social competence in adolescents with PKU (Brumm et al 2010). Negative trends 
emerged between child age and all other subscales of the behaviour measures; 
suggesting younger children experience a higher rate of behaviour problems 
generally, particularly self-absorbed behaviour. This is consistent with research 
demonstrating the predictive value of younger child age on parents’ distress (Ten 
Hoedt et al 2011). Behaviour related to anxiety was significantly correlated with 
parents’ distress, in line with the relevant research (Craig et al 2016; Jahja et al 2013).  
 
Taken together, these findings suggest that children with PKU present with different 
behaviour problems at different developmental stages, which have unique 
implications for distress in parents. However, behaviour related to anxiety can be 
considered as more troublesome for parents, especially parents of younger children. 
Of note, no significant relationships were found between subscale scores on the ECBI 
and psychological distress, whereas the anxiety subscale of the DBC significantly 
predicted distress. This indicates that generic child behaviour scales may not be 
sensitive to the specific difficulties experienced by children and young people with 
PKU. 
 
To address the third hypothesis, a multiple regression analysis was carried out to 
determine the predictors of parents’ distress. Consistent with the hypothesis, 
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behaviour problems and psychological resilience predicted distress in parents of 
children with PKU, with psychological resilience as a significant predictor. These 
findings suggest that whilst anxious behaviour in children is associated with higher 
levels of distress for parents, psychological resilience is a more power predictor of 
this. Similar findings are reported in the literature, with research demonstrating that 
psychological resilience is a stronger predictor of parents’ distress than social support 
and child care dependency (Medford et al under review). By comparison, 
psychological resilience was the only predictor of distress identified for parents in the 
general population, suggesting this trend is not unique to parents of children with 
PKU. However, no significant correlations emerged between child behaviour and 
distress for parents in this group. This suggests the association anxious child 
behaviour and parents’ distress could be a unique trend for families affected by PKU, 
however further research is needed to draw firm conclusions about this. 
 
Critical evaluation 
Whilst the current study is important in adding to the evidence regarding parents’ 
distress, there are several limitations that bear consideration. A potential constraint 
was the use of parent-report measures. Issues of reciprocal causation have been 
highlighted in the research with parents of children with health conditions (Hilliard et 
al 2010; King et al 1999; Shemesh et al 2005), whereby parents’ own distress can 
influence the over-reporting of their child’s distress. Other studies report high rates of 
child emotional and behavioural problems in families with poor psychosocial 
functioning, making it difficult to infer the direction of the relationship between child 
behaviour and parental distress (Lange et al 2005). Including an objective measure of 
child behaviour in the current study could have controlled for these potential biases.  
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The size of the sample could have limited the validity of the research findings. An a 
priori power calculation was conducted using G* Power, which suggested a minimum 
sample size of N=100 was needed for a multiple regression analysis. This indicates 
that the study design was underpowered to detect a significant effect where one 
existed. However, a range of minimum sample sizes for multiple regression are 
reported in the literature, with some as small as N=7, depending on the number of 
predictor variables (Knofczynski and Mundfrom 2007). Moreover, given the low 
prevalence of PKU in the general population, sample sizes in the literature have 
tended to be small (Ambler and Hare in press).  
 
A further limitation was the sampling method used. It could be speculated that 
recruiting members of a national charity skewed the data by representing parents who 
are currently accessing support and therefore experience lower levels of distress. 
Moreover, a large proportion of the participants were recruited through NSPKU 
events, including two conferences and a community event, which were more likely to 
have been attended by highly motivated families. Furthermore, few participants from 
lower socioeconomic backgrounds were represented in the current study sample. This 
could have influenced the findings by sampling families who are exposed to fewer 
socioeconomic pressures, thereby representing parents who are less distressed and 
children who experience fewer behaviour problems. 
 
By contrast, findings from a recent study, which recruited parents and carers through 
NHS Trusts in England, revealed higher mean scores for psychological distress 
(Medford et al under review). It could therefore be argued that recruiting through 
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clinical services provides a more representative sample of families affected by PKU. 
Moreover, it is also possible that parents who volunteered to participate in the study 
experienced lower levels of distress than those who did not. However, it was not 
possible to discern this, as reasons for non-participation were not provided.  
 
Higher rates of inherited metabolic conditions are reported in groups with 
consanguineous marriages, such as in travelling communities (Thomas et al 2017). It 
could be speculated that families from such groups experience difficulty gaining 
regular access to services due to lifestyle factors and may experience higher levels of 
distress as a result. Moreover, there may be differences in how illness and diet are 
perceived in such minority groups, which could also impact on child behaviour 
problems and parents’ distress. Therefore, future research should focus on measuring 
parents’ distress in larger, more diverse samples to gain a deeper understanding about 
parents’ distress in PKU. 
 
The cross sectional design of the study may have limited the validity of the results due 
to the lack of control over extraneous variables. Moreover, it was not possible to infer 
a causational relationship based on the design of the study. By contrast, a longitudinal 
design could have enabled greater accuracy for observing external influences on 
parents’ distress, such as developmental trends. This would have allowed firmer 
conclusions to be drawn around a causal relationship. Due to the small number of 
parents recruited in the current study, it could be argued that interviews may have 
provided more enriched data regarding the factors associated with distress. However, 
a relative strength in the design of the current study was the use of a control group to 
account for the factors associated with parenting a healthy child.  
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Implications for clinical practice 
Based on the findings in the current study, it is likely to be beneficial if support is 
tailored to enhance parents’ psychological resilience and the management child 
behaviour problems, particularly anxious behaviour. Approaches such as Acceptance 
and Commitment Therapy (ACT) are shown to reduce distress in parents of children 
with autism (Blackledge and Hayes 2006) and could help build psychological 
resilience in parents of children with PKU through managing negative, yet accurate 
thoughts about the condition. Alternatively, family-based interventions, such as 
systemic Family Therapy (Farrell et al 2002) and child-focused Cognitive Behaviour 
Therapy (CBT) with parental involvement (Barmish and Kendall 2005) could help 
parents to manage anxious child behaviour. However, it should be noted that few 
families from lower socioeconomic backgrounds were represented in the current 
study. This may limit the generalisability of the findings to clinical services, which 
are likely to be accessed by families from more diverse backgrounds. Therefore, these 
findings should be corroborated with clinical studies to inform further 
recommendations in this field. 
 
When assessing for anxious behaviour in clinical settings, it should be borne in mind 
that child behaviour problems were not identified by the ECBI. This suggests routine 
screening using the DBC could help identify an unmet need for families affected by 
PKU and highlights an area for service development.  
 
Recommendations for future research 
Longitudinal studies could help identify developmental trends in children and young 
people with PKU and the challenges for parents associated with this. This could help 
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further tailor support for families. To understand the potential causes of anxious 
behaviour in children and young people with PKU, it would be beneficial to measure 
this in relation to Phe levels, parenting practices and siblings’ behaviour. Future 
research with families from more diverse backgrounds could also help identify 
additional vulnerability factors for families.   
 
Conclusion 
Findings from this study suggest that levels of psychological distress are comparable 
between parents of children with PKU and those in the general population. However, 
children with PKU were reported to experience a higher incidence of behaviour 
problems than those in the general population. When building a model of distress for 
parents of children with PKU, multiple regression analysis showed anxious behaviour 
in children and psychological resilience in parents explained for 35% of the variance 
in distress. By comparison, generic child behaviour problems and psychological 
resilience accounted for only 19% of the variance in distress for parents in the general 
population. These findings build on existing research and further highlights the need 
to support families affected by PKU. 
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Table 1 Descriptive statistics for parent-report measures for parents in the 
experimental group (Group 1) and control group (Group 2) 
Measure Group  N Mean (SD) Range (Scale range) 
 
GHQ-12 1  38 10.29 (2.96) 4-18 (0-36) 
 
 
RSA  
2 
1 
 32 
38 
9.63 (3.66) 
179.32 (24.00) 
1-17 (0-36) 
 
123-216 (33-231) 
 
 
MSPSS friend 
2 
1 
 32 
38 
191.06 (20.15) 
21.39 (6.34) 
135-220 (33-231) 
5-28 (4-28) 
 
MSPSS family 
2 
1 
 32 
38 
24.16 (6.00) 
22.26 (5.57) 
4-28 (4-28) 
4-28 (4-28) 
 
MSPSS sig. other 
2 
1 
 32 
38 
23.38 (5.75) 
24.18 (5.62) 
4-28 (4-28) 
4-28 (4-28) 
 
MSPSS total 
2 
1 
 32 
38 
24.66 (6.42) 
67.84 (14.08) 
4-28 (4-28) 
16-84 (12-84) 
 
ECBI intensity 
2 
1 
 32 
34 
72.16 (17.39) 
103.56 (31.03) 
12-84 (12-84) 
42-168 (38-266) 
 
ECBI problem 
 
Child dependency 
2 
1 
2 
1 
 30 
34 
30 
38 
88.63 (21.48) 
6.56 (7.79) 
3.60 (4.46)  
5.89 (1.72) 
48-126 (38-266) 
0-29 (0-36) 
0-17 (0-36) 
1-7 (1-7) 
DBC antisocial/ disrup. 
DBC self-absorbed 
DBC communication 
DBC anxiety 
DBC social 
DBC total score 
1 
1 
1 
1 
1 
1 
 28 
28 
28 
28 
28 
28 
7.18 (6.86) 
3.89 (4.46) 
1.79 (2.44) 
2.89 (2.87) 
1.54 (2.22) 
18.82 (16.34) 
0-27 (0-54) 
0-21 (0-62) 
0-10 (0-26) 
0-11 (0-18) 
0-9 (0-20) 
0-60 (0-192) 
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 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1. MSPSS sig. other               
2. MSPSS family .61**                 
3. MSPSS friend .49* .30             
4. MSPSS total score .86** .77** .77**            
5. ECBI problem -.14 -.35 .24 -.08           
6. ECBI intensity -.32 -.49* -.08 -.36 .72**          
7. GHQ-12 total score -.08 -.31 .07 -.12 .11 .18         
8. RSA total score .00 .17 .03 .08 -.04 -.18 -.52**        
9. DBC disruptive -.19 -.29 .08 -.15 .65** .67** .23 -.10       
10. DBC self-absorbed -.60** -.73** -.35 -.68** .55** .73** .11 -.10 .59**      
11. DBC communicate -.38* -.66** -.17 -.48* .37 .56** .27 -.22 .61** .67**     
12. DBC anxiety -.28 -.36 -.11 -.30 .26 .38 .45* -.19 .54** .38 .53**    
13. DBC social relating -.15 -.33 .20 -.10 .48* .38 .11 .00 .71** .45* .62** .56**   
14. DBC total score -.40* -.55** -.09 -.41* .59** .71** .28 -.15 .90** .77** .82** .72** .79**  
15. Child dependency -.10 -.28 .11 -.10 .40* .50** .17 -.13 .33 .30 .28 .48** .43* .42* 
Table 2. Correlations between demographic data, parent-report measures and child behaviour for parents of children with PKU 
 
*p< .05; **p< .01 
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Table 3. Correlations between demographic data and parent-report measures 
for parents in the general population 
 1 2 3 4 5 6 7 
1. MSPSS sig. other        
2. MSPSS family .91**       
3. MSPSS friend .87** .84**      
4. MSPSS total .97** .96** .95**     
5. ECBI problem -.08 -.02 -.09 -.07    
6. ECBI intensity -.24 -.22 -.21 -.24 .22   
7. GHQ-12 -.03 
 
-.10 -.06 -.06 -.24 .02  
 
8. RSA total score .28 .21 .37* .30 .09 -.08 -.20 
 
 
 
      
 
 
 
 
 
 
 
 
 
 
 
*p< .05; **p< .01 
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Table 4. Multiple regression analysis to examine the predictors of parental 
distress 
Criterion variable: GHQ-12 total score for parents from the general population 
Enter  B SE B Finalβ p R² F change 
RSA total score 
DBC anxiety 
-.06 
.36 
.02 
.23 
 
-.45 
.36 
.04* 
.18 
 
 
.35 
 
 
8.32** 
Criterion variable: GHQ-12 total score for parents from the general population 
Enter B SE B Finalβ p R² F change 
RSA total score 
ECBI problem 
ECBI intensity 
 
-.09 
-.02 
-.20 
.03 
.04 
.15 
-.50 
-.13 
-.25 
 
.01 
.55 
.15 
 
 
 
.19 
 
 
 
3.25* 
 
      
 
 
 
 
 
 
 
 
 
 
F change *p< .05, **p< .01 
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Paper three 
  
 
 Critical Review  
 
 
Introduction 
Evidence-based practice requires clinicians to integrate clinical knowledge and 
expertise with the best available research to inform their practice (Gopalakrishnan and 
Ganeshkumar 2013). However, the vast number of studies published across health 
disciplines presents a challenge for clinicians to remain informed with the most up-to-
date research. Further, the varying methodological quality of published studies can 
make it difficult to interpret and apply the findings across clinical populations. 
Systematic reviews have become an increasingly important tool for overcoming these 
barriers, by enabling efficient access to the best quality evidence (Gopalakrishnan and 
Ganeshkumar 2013). By providing a synthesis of the body of evidence in the context 
of its scientific rigour, systematic reviews help establish the applicability of findings 
to different clinical populations (Mulrow 1994).  
 
As scientist-practitioners, clinical psychologists are trained at doctorate level to be 
critical consumers of research and to contribute to the knowledge base through further 
study and evaluation (British Psychological Society 2014). Applying these research 
competencies is therefore integral to the professional role. Moreover, contributing to 
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the evidence base through further research is valuable for informing policy, service 
development and clinical practice across disciplines. As part of the requirements for 
the Doctorate in Clinical Psychology, the systematic review and empirical paper in 
the current thesis were carried out to offer a contribution to the field of inherited 
metabolic conditions.  
 
This paper aims to provide a critical review of the research presented in the current 
thesis ‘An investigation into parental well-being and child behaviour in 
Phenylketonuria (PKU)’. The paper will be divided into three parts: part one will 
focus on the development and interpretation of the empirical study, part two will 
explore the systematic review, part three will focus on the dissemination of the 
findings and part four will provide my personal reflections.  
 
Part one. Empirical study 
This section will provide a reflection on the process of designing, implementing and 
analysing the research that was carried out for the current thesis. The rationale for the 
decisions that informed this work and the challenges that arose will be discussed. A 
critical evaluation of the research findings and their implications for theory, further 
research, clinical practice and service development will also be provided. 
 
Rationale for the research topic 
Prior to starting clinical training, my previous roles in the NHS involved working in 
medical settings with individuals who were experiencing cognitive, behavioural and 
physical health difficulties related to dementia and acquired/traumatic brain injury. 
Although the majority of my clinical work was delivered in a one-to-one format, I 
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was struck by the impact of these conditions on the whole family system. For 
example, families were often required to adjust to new treatment regimes, significant 
lifestyle changes and had to cope with the medical uncertainties associated with their 
loved one’s condition. In addition to this, I observed the ways in which family 
functioning could in turn impact on the person. From these experiences, I developed 
an interest in the way that services are configured and the potential missed 
opportunity to work alongside families and other members of the system, following 
the onset of a serious physical or mental health problem. 
 
During clinical psychology training, I have been eager to pursue my interest in 
systemic working as much of my previous experience has involved working with 
individuals. Therefore, when developing a topic for my thesis, I was motivated to 
carry out research in this area. In addition to this, much of my previous research 
experience had involved carrying out qualitative methods. Hence, discussions with 
my appraisal tutor highlighted competency needs in quantitative design, methodology 
and analysis and working with families. 
 
Initial considerations 
An initial idea I had for my research topic was to investigate the needs of families 
following the onset of maternal post-partum psychosis. I was particularly interested in 
a potential unmet need amongst fathers. Research in this area might have produced 
recommendations for clinical practice and service development. However, following a 
meeting with a consultant psychiatrist working in the field and correspondence with a 
national third sector organisation, it transpired that a similar research project was 
already being conducted with fathers at that time. I reflected on the potential practical 
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challenges this could bring in discussions with a member of the DClinPsy programme 
staff. This highlighted that, given the small sample population, recent involvement in 
a similar study could negatively impact on recruitment due to ‘participant burnout’. I 
therefore discussed alternative research opportunities with the consultant psychiatrist 
working in the field, but these were focused on the individual as opposed to the wider 
system. Hence, I chose not to pursue that research topic for the thesis. Instead, I 
carried out scoping searches of the literature on psychological functioning in families 
affected by physical health conditions. This revealed a heightened vulnerability to 
distress in parents of children and adolescents across a range of long-term conditions, 
such as neurodevelopmental disorders and type 1 diabetes (Craig et al 2016; Driscoll 
et al 2010). Several studies also demonstrated a link between parental well-being and 
the physical and psychological functioning of children. For example, family-based 
interventions were shown to reduce parenting stress and improve physical health 
outcomes in children and young people with chronic pain and diabetes (Eccleston et 
al 2003; Wysocki et al 2005). This highlighted the potential value of investigating 
parental well-being in supporting children and young people with physical health 
conditions. 
 
When considering this research topic I also consulted the relevant policy. The link 
between parental well-being and children’s emotional and physical development was 
widely documented, as was the need to support the whole family in services for 
children and young people (Public Health Wales 2013; Royal College of 
Paediatricians and Child Health Wales 2016). In addition to this, the NHS Outcomes 
Framework for 2016-2017 outlines that improving health-related quality of life for 
individuals and their carers is a key indicator for families affected by long-term 
 85 
conditions (Department of Health 2016). With these policies and with my competency 
needs in mind, I decided to carry out my research in the field of long-term conditions. 
Rationale for studying parental well-being in PKU 
When examining research conducted across different health conditions, it was evident 
that only a small number of family-based studies had been carried out in inherited 
metabolic conditions (Read 2003; Siddiq 2016; Ten Hoedt et al 2011). I therefore 
discussed potential opportunities for carrying out research in this field with a member 
of staff on the DClinPsy programme who had clinical and research expertise in this 
area. From these discussions and my own additional reading, I became aware of the 
increased vulnerability to distress in parents who have a high level of responsibility 
for managing their child’s condition (Cousino and Hazen 2013). Moreover, I learned 
about the high onus placed on parents of children with PKU to manage their child’s 
daily diet and treatment regime (Gunduz et al 2015). In particular, I was struck by the 
need for parents to gain control over their child’s Phe levels imminently following 
diagnosis, to adapt family routines accordingly and cope the adverse risk of cognitive 
impairment if treatment was not strictly adhered to. This resonated with me as 
growing up a close family friend was affected by cystic fibrosis and I observed the 
ways that her parents adapted to cope with the demands of the treatment on their 
everyday lives. Therefore, I felt there was value in examining the different factors that 
affect parental well-being in families affected by PKU.  
 
UK guidelines for the management of PKU highlight the need for multidisciplinary 
working with children, young people and their parents. For example, it is 
recommended that clinical psychologists ‘assist patient and parent understanding of 
the need for dietary treatment’ and ‘foster parent and patient motivation to comply 
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with treatment’ (NSPKU 2014). European guidelines also make recommendations for 
routine assessment of psychosocial functioning at distinct stages of the young 
person’s development, to reflect challenges such as the transition of treatment 
management from parents to patients (van Spronsen et al 2017).  
 
With these different factors in mind, I decided that further research into the well-
being of parents who care for a child with PKU was important for informing clinical 
practice, service development and potentially contributing to future policy in PKU. I 
therefore chose to study this topic for my doctorate research.  
 
Developing the research design 
Given the paucity of studies investigating parental well-being in PKU, I consulted the 
relevant evidence for other long-term conditions. A paper by King et al (1999) 
described a model of well-being for parents of children with disabilities. The factors 
that were shown to be associated with reduced parental distress included: lower levels 
of child disability; family-centred caregiving; social support; effective coping 
strategies; fewer child behaviour problems and higher satisfaction with support from 
services (King et al 1999). Findings from this research showed that family-centred 
caregiving, social support and child behaviour problems each significantly predicted 
parental well-being, with child behaviour problems as the strongest predictor (King et 
al 1999). I also researched other models of parental well-being in the literature, such 
as the risk and resilience model (Wallander et al 1989). This model suggests that ‘risk 
factors’, such as psychosocial stress and child disability, can be ameliorated by 
‘resistance factors’, such as social support and psychological resilience (Wallander et 
al 1989). Moreover, the systematic review I was simultaneously working on (see Part 
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two) highlighted a need for further research into child behaviour problems, 
psychological factors (such as resilience) and the demands of managing treatment for 
PKU. I was therefore motivated to investigate support within the social network, child 
behaviour difficulties, psychological resilience and the child’s level of dependency on 
their parent, in relation to parental well-being for the empirical study. 
 
Discussions with my research supervisor highlighted a similar study that was being 
conducted as part of the clinical psychology doctoral programme at the University of 
Manchester. I subsequently met with two trainee clinical psychologists in Manchester 
to discuss this work, which included a qualitative study investigating parents’ 
experiences of caring for a child with PKU and a quantitative study measuring 
parenting stress, treatment adherence and psychological well-being in maternal carers 
of children and adolescents with PKU. Given the overlap between these projects and 
my own in terms of studying parental well-being, we met with their respective 
supervisors and discussed the potential value of collaborating on this work. 
 
A component of the quantitative study involved analysing parenting stress, 
psychological resilience, the child’s care dependency and social support using 
multiple regression analysis, to identify the potential predictors of parental well-
being. The data for this project had already been collected and we discussed the 
option of my building on this work by measuring child behaviour problems. The aim 
would be to extend the regression model to gain a broader understanding of the 
predictors of parental well-being in PKU. We also discussed the option of my 
administering the same parent-report measures (i.e. parenting stress, psychological 
resilience, child dependency and social support) and a measure of child behaviour 
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with a control group. The aim of this would be to identify the factors that predict 
parental well-being in families affected by PKU, distinct from families in the general 
population. 
 
As the data for the parent-report measures (except child behaviour) had already been 
collected for the Manchester-based research, we agreed to submit an amendment to 
NHS ethics to enable me to access this data. I planned to contact the families from the 
database to ask them to fill in additional measures of child behaviour and recruit a 
control group independently of this. However, when I contacted the University of 
Manchester and Cardiff University ethics departments to discuss this amendment, a 
number of challenges were highlighted to me. For example, the participants who had 
been recruited for the existing research had not provided informed consent to share 
their data or to be contacted about future research. This precluded me from accessing 
the existing database or contacting these parents about my additional research without 
approval via a new NHS ethics application.  
 
It was also highlighted to me that the two trainee clinical psychologists would need to 
obtain written approval from the three NHS Research and Development departments 
involved in the recruitment of parents for their research. Unfortunately, the process of 
ascertaining whether or not I could submit an amendment had taken until June 2016 
and the trainee clinical psychologists were due to graduate from the University of 
Manchester doctoral programme in September. I felt that this was not enough time to 
process a new NHS ethics application and receive approval from the three NHS 
Research and Development departments. I therefore decided to recruit participants 
independently of the Manchester-based projects.  
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When collating the questionnaires for the study, I chose to use the same measures of 
demographic information, psychological resilience, child dependency, social support 
and psychological distress as were used in the Manchester-based research, as these 
were well-validated questionnaires which addressed the aims of my study. Moreover, 
using these questionnaires would enable the findings from my study to be compared 
with the existing Manchester-based research. When deciding on a measure of child 
behaviour, I chose to use the Eyberg Child Behavior Inventory as was a well-
validated measure of behaviour problems in the general population, enabling me to 
use this scale with both the experimental and control groups. In view of the limited 
research into child behaviour difficulties in PKU to date (Smith and Knowles 2000), I 
also decided to administer an additional measure of behaviour related to 
developmental and intellectual disabilities in the PKU sample, to identify any 
behaviour difficulties related to the condition itself.   
 
I discussed the option of excluding the measure of parenting stress (the Pediatric 
Inventory for Parents) with my research supervisor, as this did not align with my 
reading of the relevant literature on parental well-being in PKU. Moreover, I was 
wary of the potential overlap between parenting stress, the child’s care dependency 
and psychological distress. Therefore, we decided to exclude this measure from the 
study design.  
 
Recruitment 
As I planned to carry out a multiple regression analysis, I aimed to recruit a minimum 
of 40 participants in the experimental group and 40 in the control group, based on a 
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rule-of-thumb indicating 10 participants are needed per predictor variable to ensure 
adequate statistical power (Field 2009). However, given the low prevalence of PKU 
in the general population (Cleary 2015), I was wary of the potential challenges 
associated with recruiting a sample of this size. I approached local clinicians to 
discuss recruiting families through NHS settings in south Wales. Unfortunately, the 
clinicians working in this area were unable to collaborate on the project due to 
competing service demands at that time. Therefore, my supervisor and I discussed 
alternative methods of recruitment and the associated strengths and limitations. We 
decided that recruiting through national charity could pose some challenges, such as 
potentially accessing a smaller, more homogenous sample. However, a potential 
benefit was reaching families from a wider geographical area who may also be more 
motivated to participate in research. 
 
I therefore approached the National Society for Phenylketonuria (NSPKU) about 
recruiting through the charity and we agreed that I could recruit parents of children 
with PKU through adverts on the charity website and the online social media sites. I 
gained ethical approval from Cardiff University to proceed with this and to recruit 
parents from the general population through adverts posted on the Cardiff University 
premises.  
 
After several months, I had recruited a number of parents in the general population 
but very few parents of children with PKU. One of my hypotheses about this trend 
was that parents of children with PKU receive a lot of information about charity 
events, conferences and workshops run by the NSPKU and therefore may not attend 
to the study advert. A further hypothesis was that parents of children with PKU might 
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be less motivated to participate in the research given that there was no immediate 
benefit to themselves or their family. I also wondered whether high levels of stress in 
parents of children with PKU could mean they lack the time or energy to participate 
in research studies.  
 
To discuss ways of recruiting more families for the study, I had several email 
conversations with the staff from the NSPKU. One option that was discussed was 
attending events organised by the society. I felt that this would enable me to talk to 
families face-to-face about the research, my rationale for doing it and the potential 
benefits for the PKU community. As the study relied on parents’ willingness to give 
up their personal time with no direct benefit to themselves, I also thought that these 
discussions might increase their interest in contributing to the research. Therefore, 
before attending these events, I constructed a brief summary of the study and my 
rationale for carrying this out, to convey this in conversation with families. I also 
submitted an amendment to my ethics application enabling me to hand out 
questionnaire packs at these events, should families express an interest in completing 
these.  
 
Although these changes enabled me to recruit more participants, I was still 
significantly below the target number of families by December 2016. I therefore 
thought about other ways of recruiting parents, such as utilising resources within the 
NSPKU staff team. Initiating more discussions with NSPKU staff members led to 
greater activity on social media sites, with more staff posting about the study. This 
helped increase awareness of my research within the PKU community and had a 
knock-on effect on the number of parents volunteering to participate. In addition to 
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this, I arranged to attend a national three-day conference organised by the NSPKU to 
present a poster of my provisional research findings (see Appendix 9).  I felt that this 
offered a valuable opportunity to give something back to the society and allowed me 
to discuss my research with the conference attendees. Several families volunteered to 
participate in my research during the conference. It is possible that talking with 
families face-to-face and showing some of the emerging findings of my study 
encouraged them to volunteer, as did the multiple other research presentations that 
took place over the weekend. 
 
Overall, I was able to recruit 38 participants in the experimental group and 32 in the 
control group. Although small, this sample size was deemed sufficient to run my 
statistical analyses based on the literature (Knofczynski and Mundfrom 2007). On 
reflection, I could have attended more events held by the NSPKU and other 
organisations to present my research, which could have increased participation rates 
in the study. I could also have tried to recruit families through NHS trusts in the south 
west of England. This may have enabled me to access a wider range of participants, 
potentially yielding a more representative sample. Any future studies should take this 
into consideration.  
 
Critical evaluation of the empirical study findings 
Overall, the findings from the empirical paper highlighted a higher incidence of 
behaviour problems reported by parents who care for a child with PKU compared to 
parents in the general population. Child behaviour difficulties and lower levels of 
perceived social support from family predicted distress in parents of children with 
PKU, a trend that was not found for parents in the general population. Although these 
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findings are consistent with the relevant literature (Fidika et al 2013), there were some 
unexpected results and limitations of the findings that warrant further discussion.  
 
The findings revealed a non-significant difference in the reported intensity of child 
behaviour problems between parents of children with PKU and parents in the general 
population sample. However, the extent to which parents considered their child’s 
behaviour to be problematic did significantly differ between the two samples, with 
parents of children with PKU reporting more problematic behaviour. One possible 
explanation for this finding might be due to a difference in the way parents interpret 
and label their child’s behaviour. Parents of children with PKU might interpret 
behaviour changes as being the result of their child’s condition and this being 
problematic. They may also be more vigilant of changes in their child’s behaviour, 
given that this could be related to elevated Phe levels (Smith and Knowles 2000). 
 
For families in the general population sample, a negative correlation emerged 
between parental distress and reported problematic behaviour in children. This 
indicates that parents who considered their child’s behaviour to be more problematic 
were, in fact, less distressed. This could reflect a higher incidence of help-seeking 
behaviour for parents in this group or the protective impact of psychological 
resilience. However, this trend is counterintuitive to what might have been expected 
and could reflect an anomaly in the findings, especially given the small sample size of 
this group. 
 
By contrast, psychological distress was correlated with all measures of child 
behaviour for parents of children with PKU, suggesting more child behaviour 
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difficulties could lead to higher levels of distress in parents in this sample. However, 
as these findings were correlational, an alternative explanation could be that parents’ 
own distress impacts on their perceptions of their child’s behaviour as problematic. In 
line with this, findings from studies with parents of children with type 1 diabetes 
suggest higher levels of stress and anxiety are associated parents’ perceptions of their 
child’s behaviour as being more problematic (Hilliard et al 2010). 
 
Overall, the empirical findings indicated that the younger the child, the higher the 
number of behaviour problems that were identified on the parent-report measures. 
This could be explained by the relative inexperience of parents in managing the 
condition and the overall greater demands for care earlier in children’s lives. 
However, an exception to this concerned social relating difficulties and the extent to 
which parents perceived their child’s behaviour as problematic, as reflected in the 
social relating subscale of the DBC and problem subscale of the ECBI. Both of these 
variables were correlated with children’s older age. One potential explanation for 
these trends is the implications of the treatment regime for adolescents with PKU. 
Adolescence is often associated with striving for autonomy and independence from 
authority figures (Spear and Kulbok 2004). This conflicts with the close involvement 
of health professionals and parents in managing the treatment and diet regime in PKU 
(Smith & Knowles 2000). Furthermore, adolescents with PKU have been shown to 
experience low autonomy and poor integration with their peer group due to the need 
to adhere to a strict diet (Brumm et al. 2010; Weglage et al. 1992). These difficulties 
could therefore account for the higher rates of social relating problems reported by 
parents of older children in the study and the extent to which parents perceived these 
behaviours as problematic. However, a similar relationship emerged between 
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increasing child age and parent reports of problematic behaviour in the control group, 
suggesting that this trend reflects challenges associated with normal development.  
 
To assess the ecological validity of my findings and their relevance to clinical 
practice, I met with a clinical psychologist with experience of working in the field of 
inherited metabolic conditions. This highlighted a different demographic of families 
presenting to services compared to those represented in the empirical study. In 
particular, a higher incidence of families from lower socioeconomic backgrounds, and 
many from travelling communities, were presenting to paediatric health services. This 
indicates that the sample in the empirical study may not be representative of the PKU 
population in the UK, possibly due to the method of recruitment. Therefore, it is 
possible that a sampling bias in the current study skewed the data towards families 
from higher socioeconomic backgrounds, who are arguably less distressed (Mistry et 
al 2002). However, sampling through a clinical service could also introduce a 
selection bias in accessing a disproportionately distressed sample, as families who are 
coping well might not attend clinical appointments. A more accurate sampling 
strategy in future might be recruiting through a PKU case register.    
 
Implications for theory and further research 
The final regression model revealed perceived social support from family, behaviour 
related to anxiety, psychological resilience, disruptive/antisocial behaviour and the 
total number of behaviour problems related to developmental and intellectual 
disabilities, predicted psychological distress in parents of children with PKU. These 
findings are consistent with the relevant literature (Fidika et al 2013) and other 
models of well-being in parents of children with long-term conditions (King et al 
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1999). However, to date, few studies have measured the impact of child behaviour 
problems on parental well-being in PKU. Therefore, it could be argued that these 
findings offer a unique contribution to the field of inherited metabolic conditions by 
highlighting the impact of perceived child behaviour problems on parental well-being, 
informing further research in this area.  
 
Future research could corroborate the empirical findings in the current thesis with 
other family-based studies in PKU. With further research in this area, it may also be 
beneficial to construct a conceptual model of parental well-being in PKU, for example 
using structural equation modeling. This could help develop an understanding of the 
interactions between child behaviour, distress, coping and caregiving in families and 
provide a framework for future lines of enquiry. In addition to this, the impact of 
support from third-sector organisations and NHS services could be measured and 
incorporated into a theoretical model of parental well-being. Given the limited 
literature on psychological interventions with this clinical population, future studies 
could also incorporate practice-based evidence to build on the existing knowledge 
base through publishing service-based research. 
 
Investigation of why some children with PKU present with behaviour problems was 
beyond the scope of this study. However, possible explanations include the impact of 
elevated Phe levels, poor treatment adherence, cultural and family values around diet 
and illness or parenting practices. For example, children with PKU could present with 
more rigid, obsessive behaviour because this is how they have learned to manage the 
strict nature of the diet. Future studies could help identify the possible causes of 
behaviour problems in PKU, for example by measuring the behaviour of siblings 
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without the condition. Furthermore, involving families from diverse backgrounds, 
such as travelling communities, in future research could help identify potential 
vulnerability factors in relation to child behaviour problems, as higher rates of 
inherited metabolic conditions are reported in communities with consanguineous 
marriages (Thomas et al 2017).  
 
Implications for clinical practice 
The findings in the empirical study have a number of implications for clinical 
psychologists working in NHS services. As there are multiple potential explanations 
for why children might present with behaviour difficulties, this highlights the need for 
a detailed assessment and formulation of the family’s needs, incorporating the 
biological, psychological and social factors that could impact on the child’s 
behaviour. Gaining a more in-depth understanding of the family’s needs would enable 
interventions to be tailored more appropriately, which would arguably be more 
effective than offering a ‘one-size-fits’ all approach, such as a behavioural parent 
training programmes (McCart et al 2006). Further, by understanding the factors that 
contribute to a family’s distress, clinical psychologists can work at several levels of 
the system, as opposed to offering one-to-one interventions only (Barmish and 
Kendall 2005; Brestan and Eyberg 2010). This work could involve offering 
consultation to nursery staff, health visitors, GPs and pharmacists who supply low-
protein products to families on prescription. Similarly, working alongside school staff 
could help develop creative ways of adapting the child’s diet within the school 
environment.  
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Implications for professional practice and service development 
As providing detailed assessment, formulation and interventions at multiple levels of 
the system are part of the core competencies of a clinical psychologist, this highlights 
the benefits of increasing the number of clinical psychologists in services working 
with children and young people affected by rare conditions, such as PKU. However, 
given the current climate of austerity within the NHS, clinical psychologists could 
also be positioned further up-stream within services, to influence preventative work 
with children and families. For example, providing psychoeducation, consultation and 
training to staff in community programmes such as Flying Start could help build 
psychological resilience and strengthen social support within families, especially 
those from lower socioeconomic backgrounds who are arguably more vulnerable to 
distress (Mistry 2002). Working alongside multi-disciplinary agencies aligns with 
current guidelines for the management of PKU, which emphasise the role of a clinical 
psychologist in liaising with other services ‘regarding aspects of learning and 
behaviour that might be related to PKU or its treatment’ (NSPKU 2014). This form of 
preventative working could in turn reduce the volume of referrals to secondary care 
and specialist health services in the long-term, in line with the principles of prudent 
healthcare (Welsh Government 2015). Given the research competencies of clinical 
psychologists, they could also be positioned to involve families in service-based 
research to help identify gaps in the current system and inform the development of 
more family-centred services. This would align with findings in the literature 
demonstrating a link between satisfaction with support from services and better 
parental well-being in long-term conditions (King et al 1999). 
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However, the potential barriers to implementing this work should also be considered. 
Discussions with a clinical psychologist working in the field highlighted that due to 
the low prevalence of PKU, it is difficult to gain the recognition and funding required 
for developing services. Such barriers could be addressed and overcome at a political 
level. Interestingly, Rare Disease UK, a campaign run by Genetic Alliance UK, has 
worked with health departments to raise awareness of the challenges facing families 
affected by rare diseases. Similarly, the NSPKU is hosting an event at the Houses of 
Parliament in June 2017 as an opportunity to increase public understanding of the 
condition. Activities such as these are therefore essential to improve the care and 
well-being of children affected by PKU and their families. 
 
Part two. Systematic review 
The following section will focus on the stages of conducting the systematic review, 
including: the rationale for the review topic, the process of developing the search 
strategy and the application of the quality assessment tool. A discussion of the 
challenges that arose when carrying out this work will be provided with an 
explanation of how these difficulties were resolved. A critical evaluation of the 
systematic review findings and the wider implications for future research, clinical 
practice and service development will also be discussed.  
  
Rationale for choosing the systematic review topic  
In choosing a topic for the systematic review, it was important to consider the 
relevance and potential value of this work for service users, carers and families. It was 
also important to consider how the work would contribute to clinical practice, service 
development and the wider evidence base. I gathered ideas for the systematic review 
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topic by examining the existing research into PKU. Initial scoping searches failed to 
identify any randomised controlled trials, meta-analyses or evaluation studies of 
family-based psychological interventions in PKU. No systematic reviews emerged of 
studies that investigated the psychological impact of PKU on the wider family. I 
therefore consulted the wider literature on long-term conditions in children and young 
people. I was interested in the documented links between parental well-being and 
children’s physical and mental health outcomes in other research studies, such as in 
diabetes (Wysocki et al 2005). This highlighted the importance of supporting parents 
when working with families in clinical settings. A small number of studies in the 
literature on PKU investigated parental well-being, however many of the findings 
were inconsistent across studies. Therefore, to inform ways of supporting families 
affected by PKU, I chose to conduct a systematic review of the factors associated with 
parental well-being.  
 
In choosing this systematic review topic, I hoped to (i) identify the evidence regarding 
what factors are helpful for supporting parental well-being; (ii) highlight areas 
warranting further investigation and (iii) make recommendations for developing 
family-based interventions in clinical practice. As no systematic reviews on this topic 
were identified, a further aim was to address this gap in the research literature.  
 
Developing the search terms 
Given the small body of research in the area, I revised the systematic review title 
several times through discussions with my research supervisor, in order to access a 
broad range of studies. Examples of early drafts include ‘A review of the predictors of 
distress in parents of children with PKU’. However, this was revised to ‘The factors 
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associated with well-being in parents of children with PKU’ in order to include more 
diverse study methodologies and statistical analyses, such as ANOVAs and 
correlation analysis. The key search terms were developed using synonyms, which I 
expanded using MeSh terms via the online databases. This enabled me to select the 
most appropriate combination of search terms to access the relevant literature. I also 
searched several different online databases to maximise the identification of 
potentially relevant studies published across disciplines.  
 
As only 15 studies were included in the final review, on reflection I could have 
broadened the search terms further. Scoping searches identified numerous studies 
published on other metabolic conditions, such as galactosemia and type 1 diabetes. 
Broadening my search terms to include these conditions might have enabled a wider 
body of research to be reviewed. Moreover, more in-depth recommendations for 
clinical practice and further research with families affected by PKU could have been 
generated based on these findings. However, due to the different trajectories of these 
conditions and their different treatment modalities (Ten Hoedt et al 2011), it would 
have potentially been difficult to interpret the research findings specifically for 
families affected by PKU. Furthermore, given the limited data on parental well-being 
in PKU, I decided that carrying out a systematic review in this field would help 
synthesise the extant findings and make clear recommendations for further lines of 
enquiry.  
 
Another potential limitation of the search strategy was the inclusion of full-text 
articles published in peer-reviewed journals only. This could have excluded the most 
up-to-date evidence in the ‘grey literature’, such as conference abstracts and 
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dissertations. However, it is also the case that including a vast range of studies, 
abstracts and reports could have negatively impacted on the quality of the findings 
reviewed. This may have resulted in less valid conclusions and recommendations for 
clinical practice. Finally, including data from interviews and case studies could have 
highlighted additional relevant themes to the findings in the systematic review. 
However, given that few relevant qualitative studies were identified in the initial 
literature searches, I decided that it would be more rigorous to collate and synthesise 
findings from a single research modality. Hence, only quantitative studies were 
included in the review. 
 
Quality assessment tool 
The Quality Assessment Tool for Studies with Diverse Designs (QATSDD) was used 
to assess the studies included in the review. I chose to use this tool based on its 
applicability to studies with diverse methodologies and good validity and reliability 
(Sirriyeh et al 2012). However, numerous challenges arose when I was applying this 
tool to the studies in the systematic review. Namely, the lack of examples provided 
meant that the interpretation of the individual items could be somewhat subjective. 
For example, it was unclear whether item 2 ‘Statement of aims/ objectives in main 
body of report’ was applicable to papers that did not explicitly state aims and 
objectives but provided comparable information, such as detailed research 
hypotheses. Similarly, item 5 ‘Representative sample of target group of a reasonable 
size’ could also have been interpreted in a number of ways, such as in the context of 
PKU only, which, given its low prevalence (Cleary 2015), is a small population for 
researchers to draw from. Alternatively, the sample size could have been rated against 
the statistical power and type of analysis used in the study. Moreover, the 
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‘representativeness’ of study samples could have represented a number of constructs, 
such as having an equal number of men and women, participants from different ethnic 
backgrounds, or children and young people with different classifications of PKU. As 
no published demographic norms for this clinical population were available, it was 
not possible to compare the samples to a ‘representative’ standard.   
 
To resolve the dilemmas that arose around the interpretation of the QATSDD, I had 
several conversations with my research supervisor to gain a shared understanding of 
the items and their applicability to the individual studies. It was also helpful to meet 
with other colleagues who had previously used the tool and discuss similar dilemmas 
and how these were resolved. Given the complexities of interpreting the items, I also 
consulted published reviews of the QATSDD. Interestingly, similar concerns were 
raised regarding items 2 and 5, including the broad definitions of the constructs and 
their subjectivity (Fenton et al 2015). Moreover, a general limitation of the tool was 
the equal weighting assigned to different items despite their varying implications for 
the overall study quality (Fenton et al 2015). Therefore, an independent rater 
reviewed five randomly selected studies to establish inter-rater reliability using the 
tool. 
 
On reflection, it might have been useful to pilot a selection of quality assessment tools 
during an early phase of the systematic review. This would have allowed me to 
critically review and compare different tools, considering the potential limitations of 
each, hence, enabling a more informed decision about the most appropriate tool to use 
in the systematic review. To my knowledge, there are no quality assessment tools that 
are designed specifically for research into PKU. Therefore, I might also have 
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designed a new tool to assess the quality of family-based studies in PKU. However, 
based on the moderate level of inter-rater reliability with the independent rater (k= 
.55), the QATSDD was deemed appropriate for use in the systematic review.  
 
Critical evaluation of the systematic review findings 
Socioeconomic status 
The findings from the systematic review highlighted that demographic variables were 
the most widely reported factor associated with parental well-being in PKU. A more 
disadvantaged socioeconomic background, lower education level and belonging to a 
less skilled occupation group were found to be linked to parental distress (Gunduz et 
al 2015; Lord et al 2008). These findings are consistent with the diabetes literature, 
with lower socioeconomic status linked to higher levels of distress in parents 
(Streisand et al 2005). However, similar findings are also reported in the general 
population, with studies suggesting that parents and children from more 
disadvantaged socioeconomic backgrounds are more likely to report unhealthy 
behaviours and poor psychological well-being (Huurre et al 2003). Similarly, high 
rates of behaviour problems and intellectual disabilities are reported in studies with 
children and young people from more disadvantaged socioeconomic backgrounds 
(Morgan et al 2009). Lower level of academic attainment, feelings of not belonging in 
school and higher rates of distress were also found for adolescents and young adults 
in this group (Langhout et al 2009; Mistry et al 2009). Based on this research, it is 
possible that the findings in the systematic review reflect a trend present in the 
general population. However, as many of the reviewed studies did not employ a 
control group, it is not possible to determine whether this trend is unique to parents of 
children with PKU or is applicable more broadly.  
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Alternatively, findings in the literature indicate that distressed parents from more 
disadvantaged socioeconomic backgrounds report feeling less capable and effective in 
their parenting practices (Mistry et al 2002). This might lead some parents to over-
report distress when participating in family-based research, due to negative bias when 
appraising their own parenting abilities.  
 
Language and cultural factors 
Individuals whose first language was not English were found to have lower reported 
well-being in the systematic review (Lord et al 2005; Lord et al 2008). However, 
given that a proportion of the participants had immigrated from overseas, it is possible 
that these findings reflect other stressors, such as those associated with emigrating to 
a new country or integrating into the new community (Lord et al 2005; Lord et al 
2008). Furthermore, different cultural perceptions of disease and illness might have 
influenced the results reported in the studies, as these were not controlled for. Trauma 
was found to be significantly associated with perceptions of the partner being less 
caring, smaller social networks and less satisfaction with social support in one of the 
studies (Lord et al 2005). Based on this trend, another interpretation of the findings is 
that family language background presents a barrier to accessing support. However, 
due to the lack of an experimental control in this research, it was not possible to 
discern in what way language background impacted on parental well-being. 
 
Gender differences 
A further demographic factor identified in the systematic review was mothers’ higher 
vulnerability to distress (Gunduz et al 2015; Kazak et al 1988; Lord et al 2008). This 
finding could reflect gender differences in the experience or the reporting of distress 
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in the general population. For example, a study of 2,816 adults found women reported 
significantly more stress symptoms and daily stressors than men (Matud 2004). 
Moreover, despite a comparable number of life events experienced over the previous 
two years, women rated these events as being more negative and less controllable 
compared to men (Matud 2004). Therefore, it is possible that a similar gender 
difference in the reporting of distress was represented in the findings reviewed. Other 
findings in the literature highlight different coping styles in men and women. For 
example, studies indicate women are more likely to seek social support and use 
emotion-focused coping compared to men (Ptacek et al 1994). By contrast, men are 
more likely to use problem-focused coping in response to stress (Ptacek et al 1994). 
These different coping styles suggest women may be more likely to self-report feeling 
distressed than men, which too could contribute to the gender differences observed in 
the systematic review findings. Societal views of men as ‘rational’, ‘independent’ and 
‘instrumental’, and women as ‘emotional’ and ‘supportive’ (Williams and Best 1982) 
may have introduced demand characteristics in self-reports of distress in the reviewed 
research.   
 
Child age 
Children’s older age was another demographic variable highlighted as contributing to 
parental well-being in the systematic review findings (Ten Hoedt et al 2011). There 
are several possible explanations for this. As children grow older, they are likely to 
gain more autonomy and independence in managing their diet and lifestyle. For 
parents, this shift in responsibility may alleviate some of the stress associated with the 
strict diet and treatment regime for PKU (Ten Hoedt et al 2011; Lord et al 2005). In 
addition to this, as more time passes, parents are likely to adjust to the distress, and in 
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some cases the trauma, associated with receiving the diagnosis of PKU (Read 2004). 
They are also more likely to develop confidence around managing the diet and build 
larger support networks, which is shown to have a positive impact on well-being 
(Lord et al 2005). Alternatively, these findings could also be indicative of the factors 
associated with increasing age in ‘healthy’ children, such as higher levels of 
independence and maturity. However, without a normative sample or comparison 
group, it is not possible to control for this trend in the findings reviewed. 
 
Social support  
Social support was highlighted as the next most reproducible factor associated with 
parental well-being in the systematic review. In particular, larger, more dispersed 
social networks were associated with an increased sense of well-being in parents and 
perceived social support was found to buffer the impact of stress on parents’ quality 
of life. This suggests that social support could enhance parents’ psychological 
resilience and protect against the distress associated with caring for a child with PKU. 
This finding is consistent with much of research on families affected by other 
conditions, such as neurodevelopmental disorders (Craig et al 2016). However, due to 
the cross-sectional design of the study, it is difficult to determine the direction of the 
relationship between distress and social support. Moreover, other studies have found 
positive parental coping predicted better family functioning and satisfaction with 
social support (King et al 1999). This indicates that parents who are less distressed are 
more likely to access and benefit from support within their family and social network.  
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Overall limitations of the systematic review findings  
A general limitation of the studies included in the systematic review is that many did 
not use a matched control group. Therefore, it was not possible to control for the 
factors associated with distress related to caring for a child without a long-term 
condition. Furthermore, many of the studies did not measure demographic variables, 
such as religion and ethnicity, which could impact on perceptions of illness, distress 
and help-seeking behaviour. Reasons for participant attrition rates were reported in 
some of the reviewed studies. However, the majority of the studies provided no 
explanation for drop-outs or non-participation. Therefore, a sampling bias could be 
speculated, whereby families who had a greater sense of well-being were more likely 
to volunteer to participate in the research. Moreover, some of the sampling methods 
(e.g. recruiting through a listserv) may have yielded a less representative sample, by 
recruiting families who are likely to have previous experience in participating in 
studies and are therefore highly motivated (Read 2003). Based on these limitations, 
the findings of the current systematic review should be interpreted with caution. 
 
Recommendations for further research 
It may be beneficial for future research in this field to include wider, more diverse 
samples. For example, it would be beneficial to investigate the impact of cultural 
perceptions of illness and help-seeking on parental well-being and family functioning. 
Greater experimental control over demographic variables, such as the child’s 
classification of PKU number of siblings with the condition could also lead to a better 
understanding of the factors that impact on parental well-being, as these were not 
controlled for in many of the reviewed studies. The use of more sophisticated forms 
of analysis, such as mediation and regression analysis and the inclusion of a control 
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group would also enable more firm conclusions to be drawn around the factors 
important for well-being in parents of children with PKU. 
 
Given the demonstrated link between lower socioeconomic status and psychological 
distress, it may be valuable for future studies to investigate the resources available for 
families living in areas of social deprivation. For example, statistics on the family’s 
access to and use of professional support, other resources available within the 
community and access to third sector organisations may help identify families who 
are at greater risk of distress. Given the link between perceived social support and 
parental well-being, it may also be useful to investigate the benefit of different forms 
of social support. Many psychometric measures do not assess support from online 
organisations, charities, or other parents who care for a child with a serious health 
condition. Further research into this could generate recommendations for 
interventions such as peer-mentoring schemes or conferences and social events held 
by organisations, such as the National Society for Phenylketonuria (NSPKU). 
 
Few qualitative studies were identified in the initial scoping searches, as such it may 
be beneficial for future research to include interview data to address this gap in the 
literature. Furthermore, all of the studies included in the systematic review utilised 
cross-sectional designs. Longitudinal research would help determine a more causal 
relationship between demographic variables and parental well-being and could help 
identify useful forms of support for families at different stages of the child’s 
development. 
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Implications for service development 
Given the paucity of family-based intervention studies represented in the current 
literature for PKU, practice-based research could offer a valuable contribution to the 
evidence base. This could be beneficial for representing more complex difficulties 
facing families and the experience of health care professionals. Service audits and 
evaluations could also help identify unmet needs for families and locate where in the 
system clinical psychologists could have the greatest impact for reducing distress. 
Involving service users and staff in research promotes the principles of co-production 
and could help shape services to meet the needs of children and families. 
 
Implications for clinical practice  
The demonstrated link between lower socioeconomic status and psychological 
distress in parents of children with PKU could reflect several constraints on the 
family’s ability to gain the support they need to manage their child’s condition. This 
highlights the importance of reaching families from more socially disadvantaged 
backgrounds who have limited access to resources. Clinical psychologists have a role 
in widening access to psychological support for hard-to-reach communities. This 
could be achieved through providing supervision, consultation and training to staff 
across settings, such as GPs in primary care, school staff and health visitors. A 
potential aim of work could be to build competences in assessing for psychological 
distress, identifying high-risk families and referring for appropriate psychological 
support.  
 
Similarly, given the identified positive relationships between well-being, social 
support and children’s older age, clinical psychologists could work alongside third 
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sector organisations, such as the NSPKU, to co-produce parenting support groups in 
the community. This work could draw from evidence-based interventions such as 
Family-Based Cognitive Behaviour Therapy, which is associated with reduced 
anxiety in children and young people aged 7-18 (Barmish and Kendall 2005).  
 
Part three. Dissemination of the findings 
A number of steps were taken to disseminate the findings in the current thesis to 
professionals working in the field and families affected by PKU. A summary of the 
findings will be sent to participants who have requested this. An overview of the 
study and the key findings will also published in the NSPKU newsletter, which is 
circulated to society members. I have presented a research poster of the initial 
findings from the study at the NSPKU annual conference in April 2017 and have 
liaised with the staff about presenting the completed research at the next annual 
conference in 2018, which is attended by families and professionals working in the 
field.  
 
I am submitting the systematic review and empirical paper to the Journal of Inherited 
Metabolic Disease for publication. I chose this international medical journal based on 
its high impact factor (3.541) and wide audience, which includes nurses, dieticians, 
clinical psychologists and medical professionals who are likely to have contact with 
families affected by PKU in clinical settings. 
 
In addition to this, to ensure the findings are disseminated more widely to clinical 
psychologists working in a range of settings, I have submitted a poster presentation of 
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the study to the Division of Clinical Psychology conference, which is scheduled for 
January 2018.  
 
I have also discussed the findings of the research and their implications for services 
with three clinical psychologists working in the field of child health and inherited 
metabolic conditions in Cardiff, Manchester and Birmingham. I hope that these 
varying means of dissemination will enable the findings to impact on different levels 
of the system, including parents who care for a child with PKU, professionals 
working in the area and service managers. 
 
Part four. Reflection  
Recruitment to the study proved a challenging component of completing the thesis. 
On reflection, I think the study would have benefitted from being co-designed with a 
small group of parent volunteers. This may have helped recruit larger numbers of 
participants during the initial months. A potential barrier to recruitment could have 
been the length of time required to complete the study questionnaires. A co-design 
process might have helped produce a more concise set of questionnaires. Despite this, 
I was struck by parents’ generosity for giving their time to the research without any 
immediate or guaranteed result.  
 
Balancing the demands of the thesis with my clinical placement during the final year 
of the doctorate programme required me to prioritise my workload, have good 
organisational skills and time management skills. Moreover, working alongside the 
NSPKU staff to engage participants prompted me to be resourceful in my methods of 
recruiting parents. It was clear to me that written adverts would not be sufficient to 
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recruit the numbers I needed for this research to be viable and personal attendance, 
meeting and speaking with parents was more effective. This is something I will carry 
with me into my qualified role if I conduct service-based research that requires 
recruitment of participants, such as staff or service users. 
 
Considering working in a qualified clinical role, I am aware of the need to balance 
competing demands and prioritise my time effectively. Moreover, there may be 
challenges in initiating research within services due to resistance, for example, from 
staff teams. I feel that the experience of carrying out this research has prepared me 
well to manage these challenges and think creatively about ways of working 
alongside staff and other stakeholders in clinical settings. Similarly, the engagement 
skills I developed to recruit participants for the research are likely to be useful when 
working engaging service users in assessment and therapeutic interventions, 
particularly if they are ambivalent. 
 
Carrying out this research has also made me reflect on the value of understanding 
carers’ experiences and considering ways of building resilience when supporting the 
whole family system. Moreover, this has made me reflect on past clinical experiences, 
such as working with families affected by dementia and acute neurological injuries, 
strengthening my belief in the value of working with the family system.   
 
The process of doing this research has prompted me reflect on the challenges ahead 
regarding how to secure protected research time within a busy NHS environment. 
This is important because one of the unique roles of a clinical psychologist is 
contribution to and drawing from the evidence base to ensure that interventions 
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offered are likely to be the most effective to service users and families. This is 
particularly relevant during the current period of public sector austerity when 
financial constraints require prudent use of resources. 
 
Finally, I feel that completing this work has increased my confidence in using 
quantitative research methodology, prior to starting the course I had experience of 
using qualitative approaches with service users only. I feel this experience has 
rounded my competence and skills in both approaches and I plan to take this forward 
in adopting an evaluative approach to clinical work in the future.  
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Appendices 
Appendix 1: Research questionnaires 
1.1 Demographics Questionnaire 
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1.2 The General Health Questionnaire-12  
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1.3 The Resilience Scale for Adults (page 1) 
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The Resilience Scale for Adults (page 2) 
 
 
 
 125 
 
1.4 The Multidimensional Scale of Perceived Social Support 
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1.5 The Child Dependency Questionnaire 
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1.6 The Eyberg Child Behavior Inventory (page 1) 
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The Eyberg Child Behavior Inventory (page 2) 
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1.7 The Developmental Behaviour Checklist-Parent/ Carer Version (front page) 
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The Developmental Behaviour Checklist-Parent/ Carer Version (page 1) 
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The Developmental Behaviour Checklist-Parent/ Carer Version (page 2) 
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The Developmental Behaviour Checklist- Parent/ Carer Version (page 3) 
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Appendix 2: Study adverts 
2.1 Experimental group 
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2.2 Control group  
 
Are	you	the	parent	of	a	child	who	is	between	0-18	years	old?	
WHAT?	
• I	am	conducting	a	research	study	with	
parents	of	children	with	Phenylketonuria	
(PKU)	to	understand	what	impacts	on	
parent’s	well-being	and	what	helps.		
• As	part	of	this	work,	I	am	also	looking	at	
what	 impacts	 on	 the	 well-being	 of	
parents	who	care	for	healthy	children.	
WHY?	
• Currently,	 little	 is	 known	 about	 the	
factors	that	contribute	to	parents’	well-
being	 in	 PKU.	 The	 findings	 from	 this	
study	 may	 help	 clinicians	 to	 develop	
support	 packages	 for	 families	 in	 the	
future.	
WHO?	
• Parents/carers	of	children	between	0-18	years	
old	who	do	not	have	a	serious	health	condition	
and	are	not	affected	by	another	signific
a
nt 	
physical	or	mental	health	problem.	
• The	study	involves	completing	questionnaires	
and	all	participants	will	be	entered	into	a	prize	
draw	to	win	a	£100	shopping	voucher	as	a	
thank	you	for	taking	part.	
If	you	would	like	to	find	out	more	about	the	
study,	please	email	Olivia	on:	
amblero@cardiff.ac.uk	
THANK	YOU	
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Appendix 3: Approval for the study 
3.1 Ethical Approval (correspondence with Cardiff University Ethics Committee) 
| 
Fri 15/07/2016, 09:47 
Dear Olivia, 
  
The Ethics Committee has considered your PG project proposal: Parenting Experiences and 
Child Behaviour in PKU (EC.16.07.12.4554). 
  
The project has been approved. 
  
Please note that if any changes are made to the above project then you must notify the 
Ethics Committee. 
  
Best wishes, 
Mark Jones 
 
3.2 Ethics amendment approval (correspondence with Cardiff University Ethics 
Committee) 
 
 
Tue 04/04, 13:31 
Olivia Ambler; 
Dougal Hare  
Action Items 
Dear Olivia, 
  
The Ethics Committee has considered the amendment to your PG project proposal: 
Parenting Experiences and Child Behaviour in PKU (EC.16.07.12.4554A2). 
  
The amendment has been approved. 
  
Please note that if any changes are made to the above project then you must notify the 
Ethics Committee. 
  
Best wishes, 
Mark 
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Appendix 4: Participant information sheets for the experimental group 
4.1 Consent form 
 
                                 
                                      CONSENT FORM                             
 
 
1 
I confirm that I have read the information sheet for the above study. I have had 
the opportunity to consider the information, ask questions and have had these 
answered satisfactorily. 
 
2 Other than caring for my child with PKU, I confirm that I do not have any other 
significant caring responsibilities that may impact on my wellbeing.  
 
3 
Other than caring for my child with PKU, I confirm that I am not affected by any 
other serious physical or mental health problems that may impact upon my 
wellbeing. 
 
4 
I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights 
being affected, up until the research data has been analysed. 
 
5 
I understand that data collected during the study may be looked at by 
individuals from Cardiff University, regulatory authorities and members of the 
National Society for Phenylketonuria. I give permission for these individuals to 
have access to my data. 
 
6 
I understand that data from the study will be stored for a minimum of five years 
after its completion, or at least two years post-publication to allow for any further 
analysis or review to be conducted. After this time period, all paper copies of 
data will be destroyed and electronic copies will be deleted. I give permission 
for my data to be stored for this time. 
 
7 I agree to take part in the above study.  
Title of Project: Parenting a child with Phenylketonuria (PKU): An investigation into the 
factors that contribute to parental well-being  
Name of child  _____________ Name of Participant ________________ 
Participant Signature _____________________________ Date _______________ 
Participant ID:_____ 
Name of Researcher: Miss Olivia Ambler 
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4.2 Invitation letter 
 
                                                                    Invitation Letter 
 
Dear 
 
 
Parenting a child with Phenylketonuria (PKU): An investigation into the factors that 
contribute to parental well-being 
 
I am writing to invite you to take part in a research study being conducted at Cardiff University 
with parents of children with and without Phenylketonuria (PKU).  
 
To date, there has been little research into the factors that contribute to the well-being of 
parents who care for a child with PKU. It would be useful to find out more information about 
this to help support families affected by the condition.  
 
This study will investigate the different factors that affect the wellbeing of parents who care for 
a child with PKU, compared to parents who care for a child without PKU. The study will also 
investigate child behaviour in PKU and examine whether this too, impacts on parent’s 
wellbeing.  
 
As you have a child with PKU who is between the ages of 0 and 18 years old, you are invited 
to take part in this study. You will find enclosed with this letter a participant information sheet, 
consent form, a list of support services, an opt-out form and some questionnaires. 
 
If you would like to find out more about this project, please read the participant information 
sheet. If you would like to find out any further information, please email me on 
amblero@cardiff.ac.uk or telephone me on 02920 870582. 
 
If you would like to take part after reading the participant information sheet, please complete 
the enclosed consent form and questionnaires. If you would like any help with completing the 
questionnaires, please contact me using the above contact details. Please take short breaks 
when filling in the questionnaires if you feel tired. 
 
Please return the consent form and questionnaires in the addressed pre-paid envelope (no 
stamp is required), or hand them into the Department of Clinical Psychology administration 
team on the 11
th
 Floor, Tower Building, Park Place, Cardiff, CF10 3AT.  
 
If you would prefer NOT to take part in this project please complete and return the attached 
opt-out form in the pre-paid envelope along with the blank questionnaires, so that I do not 
contact you again. 
 
I look forward to hearing from you. 
 
Yours sincerely, 
 
 
 
 
Miss Olivia Ambler 
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Trainee Clinical Psychologist 
 
 
4.3 Participant information sheet 
 
Participant Information Sheet 
 
Parenting a child with Phenylketonuria (PKU): An investigation into the factors that 
contribute to parental well-being 
 
Research Team: Miss Olivia Ambler (Cardiff University), Dr Emma Medford (University of 
Manchester) and Dr Dougal Hare (Cardiff University).  
 
I would like to invite you to take part in my research study. Joining the study is entirely up to 
you. Before you decide I would like you to understand why the research is being done and 
what it would involve for you.  
Part 1 tells you the purpose of this study and what it will involve if you take part. 
Part 2 gives you more detailed information about the conduct of the study. 
I recommend that you take a minimum of 24 hours to consider the information below before 
deciding whether to take part. 
 
Part 1 
 
1.1 What is the purpose of the study? 
 
There has been little research on what it is like to look after a child with Phenylketonuria 
(PKU). This study will investigate child behaviour in PKU and how this affects parent’s well-
being. 
 
 
1.2 Why have I been invited to take part in this study? 
 
You have been invited to take part because you have a child with PKU who is between the 
ages of 0-18. You have also been invited because your family is not currently affected by any 
other serious physical or mental health problems that may impact upon your wellbeing.  
 
1.3 Do I have to take part? 
 
No, you do not have to take part in the study if you do not want to. Taking part in the research 
is voluntary; this means it is completely up to you to decide whether or not to take part. Your 
decision to participate in this study will not be connected to the care you and your family are 
receiving now or in the future. If you decide to take part and sign the consent form but change 
your mind later, you are free to withdraw at any point during the study without giving a reason 
and without any consequence to your current or future treatment. 
 
1.4 What will participation involve? 
 
Parents/ carers will complete a set of questionnaires, which ask about: 
 Demographic information 
 Levels of psychological distress 
 Levels of resilience 
 The care dependency of the child 
 Support from family and friends 
 Any behavioural problems experienced by the child 
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 Any behaviours related to developmental difficulties  
 
Together, these questionnaires will take about 45 minutes to complete. You will be provided 
with a pre-paid envelope to return the questionnaires. 
 
1.5 What are the possible disadvantages and risks of taking part?  
 
It is possible that the questionnaires might raise issues that could be distressing to think 
about. A list of agencies and people you can contact is provided should you need any 
additional information/support.  
 
 
1.6 What are the possible benefits of taking part? 
 
The information gained will help services to fully understand the demands of caring for a child 
with PKU. It will also help identify some of the most effective ways to support parents. This 
will enable clinicians to develop appropriate support packages, which may help other families 
in the future. 
 
 
1.7 Will my taking part in the study be kept confidential?  
 
Yes. Your data will be handled sensitively and in confidence; all legal and ethical guidelines 
will be followed.  More details are given in Part 2. 
 
 
Part 2 
 
2.1 What will happen if I do not want to carry on with the study? 
 
You can withdraw from the study at any time without giving a reason and without any 
consequence to your family’s current or future treatment, up until the data has been analysed. 
When the data is analysed it will not be personally identifiable. 
 
 
2.2 What if there is a problem? 
 
It is unlikely that anything would go wrong, but if you have a concern about any aspect of the 
study, you should contact one of the researchers or the School of Psychology Research 
Ethics Committee (contact information is provided in section 2.9). If you are not satisfied and 
wish to make a formal complaint, you can do so through the Cardiff University complaints 
procedure. Details can be obtained from the University. 
In the event that something does go wrong and you are harmed during the study and this is 
due to somebody’s negligence, then you may have grounds for a legal action for 
compensation against Cardiff University, but you might have to pay your legal costs.  
 
2.3 Will my data be confidential? 
 All data collected about you and your child will be kept strictly confidential and only 
viewed by members of the research team.  It will be stored securely in a locked filing cabinet 
at the University. 
 Data will be entered onto a computer database which will be password protected and 
encrypted.  Each participant will be assigned a number, thus names will not be entered onto 
the database. 
 You will be asked to provide contact details for your GP, but they will not be routinely 
contacted.  During the study if any concerns arise about risk of harm to anyone, then I will 
have to contact the appropriate agency/person to provide support.  If possible, I would speak 
to you first about this.   
 I plan to publish the research and names of participants will not be used. 
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2.4 Will I receive any payment for taking part in the study? 
 
No, participants will not receive any payment for taking part. However, when participants 
return their consent form and questionnaires, they will be entered into a prize draw, with the 
opportunity of winning a £100 shopping voucher as a thank you for taking part in the study.   
 
 
2.6 Who is organising the research? 
This research is being conducted as part of the Doctorate in Clinical Psychology at Cardiff 
University for Trainee Clinical Psychologist/postgraduate student Miss Olivia Ambler. This 
study will be carried out under the guidance of Dr Dougal Hare (Academic Supervisor). It is 
funded by Cardiff University.  
 
2.7 Where will the findings be published? 
 I intend to publish the results in peer-reviewed journals 
 I intend to present the results at scientific conferences 
 I may put a summary of the findings in an NSPKU (The National Society for 
Phenylketonuria) newsletter. 
 I will provide participants with a summary of the findings if they would like this. 
 
2.8 Who has reviewed the study?  
This study has been reviewed and given a favourable opinion by the Cardiff University School 
of Psychology Research Ethics Committee. 
 
2.9 Who can I contact for further information? 
 
If you would like to discuss the study or have any questions or concerns, please do not 
hesitate to contact Miss Olivia Ambler at amblero@cardiff.ac.uk or tel. 02920 870582.  
 
You can also contact Dr Dougal Hare using the following address: 
Department of Clinical Psychology 
11
th
 Floor Tower Building 
70 Park Place 
Cardiff University 
Cardiff  
CF10 3AT 
Tel: +44 (0)2920 870582 
Email: HareD@cardiff.ac.uk 
 
Alternatively, you can contact the School of Psychology Research Ethics Committee at 
Cardiff University using the address below: 
School of Psychology  
Cardiff University 
Tower Building  
70 Park Place 
Cardiff 
CF10 3AT 
Tel:  +44 (0)2920 870360 
Email psychethics@cardiff.ac.uk 
 
 
You can keep this copy of the information sheet. 
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4.4 Opt out form 
 
 
Parenting a child with Phenylketonuria (PKU): An investigation into the factors that 
contribute to parental well-being 
 
 
Opt out form 
                           Please tick 
  I would NOT like to take part in the above study.  
 
 
You do not have to give a reason, but if you feel able to tell us why, it will help us to 
understand why some people choose not to take part in this type of project.  
________________________________________________________________________ 
________________________________________________________________________ 
 
Name of child ___________________ 
Name of Parent / Carer ________________       
Date _______________ 
 
 
 
 
Thank you for taking the time to complete and 
return this form 
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4.5 Debrief letter 
 
 
 
Dear  
 
 
Parenting a child with Phenylketonuria (PKU): An investigation into the factors that 
contribute to parental well-being 
 
 
This study had three aims:  
1. To compare levels of psychological distress between parents of children and young 
people with PKU and parents in the general population 
2. To compare the incidence of child behaviour problems experienced by children and 
young people with PKU and compare this to the general population 
3. To examine the factors that contribute towards psychological distress in parents of 
children with PKU, distinct from parents in the general population 
 
Two groups of participants were recruited for this study: An experimental group with parents 
of children with PKU and a control group with parents of children without PKU. As the parent 
of a child with PKU, you contributed to the experimental group in the study. 
 
Parents in both groups were asked to complete the same set of questionnaires. These 
measured: 
 
 Psychological distress 
 Psychological resilience 
 Perceived social support 
 Child behaviour 
 Socio-demographic information 
 
In addition to this, parents in the experimental group were asked to complete two more 
questionnaires. These measured: 
 
 Child behaviour related to developmental difficulties  
 The care dependency of the child 
 
The responses from these questionnaires will be analysed in four stages, outlined below: 
 
1. For the first part of the analysis, levels of psychological distress in parents of children with 
PKU will be compared to parents of children without PKU.  
 
2. For the second part of the analysis, child behaviour problems will be compared between 
parents of children with PKU and parents of children without PKU. 
 
3. For the third part of the analysis, the factors contribute to psychological distress will be 
examined in both groups of parents 
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All the data we collected for this study is confidential, all personal and identifiable information 
will be kept anonymous and can only be accessed by the researcher and relevant members 
of the research team. Your participation in this study is greatly appreciated. 
 
If you have any questions or queries about this project, please phone me on 02920870582 or 
email me at amblero@cardiff.ac.uk. Alternatively, you can contact my supervisor, Dr Dougal 
Julian Hare on the above telephone number or email address HareD@cardiff.ac.uk. 
 
 
Thank you again for your participation. 
 
 
Yours sincerely, 
 
 
 
Miss Olivia Ambler 
Trainee Clinical Psychologist 
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4.6 Thank you letter 
 
Dear  
 
 
Parenting a child with Phenylketonuria (PKU): An investigation into the factors that 
contribute to parental well-being 
 
 
I am writing to express my thanks to you for taking part in the above study. Thank you very 
much for completing and returning your consent form and questionnaires. 
 
Your participation is very important, as it will help contribute toward our understanding of how 
best to support parents of children with PKU. 
 
You have now been entered into prize draw for a £100 shopping voucher as a thank you for 
taking part.  
 
If you would like to receive a summary of the study findings, please phone me on 02920 
870582 or email me at amblero@cardiff.ac.uk. 
 
 
Yours sincerely, 
 
 
 
 
Miss Olivia Ambler 
Trainee Clinical Psychologist 
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4.7 List of support services 
 
LIST OF SUPPORT SERVICES 
Parenting a child with Phenylketonuria (PKU): An investigation into the factors that 
contribute to parental well-being 
 
Some of the questionnaires used in this study covered potentially sensitive material. If you 
feel affected from contributing to this research and wish to seek additional support or advice, 
we recommend that you contact one of the following services: 
 
 Contact details for Dr Dougal Julian Hare, Clinical Psychologist in the field of 
Intellectual Disabilities: 
Address: South Wales Doctoral Programme in Clinical Psychology 
11
th
 Floor  
Tower Building 
70 Park Place 
Cardiff  
CF11 3AT 
Email: HareD@cardiff.ac.uk Telephone: 02920870582 
 
 ‘Contact a family: For parents of children with disabilities’. Online advice and support 
available via www.cafamily.org.uk/medical-information/conditions/p/phenylketonuria/  
Telephone support available Monday-Friday, 9.30am to 5.00pm on  
0808 808 3555 or email helpline@cafamily.org.uk 
 
 Online information and support about PKU and its management is available from:  
www.nhs.uk/conditions/phenylketonuria/Pages/Introduction.aspx 
Online support and advice for parents of children with PKU: 
www.pkuconnect.co.uk/overview/parents/  
A comprehensive list of other online support service is also available at 
www.pku.com/resources/related-websites  
 
 National Society for Phenylketonuria (NSPKU) www.nspku.org/contact/general  
Helpline 030 3040 1090 
Email info@nspku.org  
 
 Young minds parents, support for parents of children with or without physical/mental 
health difficulties. Advice is offered to parents who may be worried about the 
behaviour or wellbeing of their child 
www.youngminds.org.uk/for_parents/parent_helpline  
Helpline  0808 802 5544, Email ymenquiries@youngminds.org.uk 
Address Suit 11, Baden Place, Crosby Row, London SE1 1YW 
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Appendix 5: Participant information sheets for control group 
5.1 Consent form 
 
CONSENT FORM 
Participant ID:_____ 
Title of Project: Parenting a child with Phenylketonuria (PKU): An investigation into the 
factors that contribute to parental well-being 
Name of Researcher: Miss Olivia Ambler                                                                                                                                                          
 
1 
I confirm that I have read the information for the above study. I have had the 
opportunity to consider the information, ask questions and have had these 
answered satisfactorily. 
 
2 
I confirm that I do not care for a child with a serious health condition, nor do I 
have any other significant caring responsibilities that may impact on my 
wellbeing (for example, caring for an elderly relative).  
 
3 I confirm that I am not affected by any serious physical or mental health 
problems that may impact upon my wellbeing (for example, chronic pain).  
 
4 
I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights 
being affected, up until the research data has been analysed. 
 
5 
I understand that data collected during the study may be looked at by 
individuals from Cardiff University, regulatory authorities and members of the 
National Society for Phenylketonuria. I give permission for these individuals to 
have access to my data. 
 
6 
I understand that data from the study will be stored for a minimum of five years 
after its completion, or at least two years post-publication to allow for any further 
analysis or review to be conducted. After this time period, all paper copies of 
data will be destroyed and electronic copies will be deleted. I give permission 
for my data to be stored for this time. 
 
7 I agree to take part in the above study.  
 
Name of child  _____________________ Name of Participant______________ 
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Participant Signature ____________________ Date _______________ 
5.2 Invitation letter 
 
 
 
    Invitation Letter    
 
Dear 
 
Parenting a child with Phenylketonuria (PKU): An investigation into the factors that 
contribute to parental well-being 
 
 
I am writing to invite you to take part in a research study being conducted at Cardiff University 
with parents of children with and without Phenylketonuria (PKU).  
 
To date, there has been little research into the factors that contribute to parental well-being in 
PKU. It would be useful to find out more information about this to help support families 
affected by the condition.  
 
This study will investigate the different factors that affect the wellbeing of parents who care for 
a child with PKU, compared to parents who care for a child without PKU. It will also 
investigate child behaviour in PKU and examine whether this too, impacts on parent’s 
wellbeing.  
 
As you have a child who is between the ages of 0 and 18 years old and who does not have 
PKU, you are invited to take part in this study. You will find enclosed with this letter a 
participant information sheet, consent form, a list of support services, an opt-out form and 
some questionnaires. 
 
If you would like to find out more about this project, please read the participant information 
sheet. If you would like to find out any further information, please email me on 
amblero@cardiff.ac.uk or telephone me on 02920 870582. 
 
If you would like to take part after reading the participant information sheet, please complete 
the enclosed consent form and questionnaires. If you would like any help with completing the 
questionnaires, please contact me using the above contact details. Please take short breaks 
when filling in the questionnaires if you feel tired. 
 
Please return the consent form and questionnaires in the addressed pre-paid envelope (no 
stamp is required), or hand them into the Department of Clinical Psychology administration 
team on the 11
th
 Floor, Tower Building, Park Place, Cardiff, CF10 3AT.  
 
If you would prefer NOT to take part in this project please complete and return the attached 
opt-out form in the pre-paid envelope along with the blank questionnaires, so that I do not 
contact you again. 
 
I look forward to hearing from you. 
 
Yours sincerely, 
 
 
 
Miss Olivia Ambler 
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Trainee Clinical Psychologist 
 
5.3 Participant information sheet 
 
Participant Information Sheet  
 
Parenting a child with Phenylketonuria (PKU): An investigation into the factors that 
contribute to parental well-being 
 
Research Team: Miss Olivia Ambler (Cardiff Univeristy), Dr Emma Meford (University of 
Manchester) and Dr Dougal Hare (Cardiff University).  
 
I would like to invite you to take part in my research study. Joining the study is entirely up to 
you. Before you decide I would like you to understand why the research is being done and 
what it would involve for you.  
Part 1 tells you the purpose of this study and what it will involve if you take part. 
Part 2 gives you more detailed information about the conduct of the study. 
I recommend that you take a minimum of 24 hours to consider the information below before 
deciding whether to take part. 
 
Part 1 
 
1.1 What is the purpose of the study? 
 
There has been little research on what it is like to look after a child with Phenylketonuria 
(PKU). This study will investigate child behaviour in PKU and how this affects parent’s 
wellbeing. 
 
 
1.2 Why have I been invited to take part in this study? 
 
You have been invited to take part because you have a child who is between the ages of 0-18 
and who does not have a serious health condition. You have also been invited because your 
family is not currently affected by any other serious physical or mental health problems that 
may impact upon your wellbeing. In total, we will need 99 other people to also take part in this 
project. 
 
 
1.3 Do I have to take part? 
 
No, you do not have to take part in the study if you do not want to. Taking part in the research 
is voluntary; this means it is completely up to you to decide whether or not to take part. Your 
decision to participate in this study will not be connected to the care you and your family are 
receiving now or in the future. If you decide to take part and sign the consent form but change 
your mind later, you are free to withdraw at any point during the study without giving a reason 
and without any consequence to your current or future treatment. 
 
 
1.4 What will participation involve? 
 
Parents/ carers will complete a set of questionnaires, which ask about: 
 Demographic information 
 Levels of psychological distress 
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 Levels of resilience 
 Support from family and friends 
 Any behavioural problems experienced by the child 
Together, these questionnaires will take about 30 minutes to complete. You will be provided 
with a pre-paid envelope to return the questionnaires. 
 
 
1.5 What are the possible disadvantages and risks of taking part?  
 
It is possible that the questionnaires might raise issues that could be distressing to think 
about. A list of agencies and people you can contact is provided should you need any 
additional information/support.  
 
 
1.6 What are the possible benefits of taking part? 
 
The information gained will help services to fully understand the demands of caring for a child 
with PKU. It will also help identify some of the most effective ways to support parents. This 
will enable clinicians to develop appropriate support packages, which may help other families 
in the future. 
 
 
1.7 Will my taking part in the study be kept confidential?  
 
Yes. Your data will be handled sensitively and in confidence; all legal and ethical guidelines 
will be followed.  More details are given in Part 2. 
 
 
Part 2 
 
2.1 What will happen if I do not want to carry on with the study? 
 
You can withdraw from the study at any time without giving a reason and without any 
consequence to your family’s current or future treatment, up until the data has been analysed. 
When the data is analysed it will not be personally identifiable. 
 
 
2.2 What if there is a problem? 
 
It is unlikely that anything would go wrong, but if you have a concern about any aspect of the 
study, you should contact one of the researchers or the School of Psychology Research 
Ethics Committee (contact information is provided in section 2.9). If you are not satisfied and 
wish to make a formal complaint, you can do so through the Cardiff University complaints 
procedure. Details can be obtained from the University. 
 
In the event that something does go wrong and you are harmed during the study and this is 
due to somebody’s negligence, then you may have grounds for a legal action for 
compensation against Cardiff University, but you might have to pay your legal costs.  
 
2.3 Will my data be confidential? 
 
 All data collected about you and your child will be kept strictly confidential and only 
viewed by members of the research team.  It will be stored securely in a locked filing cabinet 
at the University. 
 Data will be entered onto a computer database which will be password protected and 
encrypted.  Each participant will be assigned a number, thus names will not be entered onto 
the database. 
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 You will be asked to provide contact details for your GP, but they will not be routinely 
contacted.  During the study if any concerns arise about risk of harm to anyone, then I will 
have to contact the appropriate agency/person to provide support.  If possible, I would speak 
to you first about this.   
 I plan to publish the research and names of participants will not be used. 
2.4 Will I receive any payment for taking part in the study? 
 
No, participants will not receive any payment for taking part. However, when participants 
return their consent form and questionnaires, they will be entered into a prize draw, with the 
opportunity of winning a £100 shopping voucher as a thank you for taking part in the study.   
 
 
2.6 Who is organising the research? 
 
This research is being conducted as part of the Doctorate in Clinical Psychology at Cardiff 
University for Trainee Clinical Psychologist/postgraduate student Miss Olivia Ambler. This 
study will be carried out under the guidance of Dr Dougal Hare (Academic Supervisor). It is 
funded by Cardiff University.  
 
2.7 Where will the findings be published? 
 
 I intend to publish the results in peer-reviewed journals 
 I intend to present the results at scientific conferences 
 I may put a summary of the findings in an NSPKU (The National Society for 
Phenylketonuria) newsletter. 
 I will provide participants with a summary of the findings if they would like this. 
 
2.8 Who has reviewed the study?  
 
This study has been reviewed and given a favourable opinion by the Cardiff University School 
of Psychology Research Ethics Committee. 
 
2.9 Who can I contact for further information? 
 
If you would like to discuss the study or have any questions or concerns, please do not 
hesitate to contact Miss Olivia Ambler at amblero@cardiff.ac.uk or tel. 02920 870582.  
 
You can also contact Dr Dougal Hare using the following address: 
Department of Clinical Psychology 
11
th
 Floor Tower Building 
Park Place 
Cardiff University 
Cardiff  
CF10 3AT 
Tel: +44 (0)2920 870582 
Email: HareD@cardiff.ac.uk 
 
Alternatively, you can contact the School of Psychology Research Ethics Committee at 
Cardiff University using the address below: 
School of Psychology  
Cardiff University 
Tower Building 
70 Park Place 
Cardiff 
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CF10 3AT 
Tel:  +44 (0)2920 870360 
Email psychethics@cardiff.ac.uk 
 
You can keep this copy of the information sheet. 
5.4 Opt out form 
 
Parenting a child with Phenylketonuria (PKU): An investigation into the factors that 
contribute to parental well-being 
 
 
Opt out form 
                           Please tick 
  I would NOT like to take part in the above study.  
 
 
You do not have to give a reason, but if you feel able to tell us why, it will help us to 
understand why some people choose not to take part in this type of project.  
________________________________________________________________________ 
________________________________________________________________________ 
 
Name of child ___________________ 
Name of Parent / Carer ________________       
Date _______________ 
 
 
 
 
Thank you for taking the time to complete and 
return this form 
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5.5 Debrief letter 
 
Debrief Letter 
 
Dear  
 
 
Parenting a child with Phenylketonuria (PKU): An investigation into the factors that 
contribute to parental well-being 
 
 
This study had three aims:  
4. To compare levels of psychological distress between parents of children and young 
people with PKU and parents in the general population 
5. To compare the incidence of child behaviour problems experienced by children and 
young people with PKU and compare this to the general population 
6. To examine the factors that contribute towards psychological distress in parents of 
children with PKU, distinct from parents in the general population 
 
Two groups of participants were recruited for this study: An experimental group with parents 
of children with PKU and a control group with parents of children without PKU. As the parent 
of a child without PKU or any other health condition, you contributed to the control group in 
the study. 
 
Parents in both groups were asked to complete the same set of questionnaires. These 
measured: 
 
 Psychological distress 
 Psychological resilience 
 Perceived social support 
 Child behaviour 
 Socio-demographic information 
 
In addition to this, parents in the experimental group were asked to complete two more 
questionnaires. These measured: 
 
 Child behaviour related to developmental difficulties  
 The care dependency of the child 
 
The responses from these questionnaires will be analysed in four stages, outlined below: 
 
1. For the first part of the analysis, levels of psychological distress in parents of children with 
PKU will be compared to parents of children without PKU.  
 
2. For the second part of the analysis, child behaviour problems will be compared between 
parents of children with PKU and parents of children without PKU. 
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3. For the third part of the analysis, the factors contribute to psychological distress will be 
examined in both groups of parents 
 
All the data we collected for this study is confidential, all personal and identifiable information 
will be kept anonymous and can only be accessed by the researcher and relevant members 
of the research team. Your participation in this study is greatly appreciated. 
 
If you have any questions or queries about this project, please phone me on 02920870582 or 
email me at amblero@cardiff.ac.uk. Alternatively, you can contact my supervisor, Dr Dougal 
Julian Hare on the above telephone number or email address HareD@cardiff.ac.uk. 
 
 
Thank you again for your participation. 
 
 
Yours sincerely, 
 
 
 
Miss Olivia Ambler 
Trainee Clinical Psychologist 
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5.6 Thank you letter 
 
Dear  
 
 
Parenting a child with Phenylketonuria (PKU): An investigation into the factors that 
contribute to parental well-being 
 
 
I am writing to express my thanks to you for taking part in the above study. Thank you very 
much for completing and returning your consent form and questionnaires. 
 
Your participation is very important, as it will help contribute toward our understanding of how 
best to support parents of children with PKU. 
 
You have now been entered into prize draw for a £100 shopping voucher as a thank you for 
taking part.  
 
If you would like to receive a summary of the study findings, please phone me on 02920 
870582 or email me at amblero@cardiff.ac.uk. 
 
 
Yours sincerely, 
 
 
 
 
Miss Olivia Ambler 
Trainee Clinical Psychologist 
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5.7 List of support services 
 
LIST OF SUPPORT SERVICES 
Parenting a child with Phenylketonuria (PKU): An investigation into the factors that 
contribute to parental well-being 
 
Some of the questionnaires used in this study covered potentially sensitive material. If you 
feel affected from contributing to this research and wish to seek additional support or advice, 
we recommend that you contact one of the following services: 
 
 Contact details for Dr Dougal Julian Hare, Clinical Psychologist in the field of 
Intellectual Disabilities: 
Address: South Wales Doctoral Programme in Clinical Psychology 
11
th
 Floor  
Tower Building 
70 Park Place 
Cardiff  
CF11 3AT 
Email: HareD@cardiff.ac.uk Telephone: 02920870582 
 
 ‘Contact a family: For parents of children with disabilities’. Online advice and support 
available via www.cafamily.org.uk/medical-information/conditions/p/phenylketonuria/  
Telephone support available Monday-Friday, 9.30am to 5.00pm on 0808 808 3555 or 
email helpline@cafamily.org.uk 
 
 Online information and support about PKU and its management is available from:  
www.nhs.uk/conditions/phenylketonuria/Pages/Introduction.aspx 
Online support and advice for parents of children with PKU: 
www.pkuconnect.co.uk/overview/parents/  
A comprehensive list of other online support service is also available at 
www.pku.com/resources/related-websites  
 
 National Society for Phenylketonuria (NSPKU) www.nspku.org/contact/general  
Helpline 030 3040 1090 
Email info@nspku.org 
 
 Young minds parents, support for parents of children with or without physical/mental 
health difficulties. Advice is offered to parents who may be worried about the 
behaviour or wellbeing of their child 
www.youngminds.org.uk/for_parents/parent_helpline  
 156 
Helpline  0808 802 5544, Email ymenquiries@youngminds.org.uk 
Address Suit 11, Baden Place, Crosby Row, London SE1 1YW 
 
5.8 Reminder letter for participants in experimental and control groups 
 
 
Dear  
 
 
Parenting a child with Phenylketonuria (PKU): An investigation into the factors that 
contribute to parental well-being 
 
I am writing to invite you to take part in a major research study being conducted at Cardiff 
University with parents of children with and without Phenylketonuria (PKU). The study is 
under the direction of Dr Dougal Hare from Cardiff University.  
 
There has been little research on what it is like to look after a child with PKU and how PKU 
affects children’s behaviour. This study will investigate child behaviour in PKU and the impact 
of this on parent’s wellbeing. It will also look at the different things that affect parent’s 
wellbeing and to help identify what might improve this.  
 
You will find enclosed with this letter a participant information sheet, a consent form, some 
questionnaires, a list of support services and an opt-out form. 
 
If you are interested in finding out more about this project, please read the participant 
information sheet for further details. If you would like any further information, please phone 
me on 02920 870582 or email me at amblero@cardiff.ac.uk. 
 
If you would like to take part in this project after reading the participant information sheet, 
please complete the enclosed consent form and questionnaires. If you would like any 
assistance with completing the questionnaires please contact me using the above contact 
details.  
 
Please return the consent form and questionnaires in the addressed pre-paid envelope (no 
stamp is required), or hand them in to the administration team at the Department of Clinical 
Psychology, 11
th
 Floor Tower Building, Park Place, Cardiff University, Cardiff CF10 3AT. 
 
If you experience any tiredness or fatigue when completing the questionnaires, please take 
short breaks as necessary. If you would like any support or information regarding your 
emotional wellbeing, please see the list of support services and contacts. 
 
Participation in this study is voluntary and will in no way affect the medical treatment of your 
family.  
 
 
I look forward to hearing from you. 
 
 
Yours sincerely, 
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Miss Olivia Ambler 
Trainee Clinical Psychologist 
 
Appendix 6: SPSS output  
6.1 Tests of normality for experimental and control groups 
6.1.2 Normality statistics experimental group 
 
Tests of Normality 
 Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Ex_MPSS_SO .240 26 .000 .696 26 .000 
Ex_MPSS_Fa .213 26 .004 .781 26 .000 
Ex_MPSS_Fr .217 26 .003 .838 26 .001 
Ex_MPSS_Total .179 26 .031 .793 26 .000 
Ex_ECBI_Problem .187 26 .020 .834 26 .001 
Ex_ECBI_Intensity .094 26 .200* .961 26 .412 
Ex_GHQ12_Total .219 26 .002 .908 26 .024 
Ex_RSA_Total .142 26 .193 .927 26 .067 
Disruptive/antisocia
l 
.198 26 .010 .887 26 .008 
DBC_self_absorbe
d 
.199 26 .009 .783 26 .000 
Communication 
disturbance 
.279 26 .000 .746 26 .000 
DBC_anxiety .247 26 .000 .862 26 .002 
DBC_social_relatin
g 
.325 26 .000 .708 26 .000 
Total score .193 26 .014 .864 26 .003 
Child_dependency .296 26 .000 .795 26 .000 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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6.1.3 Normality statistics control group 
 
Tests of Normality 
 Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Significant Other .319 30 .000 .603 30 .000 
Family .231 30 .000 .776 30 .000 
Friends .251 30 .000 .702 30 .000 
Total score .258 30 .000 .678 30 .000 
Problem t score .223 30 .001 .802 30 .000 
Intensity t score .095 30 .200* .968 30 .481 
C_GHQ12_total .134 30 .179 .971 30 .577 
Total score .125 30 .200* .950 30 .166 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
 
6.2 Descriptive statistics for experimental and control groups 
 
Descriptive Statistics 
 N Range Mean Std. Deviation 
Statistic Statistic Statistic Std. Error Statistic 
Ex_MPSS_SO 38 24.00 24.1842 .91211 5.62261 
Significant Other 32 24.00 24.6563 1.13469 6.41877 
Ex_MPSS_Fa 38 24.00 22.2632 .90336 5.56866 
Family 32 24.00 23.3750 1.01575 5.74597 
Ex_MPSS_Fr 38 23.00 21.3947 1.02912 6.34392 
Friends 32 24.00 24.1563 1.06076 6.00059 
Ex_MPSS_Total 38 68.00 67.8421 2.28344 14.07610 
Total score 32 72.00 72.1562 3.07471 17.39319 
Ex_ECBI_Problem 34 29.00 6.5588 1.33524 7.78573 
Problem t score 30 17.00 3.6000 .81452 4.46133 
Ex_ECBI_Intensity 34 126.00 103.5588 5.32244 31.03487 
Intensity t score 30 78.00 88.6333 3.92237 21.48373 
Ex_GHQ12_Total 38 14.00 10.2895 .47991 2.95834 
C_GHQ12_total 32 16.00 9.6250 .64719 3.66104 
Ex_RSA_Total 38 93.00 179.3158 3.89315 23.99899 
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Total score 32 85.00 191.0625 3.56165 20.14774 
Disruptive/antisocia
l 
28 27.00 7.1786 1.29718 6.86404 
DBC_self_absorbe
d 
28 21.00 3.8929 .84255 4.45836 
Communication 
disturbance 
28 10.00 1.7857 .46107 2.43975 
DBC_anxiety 28 11.00 2.8929 .54272 2.87182 
DBC_social_relatin
g 
28 9.00 1.5357 .41938 2.21914 
Total score 28 60.00 18.8214 3.08738 16.33686 
Child_dependency 38 6.00 5.8947 .27917 1.72093 
Valid N (listwise) 18     
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6.3 Independent t-test results using bootstrapping 
 
Group Statistics 
 GROUP Statistic Bootstrapa 
 Bias Std. Error 95% Confidence Interval 
 Lower Upper 
GHQ12_total 
Control 
N 30     
Mean 9.7000 -.0072 .6595 8.4287 11.0000 
Std. Deviation 3.65919 -.09415 .48420 2.49780 4.46526 
Std. Error Mean .66807     
Experimental 
N 36     
Mean 10.4722 -.0141 .4882 9.5627 11.4496 
Std. Deviation 2.93244 -.07436 .36855 2.11962 3.55128 
Std. Error Mean .48874     
Int_ECBI_Raw 
Control 
N 30     
Mean 88.6333 -.0656 3.8911 80.4253 96.1411 
Std. Deviation 21.48373 -.50451 2.05928 16.62855 24.80325 
Std. Error Mean 3.92237     
Experimental 
N 36     
Mean 101.5278 .0757 5.1401 91.7634 111.9716 
Std. Deviation 31.31270 -.43494 3.35083 23.77832 37.50389 
Std. Error Mean 5.21878     
Prob_ECBI_Raw Control 
N 30     
Mean 3.6000 .0194 .8244 2.0371 5.3124 
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Std. Deviation 4.46133 -.13584 .73952 2.84517 5.80226 
Std. Error Mean .81452     
Experimental 
N 36     
Mean 6.3333 .0444 1.2442 4.0338 9.0000 
Std. Deviation 7.61952 -.14152 1.21510 4.83580 9.67130 
Std. Error Mean 1.26992     
a. Unless otherwise noted, bootstrap results are based on 1000 bootstrap samples 
 
 
 
 
 
 Levene's Test for Equality of 
Variances 
F Sig. t df Sig. (2-
tailed) 
95% Confidence Interval of the Difference 
Lower Upper 
GHQ12_total 
Equal 
variances 
assumed 
.965 .329 -.840 68 .404 -2.24313 .91418 
Equal 
variances 
not 
assumed 
  
-.825 59.414 .413 -2.27645 .94750 
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Bootstrap for Independent Samples Test 
 Mean 
Difference 
Bootstrapa 
Bias Std. Error Sig. (2-tailed) 95% Confidence Interval 
Lower Upper 
GHQ12_total 
Equal variances 
assumed 
-.66447 .02351 .76313 .404 -2.10584 .93174 
Equal variances not 
assumed 
-.66447 .02351 .76313 .404 -2.10584 .93174 
a. Unless otherwise noted, bootstrap results are based on 1000 bootstrap samples 
 
 
 
 
 Levene's Test for 
Equality of Variances 
F Sig. t df Sig. (2-
tailed) 
95% Confidence Interval  
Lower Upper 
Int_ECBI_Raw 
Equal 
variances 
assumed 
3.190 .079 -1.911 64 .061 -26.37708 .58819 
Equal 
variances not 
assumed 
  
-1.975 61.880 .053 -25.94514 .15625 
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Prob_ECBI_Raw 
Equal 
variances 
assumed 
4.886 .031 -1.732 64 .088 -5.88660 .41993 
Equal 
variances not 
assumed 
  
-1.812 57.895 .075 -5.75342 .28675 
 
 
 
 
 
Bootstrap for Independent Samples Test 
 Mean 
Difference 
Bootstrapa 
Bias Std. Error Sig. (2-tailed) 95% Confidence Interval 
Lower Upper 
Int_ECBI_Raw 
Equal variances 
assumed 
-12.89444 .26557 6.29538 .049 -24.58161 -.36088 
Equal variances not 
assumed 
-12.89444 .26557 6.29538 .049 -24.58161 -.36088 
a. Unless otherwise noted, bootstrap results are based on 1000 bootstrap samples 
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Bootstrap for Independent Samples Test 
 Mean 
Difference 
Bootstrapa 
Bias Std. Error Sig. (2-tailed) 95% Confidence Interval 
Lower Upper 
Prob_ECBI_Raw 
Equal variances 
assumed 
-2.73333 -.09832 1.51507 .077 -5.95445 .03187 
Equal variances not 
assumed 
-2.73333 -.09832 1.51507 .076 -5.95445 .03187 
a. Unless otherwise noted, bootstrap results are based on 1000 bootstrap samples 
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6.4 Correlation analysis with bootstrapping for experimental group 
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Correlations between variables for control group using bootstrapping  
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Appendix 6.5 
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Multiple regression output with boostrapping for experimental group
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Multiple regression with bootstrapping output for control group
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Appendix 7: Author guidelines for the Journal of Inherited Metabolic Disease 
 
JIMD – Journal of Inherited Metabolic Disease 
Aims and Scope 
The Journal of Inherited Metabolic Disease (JIMD) is the official journal of the 
Society for the Study of Inborn Errors of Metabolism (SSIEM). By enhancing 
communication between workers in the field throughout the world, the JIMD aims to 
improve the management and understanding of inherited metabolic disorders. It 
publishes results of original research and new or important observations pertaining to 
any aspect of inherited metabolic disease in humans and higher animals. This includes 
clinical (medical, dental and veterinary), biochemical, genetic (including cytogenetic, 
molecular and population genetic), experimental (including cell biological), 
methodological, theoretical, epidemiological, ethical and counselling aspects. The 
JIMD also reviews important new developments or controversial issues relating to 
metabolic disorders and publishes reviews and short reports arising from the Society's 
annual symposia. A distinction is made between peer-reviewed scientific material that 
is selected because of its significance for other professionals in the field and non-
peerreviewed material that aims to be important, controversial, interesting or 
entertaining (“Extras”). 
 
The JIMD exists as two sister publications which are served by a single Editorial 
Team and a single manuscript submission and review process: the traditional print 
and online journal JIMD and JIMD Reports, which publishes scientifically sound 
research findings or clinical observations that warrant communication in the peer-
reviewed literature but are of more limited interest to the readers. In addition to full 
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electronic publication, and print publication as book chapters, the abstract of a JIMD 
Reports publication is also printed in the JIMD, to each the widest possible 
readership. All other types of articles are published electronically and in print in the 
JIMD. 
 
Instructions for submission 
Manuscript submission 
Material submitted to the JIMD (including JIMD Reports) must conform to the 
uniform requirements for manuscripts submitted to biomedical journals as outlined by 
the International Committee of Medical Journal Editors (ICMJE); see 
http://www.icmje.org/icmjerecommendations.pdf for details. 
 
Online Submission 
All scientific contributions for publication in the JIMD (including JIMD Reports) 
must be submitted by the web-enabled online manuscript submission and review 
system. As the review process is also fully web-based, this system allows editors to 
keep review times as short as possible and offers authors the option to track progress 
of the review of their manuscripts. The online manuscript submission and review 
system for the JIMD offers easy and straightforward log-in and submission 
procedures. Please refer to: www.editorialmanager.com/boli. The system supports a 
wide range of submission file formats for manuscripts (Word,WordPerfect, RTF, 
TXT and LaTex) and figures (TIFF, EPS, Microsoft® Office formats and Postscript). 
PDF is not an acceptable file format. 
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If you encounter any difficulties while submitting your manuscript online, please 
contact the responsible Editorial Assistant by clicking on "CONTACT US" from the 
tool bar. 
 
Manuscript Structure 
The first page should include: 
of the article 
JIMD 
uding postal (ZIP) code, of the 
author who will be dealing with correspondence and proofs. 
counts for the text (excluding summary, acknowledgments, references and 
figure legends) and the summary. 
 
or the front cover of the 
issue in which the article appears. 
 
The next page should include: 
edline allows a maximum 
of 4096 characters and will truncate longer abstracts). 
-home message (synopsis) of the article, outlining what 
the 
reader learns from the article (this is usually printed on the inside back cover of the 
JIMD). 
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Following these pages, authors are required to provide the following, which are 
detailed above in the section “General Rules.” 
ividual authors 
 
 
 
 
 
l Committee for Care and Use of 
Laboratory Animals (or comparable committee) 
t of approximately six keywords  
 
Recommendations for Manuscript Length 
Competition for publication in all scientific journals has become increasingly intense, 
and the JIMD is no exception. We strongly encourage prospective authors to consider 
brevity in their presentation, and if needed to avail themselves of the online 
supplementary material for those Figures and Tables that could be accommodated in 
that venue. In order for the Editorial Board to accommodate the broadest perspective 
of submissions, and to maximize the access for prospective authors to both the JIMD 
and JIMD Reports, the following recommendations for length have been formulated: 
 
for the Introduction and 
a 
maximum of 4 combined figures/tables. 
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e introduction and a 
maximum of 3 total figures/tables. It is expected that more comprehensive reviews 
will exceed these limits, but the authors of such reviews are again encouraged to work 
for brevity and succinctness in presentation. In all instances, literature citations should 
be reasonable and appropriate for the presentation, but should not exceed 30 citations 
for full articles and 25 citations for reports. Appropriate use of the cited literature is 
one way in which prospective authors can constrain the length of their submissions. 
 
Number of authors: The number of authors needs to be limited to a maximum of 20; 
additional authors may be included as consortium, listed as individual contributors at 
the end of the manuscript and recognized in PubMed. 
 
Covering letter 
Submit a covering letter and use it to explain why your paper should be published in 
The Journal of Inherited Metabolic Disease. 
 
General Rules 
It is a condition of acceptance that all articles have not been and will not be published 
elsewhere in substantially the same form. The submitting author must have circulated 
the article and secured final approval of the version to be peer-reviewed from all co-
authors prior to article submission. This includes confirmation of 
ons, 
 
hould have been involved in 
(a) conception and design, or analysis and interpretation of data, and (b) drafting the 
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article or revising it critically for important intellectual content), and their agreement 
to submission. 
It should be noted that these conditions are later confirmed in writing by the 
corresponding author in a copyright transfer form at the time of acceptance. 
Publication elsewhere, at any time, of a similar article perhaps only differing in some 
aspects of data, especially if the JIMD article is not cross-referenced, may justify 
formal retraction at a later date. Supplementary (internet-only) material may be 
published for all articles; we encourage or request deposition of raw data when this 
appears appropriate. 
 
The following information will be required at the time of online manuscript 
submission and is required on the page following the details listed in the section 
“Manuscript Structure” (below): 
 
pertinent aspects of the planning, conduct, and reporting of the work described in the 
article. 
epts full 
responsibility for the work and/or the conduct of the study, had access to the data, and 
controlled the decision to publish. 
 
authors or a declaration that they have nothing to declare, based on the “Competing 
Interests Questions” outlined below. 
 
confirm(s) independence from the sponsors; the content of the article has not been 
influenced by the sponsors” 
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studies  
 
information about a patient; proof that informed consent was obtained must be 
available upon request 
Institutional Committee for Care and Use of Laboratory Animals (or comparable 
committee). 
r importance for 
recognition of the manuscript after publication by some search engines. 
 
Statements, permissions, and signatures 
Authors and contributors 
The number of authors needs to be limited to a maximum of 20; additional authors 
may be included as consortium, listed as individual contributors at the end of the 
manuscript and recognized in PubMed. 
 
Declaration of interests and competing Interests Conflict of interest exists when an 
author (or the author’s institution), reviewer or editor has financial or personal 
relationships that inappropriately influence (bias) his or her actions (such 
relationships are also known as dual commitments, competing interests or competing 
loyalties). These relationships vary from those with negligible potential to those with 
great potential to influence judgment, and not all relationships represent true conflict 
of interest. The potential for conflict of interest can exist whether or not an individual 
believes that the relationship affects his or her scientific judgment. Financial 
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relationships (such as employment, consultancies, stock ownership, honoraria, or paid 
expert testimony) are the most easily identifiable conflicts of interest and the most 
likely to undermine the credibility of the journal, the authors and science itself. 
However, conflicts can occur for other reasons, such as personal relationships, 
academic competition and intellectual passion. All authors (co-authors) of articles, 
reports, reviews, editorials and other material submitted to the JIMD (including JIMD 
Reports) as well as reviewers of manuscripts must answer the following questions: 
 
1. Have you in the past five years accepted the following from an organisation that 
may in any way gain or lose financially from the results of your study or the 
conclusions of your review, editorial or letter: 
 
 
 
r consulting? 
 
2. Have you in the past five years been employed by an organisation that may in any 
way gain or lose financially from the results of your study or the conclusions of your 
review, editorial or letter? Do you hold any stocks or shares in such an organisation? 
 
3. Have you acted as an expert witness on the subject of your study, review, editorial 
or letter? 
 
4. Do you have any other competing financial interests?  
 
 198 
Authors who have answered "yes" to any of these questions may have a competing 
interest which should be declared at the time of submission of the article (review, 
editorial or other material) and which will be published in JIMD. 
 
Other non-financial interests that authors may like to disclose include: 
 close relationship with, or a strong antipathy to, a person whose interests may be 
affected by publication of the article. 
 may be affected by 
publication of the article. 
l party or special interest group whose interests may be 
affected by publication of the article. 
wrote and that readers should be aware of when reading the article. 
 
Expert reviewers approached for assessment of submitted articles are also requested 
to declare conflicts of interest that may impede on their judgement of that article. This 
specifically includes competing research in the same area that could be negatively 
affected by publication of the submitted article. For additional information see also 
the ICJME’s “Recommendations for the Conduct, Reporting, Editing, and Publication 
of Scholarly Work in Medical Journals” at http://www.icmje.org/about-
icmje/faqs/icmje-recommendations/ 
 
Ethical guidelines, human and animal rights and consents 
If the work involves the use of human subjects, the author should ensure that the work 
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described has been carried out in accordance with The Code of Ethics of the World 
Medical Association (Declaration of Helsinki) for experiments involving humans 
(Uniform Requirements for manuscripts submitted to Biomedical journals). Authors 
should include a statement in the manuscript that informed consent was obtained for 
experimentation with human subjects. The privacy rights of human subjects must 
always be observed. All animal experiments should comply with the ARRIVE 
guidelines and should be carried out in accordance with the U.K. Animals (Scientific 
Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for 
animal experiments, or the National Institutes of Health guide for the care and use of 
Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should 
clearly indicate in the manuscript that such guidelines have been followed. 
 
Types of article and manuscript requirements 
Scientific contributions 
Full Articles 
The JIMD welcomes scientific contributions for publication as printed full articles in 
the following categories: 
change clinical or research practice with regard to inherited metabolic disorders. 
Original articles may include comprehensive studies on disease features in groups of 
patients, important novel information on a disease or relevant research findings. Case 
reports are unlikely to be accepted as original papers in print JIMD, unless they 
describe novel diseases or new aspects of the basic pathomechanism of a disease, 
supported by novel functional data. The editors may reject submitted manuscripts as 
original articles but invite revision or resubmission for publication as Reports in 
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“JIMD Reports”. All authors are invited to provide a colour picture that may be used 
for the front cover of the issue in which the article appears. 
manuscripts; please contact 
theeditorial office: editor@jimd.org. 
tative analysis of the 
clinical features, treatment and outcome of inborn errors of metabolism. For detailed 
information, we refer to the Editorial: Zschocke J, Baumgartner MR, Morava E, 
Patterson MC, Peters V and Rahman S (2016) Recommendations and guidelines in 
the JIMD: suggested procedures and avoidance of conflicts of interest. J Inherit Metab 
Dis, 39:327-330 
 
treatment options etc. 
es all researchers who have completed a 
Ph.D. or M.D. thesis in the field of inborn errors of metabolism to submit a 
comprehensive review of the topic of their thesis. The article should not focus solely 
on the research findings but should cover all relevant information in the respective 
field. Such reviews preferably (but not necessarily) have a single author (other 
contributors should be acknowledged) and will be published with a photograph of the 
investigator. 
 
Images in Metabolic Medicine 
The Editors will consider clear and interesting clinical pictures or other types of 
images (e.g. laboratory results or observations) submitted with a descriptive 
paragraph of up to 250 words. 
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Prints, slides or electronic copy are all acceptable. Authors must obtain informed 
consent for publication of patient-related materials. Case reports or additional 
information may be added as supplementary material. Images will be fully printed; 
title and author(s) will be listed in bibliographical databases such as Medline. 
 
Editorials 
The JIMD invites communicating editors and reviewers of articles that have been 
accepted for publication in the JIMD to provide an editorial that places the article in a 
broader context. Editorials have no abstract, may be comprised of up to 500 words 
and should contain no more than two (if any) references. Additional material can be 
added as supplementary material online. Editorials will be fully printed; title and 
author(s) will be listed in bibliographical databases such as Medline. 
 
Letters and Clinical/Research Observations 
The JIMD is happy to receive comments on previously published articles in the 
journal which should reach the editorial office within 4 weeks of publication of the 
original item. Correspondence may be subjected to peer review and counter-replies 
are usually invited from the authors of the original publication. The concise form of a 
letter may also be used to report exceptionally important clinical or research 
observations unrelated to a previous JIMD publication that merit communication but 
do not fulfil the requirements for scientific articles or short reports. These items will 
be peer reviewed and if accepted will be published under the heading “Observation”. 
Letters should have no more than five authors. They have no abstract, are limited to a 
maximum of 500 words and should contain no more than two (if any) references.  
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Additional material can be added as supplementary material online. Letters will be 
fully printed; title and author(s) will be listed in bibliographical databases such as 
Medline. 
 
JIMD Reports 
Some manuscripts present scientifically sound research findings or clinical 
observations that are worth communicating but are of more limited interest to the 
readers of the JIMD and may be sufficiently summarised in an abstract of 250 words. 
In order to facilitate publication of these types of manuscripts, JIMD Reports has been 
introduced as a sister publication of the traditional JIMD. It is an independent 
periodical with its own ISSN number. All manuscripts submitted as Reports to the 
JIMD website will be considered for JIMD Reports rather than for the traditional 
journal. They will undergo the same review process as Original Articles (and in 
exceptional cases may be reassigned for publication in the JIMD). In addition, the 
Editorial Team (based on the advice of reviewers and Communicating Editors) may 
reject Original Articles for publication in the JIMD but offer publication in JIMD 
Reports. After acceptance, articles in JIMD Reports are professionally typeset in the 
same manner as articles in the JIMD, and full documents are available online to 
SSIEM members and institutional subscribers via the Springer website. Articles from 
JIMD Reports are submitted to PubMedCentral and are listed in PubMed as well as 
other abstracting and indexing services. After an embargo period of 12 months, all 
manuscripts published in JIMD Reports (in contrast to JIMD articles) are available 
free of charge world-wide, thereby ensuring widest possible readership. In addition, 
titles and abstracts of Reports are printed in the print-only “Extras” section of the 
JIMD. It is recommended to make use of the full allowance of 250 words for the 
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abstract of Reports to convey the message of the article to the readers of the print 
journal. Reports follow the same rules as Full Articles; they should not be used as a 
form of preliminary communication. They may take the form of Research Reports, 
with content similar to that of original articles, or Case Reports. Case Reports will 
only be considered when they highlight some unusual or previously unrecorded 
feature relevant to the disorder or serve as an important reminder of clinical or 
biochemical features of a Mendelian disorder. Chance associations of two conditions 
or sporadic cases from new geographical locations (as opposed to systematic 
epidemiological studies) are not in themselves of sufficient scientific merit to justify 
publication. 
 
Extras in the JIMD 
The Editors of the JIMD invite submission of short items that are interesting, 
stimulating, important or entertaining to professionals working in the field of inborn 
errors of metabolism. These items will not usually be reviewed outside the editorial 
board and usually will not be referenced in bibliographic databases. All items of this 
type should be submitted by email to the editorial office (editor@jimd.org); please 
provide full personal details for all authors of each contribution. 
 
Garrodian 
Small texts that are used to fill gaps (e.g. at the end of original articles) have been a 
long and cherished tradition in some journals. They usually have the added advantage 
of entertaining readers and stimulating thought. The Editors are happy to receive 
interesting stories or personal experiences of up to a few hundred words on topics 
such as: 
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er / experience that changed my practice  
 
 
 
ying instruction, pathos or humour 
 
If the Garrodian refers to an identifiable person, written consent for publication from 
that person or an appropriate relative is required. 
 
Book Reviews 
Instructive reviews of up to 400 words are invited on new books published in the field 
of inborn errors of metabolism, or closely affiliated areas. 
 
Obituaries 
The Editors of the JIMD strongly encourage submission of obituary notices for all 
recently deceased SSIEM members or other persons in the field of inborn errors of 
metabolism. Obituary notices should be emailed to the editorial office. Please give 
your name and contact details, including a phone number and email address. 
Obituaries will be considered by the editorial board and may be shortened; they will 
be published (without proofs) with the name of the person(s) who submitted the 
notice. 
 
Please provide: 
1. The full name of the deceased 
2. A photograph 
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3. A summary of important data: 
a. (Last) professional position and title, place of work 
b. Date and place of birth 
c. Primary degree with university and year when obtained 
d. Additional professional qualifications with university and year when obtained 
e. Date of death, cause of death 
4. The main text summarising important contributions and personal characteristics of 
the deceased. The last sentence should state the remaining relatives such as spouse 
and/or the number of children and grandchildren. 
 
Formatting guidelines 
Language 
Please write your text in good English (American or British usage is accepted, but not 
a mixture of these). 
 
Text formatting 
Standard text formatting is recommended in word, with the preferential use of Times 
New Roman, 12 font letters and double spaced text documents. The submission 
process automatically converts text files to pdf. 
 
Units, Symbols, and Database References 
At the time of first mention, diseases, enzymes or genes should be referenced to the 
appropriate classification, nomenclature or database: 
es to the OMIM catalogue number 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM) 
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(http://www.chem.qmul.ac.uk/iubmb/enzyme/)   
-approved gene symbol 
(http://www.gene.ucl.ac.uk/nomenclature/) 
 
Authors should use SI units throughout the manuscript. Biochemical nomenclature 
should follow IUPAC-IUB recommendations 
(http://www.chem.qmul.ac.uk/iupac/jcbn/). Nomenclature of mutations or genetic 
variants should follow HGVS recommendations (http://www.hgvs.org/mutnomen/).  
 
At the time of first mention, genetic variants should be described with both protein 
designation and DNA designation (based preferably on cDNA reference numbers). 
Previously published material should be acknowledged, and written permission from 
copyright holders must be obtained to reproduce figures, tables or substantial sections 
of text. Where a paper relies on material that is under consideration by or in press in 
another journal, a copy of this must be provided for the referees. When writing the 
articles, please keep in mind the broad readership of the JIMD. For example, for 
methods that are widely reported or published it may be worthwhile to provide a brief 
two to three sentence description of the protocol to provide the reader with some 
insight into the methods used. 
 
References 
Consult a current issue of the journal. Citations in the text should use authors’ names 
then the date, e.g. (Smith and Smith 1977); for 3 or more authors use et al, e.g. (Jones 
et al 1989). 
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The full references are listed in alphabetical order at the end of the paper. Authors are 
listed without ‘and’. Give the first 3 authors plus et al when there are 7 or more 
authors. Both in the text and list use ‘et al’ without punctuation or italicization. 
Journal abbreviations follow Index Medicus or Chemical Abstracts. Examples are: 
 
Journals: 
Smith AL, Smith JD (1977) Hybridisation methods. Nucl Acids Res 8: 1095–1098. 
 
Chapter in an edited book: 
Weinstein L, Swartz MN (1974) Pathologic mechanisms of invading microorganisms. 
In Sodeman WA Jr, Sodeman WA, eds. Pathogenic Physiology: Mechanisms of 
Disease. Philadelphia: WB Saunders, 457–472. 
 
To cite a web site in the text (but not a specific document), it is sufficient to give the 
address/URL (e.g., http://www.ssiem.org) without an entry in the reference list. 
However, when citing a specific web document or information, a standard citation in 
the text (e.g. Gaten 2000) and an entry in the reference list is required. Internet 
references should include the same information that would be provided for a printed 
source (or as much information as possible). The Web information is then placed at 
the end of the reference. It is important to use "Retrieved from" and the date because 
documents on the Web may change in content, move or be removed from a site 
altogether.  
 
Reference to personal communications requires the explicit approval of the person 
quoted; written confirmation must be provided. Authors — not journal editors or copy 
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editors — are responsible for the accuracy of all references, which includes verifying 
the source of email communications, before citing them as personal communications 
in manuscripts.  
 
Tables 
Please submit tables as editable text and not as images. Tables should be placed on 
separate page(s) at the end. Number tables consecutively in accordance with their 
appearance in the text and place any table notes below the table body. Be sparing in 
the use of tables and ensure that the data presented in them do not duplicate results 
described elsewhere in the article. Please avoid using vertical rules.  
 
Figures 
Please make sure that artwork files are in an acceptable format (TIFF, JPEG or PDF), 
and with the correct resolution (>300 dpi). If, together with your accepted article, you 
submit usable color figures, it will be ensured, at no additional charge, that these 
figures will appear in color online regardless of whether or not these illustrations are 
reproduced in color in the printed version. For color reproduction in print, you will 
receive information regarding the costs after receipt of your accepted article. Please 
indicate your preference for color: in print or online only. Figures should be submitted 
as separate files. Ensure that each illustration has a caption. A caption should 
comprise a brief title (not on the figure itself) and a description of the illustration. 
Keep text in the illustrations themselves to a minimum but explain all symbols and 
abbreviations used. Figure legends should be included in the submitted manuscript at 
the end of the manuscript on a separate page. 
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Online material 
Supplementary files will only appear as online material. Supplementary material can 
support and enhance your scientific research. Supplementary files offer the author 
additional possibilities to publish supporting applications, high-resolution images, 
background datasets, sound clips and more. Please note that such items are published 
online exactly as they are submitted; there is no typesetting involved (supplementary 
data supplied as an Excel file or as a PowerPoint slide will appear as such online). 
Please submit the material together with the article and supply a concise and 
descriptive caption for each file. 
 
Research Materials 
It is assumed that authors whose research is published by the JIMD will make 
antibodies, cloned DNA sequences, and similar materials available to other 
investigators in noncommercial institutions, so as to permit replication of the reported 
work. 
 
After Acceptance of a Manuscript 
Proofs 
Proofs will be sent to the corresponding author by email. Responses, with or without 
corrections, should be sent within 72 hours. Please do not correct or edit the PDF file. 
Extensive corrections must be clearly marked on a printout of the PDF file and should 
be sent by first-class mail (airmail overseas). Minor corrections (+/- 10) may be sent 
via email attachment to proofscorrection@springer.com. Always quote the four-letter 
journal code (BOLI) and article number from your proof in the subject field of your 
email. 
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Page charges  
No page charges are levied on authors or their institutions except for colour pages. 
The corresponding author will be contacted regarding costs and invoicing if the 
printed manuscript includes colour figures. Colour page charges may be waived at the 
discretion of the editors. 
 
Copyright transfer 
Authors will be asked to transfer copyright of the article to the Publisher. This will 
ensure the widest possible dissemination of information under copyright laws. 
 
Open Access 
In addition to the normal publication process (whereby an article is submitted to the 
journal and access to that article is granted to customers who have purchased a 
subscription), Springer now provides an alternative publishing option: Springer Open 
Choice. A Springer Open Choice article receives all the benefits of a regular 
subscription-based article, but in addition is made available publicly through 
Springer’s online platform SpringerLink. To publish via Springer Open Choice, upon 
acceptance please click on the link sent to you by email to complete the relevant order 
form and provide the required payment information. Payment must be received in full 
before publication or articles will be published as regular subscription-model articles. 
We regret that Springer Open Choice cannot be ordered for published articles. See 
also: www.springeronline.com/openchoice. 
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Additional Information 
Additional information can be obtained from: 
 
Dr. Verena Peters 
Managing Editor, Journal of Inherited Metabolic Disease 
University Children´s Hospital 
Im Neuenheimer Feld 150 
69120 Heidelberg 
Germany 
Tel: +49 (6221) 5631715 
Fax: +49 (6221) 565565 
Email: Verena.Peters@med.uni-heidelberg.de 
 
Kathleen P. Lyons 
Executive Editor 
Nature Publishing Group 
One New York Plaza 
Suite 4500 
New York, NY 10004-1562 
USA 
T: 212-726-9230 
Email: Kathleen.Lyons@springernature.com 
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Appendix 8: Quality Assessment Tool for Studies with Diverse Designs (QATSDD) 
 
Instruction sheet 
 
Eligibility criteria for papers: 
 
1. Original research papers for inclusion into a systematic review  
2. Study design must be qualitative, quantitative or mixed methods 
 
Method: 
 
Scoring the studies: 
 
1. Read through the research paper carefully. 
2. There are 16 quality criteria in the tool; 14 of these criteria apply to 
qualitative studies, 14 apply to quantitative studies and all 16 apply to 
any mixed methods papers. The applicable questions are indicated in 
brackets in the grid under the item. 
3. Read each of the criteria and look at the descriptions under each score 
from 0-3 to find out what is required to obtain each score.   
4. Using the descriptions for each score to guide your response, give the 
paper a score from 0-3 on each item on your scoring grid.   
5. This will result in a score out of a maximum of 48 (16x3) for mixed 
methods papers, and 42 (14x3) for qualitative or quantitative papers. 
 
Comparing the quality of studies: 
 
1. In order to compare quality of the papers you should calculate what % of 
the maximum possible score was obtained see example below: 
 
A quantitative paper scores 39 out of 42 = 92.9% of the maximum quality score. 
 
This could be compared to a qualitative paper that scores 9 out of 42 = 21.4% of 
maximum quality score, suggesting that the quantitative work was of a higher 
quality. 
 
2. In addition you can calculate a quality score for all studies using the same 
design as a group e.g. the qualitative studies.  This allows comparisons to 
be drawn for example between the qualitative and quantitative papers. 
3. To do this you would take an average of the quality scores calculated for 
each paper for each group and then compare these. 
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Criteria 0 = Not at all 1 = Very slightly 2 = Moderately 3 = Complete 
1. Explicit theoretical 
framework 
No mention at all. Reference to broad 
theoretical basis. 
Reference to a specific theoretical 
basis. 
Explicit statement of theoretical 
framework and/or constructs applied 
to the research. 
2. Statement of 
aims/objectives in main 
body of report 
No mention at all. General reference to 
aim/objective at some 
point in the report 
including abstract. 
Reference to broad aims/objectives 
in main body of report. 
Explicit statement of aims/objectives 
in main body of report. 
3. Clear description of 
research setting 
No mention at all. General description of 
research area and 
background, e.g. ‘in 
primary care’. 
General description of research 
problem in the target population, 
e.g. ‘among GPs in primary care’. 
Specific description of the research 
problem and target population in the 
context of the study, e.g. nurses and 
doctors from GP practices in the east 
midlands. 
4. Evidence of sample size 
considered in terms of 
analysis 
No mention at all. Basic explanation for 
choice of sample size. 
Evidence that size of the 
sample has been 
considered in study 
design. 
Evidence of consideration of sample 
size in terms of 
saturation/information redundancy 
or to fit generic analytical 
requirements. 
Explicit statement of data being 
gathered until information 
redundancy/saturation was reached 
or to fit exact calculations for 
analytical requirements. 
5. Representative sample 
of target group of a 
reasonable size 
No statement of 
target group. 
Sample is limited but 
represents some of the 
target group or 
representative but very 
small. 
Sample is somewhat diverse but not 
entirely representative, e.g. inclusive 
of all age groups, experience but 
only one workplace. Requires 
discussion of target population to 
determine what sample is required 
Sample includes individuals to 
represent a cross section of the 
target population, considering factors 
such as experience, age and 
workplace. 
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to be representative. 
6. Description of 
procedure for data 
collection 
No mention at all. Very basic and brief 
outline of data collection 
procedure, e.g. ‘using a 
questionnaire distributed 
to staff’. 
States each stage of data collection 
procedure but with limited detail, or 
states some stages in details but 
omits others. 
Detailed description of each stage of 
the data collection procedure, 
including when, where and how data 
were gathered. 
7. Rationale for choice of 
data collection tool(s) 
No mention at all. Very limited explanation 
for choice of data 
collection tool(s). 
Basic explanation of rationale for 
choice of data collection tool(s), e.g. 
based on use in a prior similar 
study. 
Detailed explanation of rationale for 
choice of data collection tool(s), e.g. 
relevance to the study aims and 
assessments of tool quality either 
statistically, e.g. for reliability & 
validity, or relevant qualitative 
assessment. 
8. Detailed recruitment 
data 
No mention at all. Minimal recruitment 
data, e.g. no. of 
questionnaire sent and 
no. returned. 
Some recruitment information but 
not complete account of the 
recruitment process, e.g. 
recruitment figures but no 
information on strategy used. 
Complete data regarding no. 
approached, no. recruited, attrition 
data where relevant, method of 
recruitment. 
9. Statistical assessment 
of reliability and validity of 
measurement tool(s) 
(Quantitative only) 
No mention at all. Reliability and validity of 
measurement tool(s) 
discussed, but not 
statistically assessed. 
Some attempt to assess reliability 
and validity of measurement tool(s) 
but insufficient, e.g. attempt to 
establish test–retest reliability is 
unsuccessful but no action is taken. 
Suitable and thorough statistical 
assessment of reliability and validity 
of measurement tool(s) with 
reference to the quality of evidence 
as a result of the measures used. 
10. Fit between stated No research Method of data collection Method of data collection can Method of data collection selected is 
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research question and 
method of data collection 
(Quantitative) 
question stated. can only address some 
aspects of the research 
question. 
address the research question but 
there is a more suitable alternative 
that could have been used or used 
in addition.3 
the most suitable approach to 
attempt answer the research 
question 
11. Fit between stated 
research question and 
format and content of data 
collection tool e.g. 
interview schedule 
(Qualitative) 
No research 
question stated. 
Structure and/or content 
only suitable to address 
the research question in 
some aspects or 
superficially. 
Structure & content allows for data 
to be gathered broadly addressing 
the stated research question(s) but 
could benefit from greater detail. 
Structure & content allows for 
detailed data to be gathered around 
all relevant issues required to 
address the stated research 
question(s). 
12. Fit between research 
question and method of 
analysis 
No mention at all.  Method of analysis can 
only address the 
research question 
basically or broadly. 
Method of analysis can address the 
research question but there is a 
more suitable alternative that could 
have been used or used in addition 
to offer greater detail. 
Method of analysis selected is the 
most suitable approach to attempt 
answer the research question in 
detail, e.g. for qualitative IPA 
preferable for experiences vs. 
content analysis to elicit frequency of 
occurrence of events, etc. 
13. Good justification for 
analytical method selected 
No mention at all. Basic explanation for 
choice of analytical 
method 
Fairly detailed explanation of choice 
of analytical method. 
Detailed explanation for choice of 
analytical method based on nature of 
research question(s). 
14. Assessment of 
reliability of analytical 
process (Qualitative only) 
No mention at all. More than one 
researcher involved in 
the analytical process 
but no further reliability 
assessment. 
Limited attempt to assess reliability, 
e.g. reliance on one method. 
Use of a range of methods to assess 
reliability, e.g. triangulation, multiple 
researchers, varying research 
backgrounds. 
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15. Evidence of user 
involvement in design 
No mention at all. Use of pilot study but no 
involvement in planning 
stages of study design. 
Pilot study with feedback from users 
informing changes to the design. 
Explicit consultation with steering 
group or statement or formal 
consultation with users in planning of 
study design. 
16. Strengths and 
limitations critically 
discussed 
No mention at all. Very limited mention of 
strengths and limitations 
with omissions of many 
key issues. 
Discussion of some of the key 
strengths and weaknesses of the 
study but not complete. 
Discussion of strengths and 
limitations of all aspects of study 
including design, measures, 
procedure, sample & analysis. 
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Appendix 9: Research poster presented at the NSPKU national conference 
